
<html lang="en"     class="pb-page"  data-request-id="beb5df6e-150e-41c1-8a72-97897d4b52b6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00485;issue:issue:10.1021/jmcmar.2017.60.issue-14;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization" /></meta><meta name="dc.Creator" content="Agnès  Quéméner" /></meta><meta name="dc.Creator" content="Mike  Maillasson" /></meta><meta name="dc.Creator" content="Laurence  Arzel" /></meta><meta name="dc.Creator" content="Benoit  Sicard" /></meta><meta name="dc.Creator" content="Romy  Vomiandry" /></meta><meta name="dc.Creator" content="Erwan  Mortier" /></meta><meta name="dc.Creator" content="Didier  Dubreuil" /></meta><meta name="dc.Creator" content="Yannick  Jacques" /></meta><meta name="dc.Creator" content="Jacques  Lebreton" /></meta><meta name="dc.Creator" content="Monique  Mathé-Allainmat" /></meta><meta name="dc.Description" content="Interleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to IL-2 and shares with it the IL-2 β and γ receptor (R) subunits. By promoting the activation and proliferation of NK, NK..." /></meta><meta name="Description" content="Interleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to IL-2 and shares with it the IL-2 β and γ receptor (R) subunits. By promoting the activation and proliferation of NK, NK..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 18, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00485" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00485" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00485" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00485" /></link>
        
    
    

<title>Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00485" /></meta><meta property="og:title" content="Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0019.jpeg" /></meta><meta property="og:description" content="Interleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to IL-2 and shares with it the IL-2 β and γ receptor (R) subunits. By promoting the activation and proliferation of NK, NK-T, and CD8+ T cells, IL-15 plays important roles in innate and adaptative immunity. Moreover, the association of high levels of IL-15 expression with inflammatory and autoimmune diseases has led to the development of various antagonistic approaches targeting IL-15. This study is an original approach aimed at discovering small-molecule inhibitors impeding IL-15/IL-15R interaction. A pharmacophore and docking-based virtual screening of compound libraries led to the selection of 240 high-scoring compounds, 36 of which were found to bind IL-15, to inhibit the binding of IL-15 to the IL-2Rβ chain or the proliferation of IL-15-dependent cells or both. One of them was selected as a hit and optimized by a structure–activity relationship approach, leading to the first small-molecule IL-15 inhibitor with sub-micromolar activity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00485"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00485">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00485&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00485&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00485&amp;href=/doi/10.1021/acs.jmedchem.7b00485" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 14</span><span class="cit-fg-pageRange">, 6249-6272</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/14" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00497" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00584" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agn%C3%A8s++Qu%C3%A9m%C3%A9ner">Agnès Quéméner</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4026-8496" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike++Maillasson">Mike Maillasson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurence++Arzel">Laurence Arzel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Sicard">Benoit Sicard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romy++Vomiandry">Romy Vomiandry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erwan++Mortier">Erwan Mortier</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Dubreuil">Didier Dubreuil</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yannick++Jacques">Yannick Jacques</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacques++Lebreton">Jacques Lebreton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monique++Math%C3%A9-Allainmat">Monique Mathé-Allainmat</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">CRCINA, INSERM, CNRS, University of Nantes, Nantes 44007, France</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">CEISAM, CNRS, Faculty of Sciences, University of Nantes, Nantes 44322, France</span></div><div class="corresp-info"><strong>*</strong>For M.M. Mailing address: CNRS, Université de Nantes, Chimie et Interdisciplinarité: Synthèse, Analyse, Modélisation (CEISAM), UMR CNRS 6230, 2 rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France. Phone: +33 276 645 177. Fax: +33 251 125 402. E-mail: <a href="/cdn-cgi/l/email-protection#afc2c0c1c6dedaca81c2cedbc7caefdac1c6d982c1cec1dbcadc81c9dd"><span class="__cf_email__" data-cfemail="5b363435322a2e3e75363a2f333e1b2e35322d76353a352f3e28753d29">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For A.Q. Mailing address: INSERM, CNRS, Université de Nantes, Centre de Recherche en Cancérologie et en Immunologie Nantes Angers (CRCINA), INSERM UMR 1232, CNRS ERL 6001, Université de Nantes, IRS-UN, 8 quai Moncousu, BP 70721, 44007 Nantes Cedex 1, France. Phone: +33 228 080 306. Fax: +33 228 080 204. E-mail: <a href="/cdn-cgi/l/email-protection#3a5b5d545f49144b4f5f575f545f487a4f54534c17545b544e5f49145c48"><span class="__cf_email__" data-cfemail="18797f767d6b36696d7d757d767d6a586d76716e357679766c7d6b367e6a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00485&amp;href=/doi/10.1021%2Facs.jmedchem.7b00485" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 14</span><span class="cit-pageRange">, 6249–6272</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 28, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 April 2017</li><li><span class="item_label"><b>Published</b> online</span>18 July 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 July 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00485" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00485</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6249%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAgn%25C3%25A8s%2BQu%25C3%25A9m%25C3%25A9ner%252C%2BMike%2BMaillasson%252C%2BLaurence%2BArzel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D14%26contentID%3Dacs.jmedchem.7b00485%26title%3DDiscovery%2Bof%2Ba%2BSmall-Molecule%2BInhibitor%2Bof%2BInterleukin%2B15%253A%2BPharmacophore-Based%2BVirtual%2BScreening%2Band%2BHit%2BOptimization%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6272%26publicationDate%3DJuly%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00485"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2389</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00485" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Agnès&quot;,&quot;last_name&quot;:&quot;Quéméner&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;Maillasson&quot;},{&quot;first_name&quot;:&quot;Laurence&quot;,&quot;last_name&quot;:&quot;Arzel&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Sicard&quot;},{&quot;first_name&quot;:&quot;Romy&quot;,&quot;last_name&quot;:&quot;Vomiandry&quot;},{&quot;first_name&quot;:&quot;Erwan&quot;,&quot;last_name&quot;:&quot;Mortier&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Dubreuil&quot;},{&quot;first_name&quot;:&quot;Yannick&quot;,&quot;last_name&quot;:&quot;Jacques&quot;},{&quot;first_name&quot;:&quot;Jacques&quot;,&quot;last_name&quot;:&quot;Lebreton&quot;},{&quot;first_name&quot;:&quot;Monique&quot;,&quot;last_name&quot;:&quot;Mathé-Allainmat&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;14&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;6249-6272&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00485&quot;},&quot;abstract&quot;:&quot;Interleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to IL-2 and shares with it the IL-2 β and γ receptor (R) subunits. By promoting the activation and proliferation of NK, NK-T, and CD8+ T cells, IL-15 plays important roles in innate and adaptative immunity. Moreover, the association of high levels of IL-15 expression with inflammatory and autoimmune diseases has led to the development of various antagonistic approaches targeting IL-15. This study is an original approach aimed at discovering small-molecule inhibitors impeding IL-15/IL-15R interaction. A pharmacophore and docking-based virtual screening of compound libraries led to the selection of 240 high-scoring compounds, 36 of which were found to bind IL-15, to inhibit the binding of IL-15 to the IL-2Rβ chain or the proliferation of IL-15-dependent cells or both. One of them was selected as a hit and optimized by a structure–activity relationship approach, leading to the first small-molecule IL-15 inhibitor with sub-micromolar activ&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00485&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00485" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00485&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00485" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00485&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00485" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00485&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00485&amp;href=/doi/10.1021/acs.jmedchem.7b00485" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00485" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00485" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00485%26sid%3Dliteratum%253Aachs%26pmid%3D28657314%26genre%3Darticle%26aulast%3DQu%25C3%25A9m%25C3%25A9ner%26date%3D2017%26atitle%3DDiscovery%2Bof%2Ba%2BSmall-Molecule%2BInhibitor%2Bof%2BInterleukin%2B15%253A%2BPharmacophore-Based%2BVirtual%2BScreening%2Band%2BHit%2BOptimization%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D14%26spage%3D6249%26epage%3D6272%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291305" title="Cell physiology">Cell physiology</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/14" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/jmcmar.2017.60.issue-14/20170727/jmcmar.2017.60.issue-14.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Interleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to IL-2 and shares with it the IL-2 β and γ receptor (R) subunits. By promoting the activation and proliferation of NK, NK-T, and CD8+ T cells, IL-15 plays important roles in innate and adaptative immunity. Moreover, the association of high levels of IL-15 expression with inflammatory and autoimmune diseases has led to the development of various antagonistic approaches targeting IL-15. This study is an original approach aimed at discovering small-molecule inhibitors impeding IL-15/IL-15R interaction. A pharmacophore and docking-based virtual screening of compound libraries led to the selection of 240 high-scoring compounds, 36 of which were found to bind IL-15, to inhibit the binding of IL-15 to the IL-2Rβ chain or the proliferation of IL-15-dependent cells or both. One of them was selected as a hit and optimized by a structure–activity relationship approach, leading to the first small-molecule IL-15 inhibitor with sub-micromolar activity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">First identified as a T cell growth factor, interleukin (IL)-15 is a 14–15 kDa cytokine belonging to the IL-2 cytokine family and involved in the differentiation and proliferation of NK and T cells.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> IL-15 binds a trimeric IL-15 receptor (IL-15R) complex formed by a specific receptor chain (IL-15Rα) combined with the β and γ chains of the IL-2R, acting as signal transducing components. Binding of IL-15 to IL-2Rβ/γ induces Jak1 and Jak3 activation and subsequently phosphorylation of Stat3 and Stat5 (where Jak and Stat stand for Janus kinase and signal transducer and activators of transcription, respectively). High levels of IL-15 expression have been associated with the pathogenesis of autoimmune and inflammatory diseases like Crohn’s disease,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> psoriasis,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> leukemias,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> rheumatoid arthritis (RA),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and graft rejection,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> resulting in the IL-15 system being a target of interest for the treatment of these diseases. Several biological approaches have validated this concept <i>in vivo</i>, including the use of soluble forms of IL-15Rα, antagonist IL-15 mutants, IL-15- or IL-15R-directed monoclonal antibodies and fusion proteins that have proved effective in reducing RA in animal models.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> However, their therapeutic benefit in human diseases has not yet been demonstrated, and further studies and clinical trials are required in human systems to evaluate their safety and efficacy.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In this context, the design of small-molecule inhibitors of protein–protein interactions (PPIs) is an emerging and challenging research area,<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> which could be envisaged as an alternative approach to target the IL-15/IL-15R interfaces.</div><div class="NLM_p">In fact, potent small-molecule inhibitors of the IL-2/IL-2Rα interface have already been identified using fragment-based approaches<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> or library screening<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> combined with chemistry optimization. Moreover, the targeting of the IL-2Rβ chain by siRNA has been shown to be effective in reducing disease severity in adjuvant-induced arthritis in rats,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> highlighting the interest of IL-2Rβ as a therapeutic target for the treatment of RA. To date, no small-molecule inhibitor of the IL-15 system has been reported, nor has the targeting of the IL-2Rβ interface been explored by a PPI approach. This work is the first attempt to discover such low MW nonpeptidic inhibitors by targeting the IL-15/IL-2Rβ interface. For this purpose, a pharmacophore model was built (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) based on IL-15 specific residues<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> involved in this interface and was used to screen virtually commercial and academic chemical databases (ca. 160 000 compounds). The resulting filtered libraries were subsequently docked to the binding site of IL-15 with IL-2Rβ, and the best-docked compounds were retained. On the basis of experimental <i>in vitro</i> properties such as the capacity to bind to IL-15, to reduce the binding of IL-15 to IL-2Rβ, or to inhibit the proliferation of IL-15-dependent cells, one hit was chosen among 240 purchased compounds. After chemical optimization of its structure, this led to the development of a low MW inhibitor of the IL-15/IL-15R system with sub-micromolar efficiency.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IL-2– and IL-15–IL-2Rβ interfaces and pharmacophore model. (A) Ribbon diagram of IL-2 in complex with IL-2Rβ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I">2B5I</a>) and (B) of IL-15 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q">2Z3Q</a>) showing the side chains of Asp20 (D20), Asn88 (N88) and Ile92 (I92) of IL-2 involved in the hydrogen bonding networks to 2 water molecules and Gln70 (Q70) and Tyr134 (Y134) of IL-2Rβ, and the homologous residues Asp8 (D8), Asn65 (N65) and Leu69 (L69) of IL-15. (C) Pharmacophore model used for database searches. HB donor projection (HBD) indicated as pink spheres, HB donor or acceptor (HBDA) projection as a purple sphere, hydrophobic feature (HY) as a cyan sphere, and exclusion spheres in gray.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27150" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27150" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3">2.1 Pharmacophore-Based and Docking-Based Virtual Screening</h3><div class="NLM_p">In order to disrupt IL-15/IL-15R recognition and impede IL-15 signaling, our approach was to use small MW molecules to target one of the IL-15 domains that are interacting with the signal transducing receptor chains IL-2Rβ or IL-2Rγ. The IL-15/IL-2Rγ interface was set aside to avoid specificity problems due to the sharing of this receptor chain by numerous other cytokine systems (IL-15, IL-2, IL-4, IL-7, IL-9, and IL-21).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, we chose to target the IL-15/IL-2Rβ binding domain, a strategy that has not yet been described in the literature.</div><div class="NLM_p">Our virtual screening strategy consisted of using pharmacophore searching and docking methods. The 3D structure of IL-15 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q">2Z3Q</a>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was used to generate a pharmacophore model based on three residues, Asp8, Asn65, and Leu69, previously shown by directed-mutagenesis studies<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> or by homology to the IL-2/IL-2Rβ complex<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> to be involved in the binding of IL-15 to IL-2Rβ. Comparison of IL-15 and IL-2 structures after superimposition of IL-15 onto IL-2 in the tetrameric complex structure IL-2–IL-2Rα/β/γ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I">2B5I</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (available at the time of this work unlike that of the IL-15 tetrameric complex)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> led us to consider (a) an additional orientation for the side chain of Asn65, similar to that of its homologous Asn88 in IL-2 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A) and (b) the potential participation of two water molecules close to residues Asp8 and Asn65 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B). The final model consisted of three main features (one projection of hydrogen bond donor (HBD) and one projection of hydrogen bond donor or acceptor (HBDA) centered on Asp8 and one hydrophobic feature in front of Ile68 and Leu69) completed by ten exclusion spheres centered on the main residues of the defined binding site. In addition, three accessory features (one projection of HBD centered on Asn65, considering two side chain orientations, and finally two projections of HBDA placed on both water molecules) were created (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C). The pharmacophore model was used to search a database of 160 828 chemical compounds derived from commercial (Chembridge, Maybridge, and Preswick) or academic libraries (National Cancer Institute (NCI) and the French national chemical library Chimiothèque Nationale). To be retained, a hit had to match at least the main features, whereas the presence of the accessory features was not mandatory. A total of 24 115 molecules were returned by the pharmacophore searching and were subjected to docking-based virtual screening using the LigandFit program implemented under Discovery Studio (DS) 3.0 (Accelrys Software Inc., San Diego, CA). More than 30% of the filtered molecules passed the docking stage and were ranked using 5 scoring functions. A consensus strategy was adopted (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>), and the 240 top-ranked molecules were purchased (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Table S1</a>). They were first tested at a concentration of 100 μM for their ability to bind to IL-15 using the surface plasmon resonance (SPR) technology (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A) or to inhibit the binding of IL-15 to soluble IL-2Rβ in a homogeneous time resolved fluorescence (HTRF) assay (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). Thirty-six compounds were found to bind to IL-15 as well as to our IL-15 superagonist RLI (a fusion protein linking IL-15 to the IL-15Rα sushi domain)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A,B), thus discarding any binding of compounds to IL-15 at its interface with IL-15Rα. Some were also shown to reduce the FRET signal induced by the interaction between recombinant IL-2Rβ and IL-15 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D). To evaluate their impact on a specific IL-15 functional effect, we further tested these hits for their ability to inhibit IL-15-dependent cell proliferation. Most of them were inhibitors and five of them showed IC<sub>50</sub> values around or below 10 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S2</a>). One of these, named compound <b>1</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), was selected for chemical optimization. Its binding mode to the IL-15 structure was predicted by a molecular docking technique using LigandFit and C-Docker programs. The interactions<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> involved, as predicted by the last fine docking step, were π–alkyl hydrophobic interactions with residues Ile68 and Leu69, an amide−π stacked interaction with the Ser7 and Asp8 peptidic bond, a hydrogen bond (HB) with Asp8, and a carbon HB with Asn65 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR analysis and HTRF assays. SPR sensorgrams of binding to immobilized IL-15 with (A) one concentration of 100 μM or (B) increasing concentrations (3.125, 6.25, 12.5, 25, 50, and 100 μM) of one positive compound. (C) HTRF principle with Lumi4-Tb-NHS cryptate (Tb) and D2 as donor and acceptor, respectively. If the labeled soluble IL-2Rβ binds to biotinylated IL-15, the two fluorophores will be in close proximity to allow FRET to occur, which results in a specific long-lived fluorescence emission of D2 at 665 nm. A chemical inhibitor binding to IL-15 will modify the intensity of the fluorescence emission. (D) An example of HTRF screening of a hundred small molecular compounds against IL-15/IL-2Rβ interaction. Data are normalized based on negative (○) and positive (□) controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of the selected hit <b>1</b> with three modulable fragments and both chemical disconnections considered (route 1 and route 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of compound <b>1</b>. (A) Binding mode of compound <b>1</b> as predicted by LigandFit and C-Docker docking simulation. Compound <b>1</b> made π–alkyl hydrophobic interactions with residues Ile68 (I68) and Leu69 (L69), an amide−π stacked interaction with Asp8 (D8) and Ser7 (S7) peptidic bond, a HB with Asp8 (D8), and a carbon HB with Asn65 (N65, the distance between the hydrogen and acceptor atoms is 2.690 Å). (B) Two views of the Connolly surface of IL-15 colored according to the hydrophobicity index of the exposed residues (hydrophobic in brown; hydrophilic in blue) showing the environment of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.2 Synthesis</h3><div class="NLM_p">Among the identified hits, the chemical structure of compound <b>1</b> emerged as a good platform to initiate synthetic modifications to improve its biological activity. The chemical structure of this compound can be regarded as the association of three fragments: a dihydro-phthalazinone tethered to a triazole moiety, which can be considered the main core of the molecule, a terminal aromatic group, and an alkyl linker chain to join both parts of the molecule through S–C bond and amide bond formation (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). To the best of our knowledge, the synthesis of compound <b>1</b> has never been described in the literature, and we began our synthetic work to define the best strategy to access this hit. A good and combinatorial approach consisted of condensing anilines with a carboxylic acid derived from the <i>S</i>-alkylation of the main dihydro-phthalazinone core with bromoacetic acid (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, route 1). Although this carboxylic acid derivative could easily be prepared with a 60% yield in Williamson-type alkylation conditions,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> all attempts to access to the amide <b>1</b> in common coupling conditions with carbodiimide reagents<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> and 2,4-dichloroaniline failed. We thus turned to a second strategy, exploring the <i>S</i>-alkylation of the dihydro-phthalazinone main core with a variety of halogenoalkylamides previously prepared (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>, route 2).</div><div class="NLM_p">The key dihydro-phthalazinone intermediates <b>4</b> and <b>5</b> were prepared from conjugated ester <b>2-</b><i><b>E</b></i> obtained by Wittig olefination of phthalic anhydride with the (carbethoxymethylidene)triphenylphosphorane.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Successive additions of methylhydrazine and hydrazine<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in a one-pot, two-step manner afforded the phthalazinone hydrazide <b>3</b> in good yield. This latter intermediate was condensed with methyl isothiocyanate<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to give the mercapto-triazole main intermediate <b>4</b> or with CS<sub>2</sub> in the presence of KOH to afford oxadiazole <b>5</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Phathalazinone Main Cores <b>4</b> and <b>5</b> of the Targeted Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P═CHCOOEt (1 equiv), toluene, 3 h, then reflux 30 min, 90% yield; (b) MeNHNH<sub>2</sub> (1 equiv), EtOH, rt, 30 min, then NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O (4 equiv), reflux, 2 h, 97% yield; (c) MeNCS (5 equiv), Et<sub>3</sub>N (5 equiv), EtOH, reflux, 5 h, 99% yield; (d) CS<sub>2</sub>, KOH (2.5 equiv), reflux, 3 h, 65% yield.</p></p></figure><div class="NLM_p">Next, halogenoalkylamide linkers <b>6</b>–<b>24</b> and <b>27</b>–<b>38</b> were obtained from commercially available bromoalkyl carboxylic acids activated as their acid chloride and coupled to the selected amines, mainly substituted anilines but also hydrophobic amines such as 1-adamantylamine or 1-naphthylamine (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). To substitute hydrophobic halogenes at the terminal aromatic part of the molecule with hydrophilic substituents, dimethoxy compound <b>24</b> was subjected to a demethylation step in the presence of BBr<sub>3</sub> to give the phenolic derivatives <b>25</b> and <b>26</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Because all attempts to prepare the <i>N</i>-methylamide analog <b>47</b> later from the hit <b>1</b> failed, we had to introduce the <i>N</i>-methyl group earlier by methylation of the alkylating agent <b>6</b> with an excess of methyl iodide. This alkylation step was also reluctant and iodo amide <b>39</b> was isolated in poor yield (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). However, it should be noted that the amide compound <b>43</b> bearing a longer alkyl linker chain than <b>1</b>, could easily be <i>N</i>-methylated in mild conditions (NaH, MeI, DMF, 0 °C) to give derivative <b>63</b> in 74% yield.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Halogenoalkylamide Reagents <b>6–39</b> and the Azide Reagent <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub> (1.2 equiv), DMF cat, DCM, rt, 18 h; (b) RNH<sub>2</sub>, Et<sub>3</sub>N (5 equiv), THF, rt, 3–24 h, 20–93%; (c) MeI (5 equiv), K<sub>2</sub>CO<sub>3</sub> (1.2 equiv), DMF, 40 °C, 4 h, 8%; (d) NaN<sub>3</sub> (5 equiv), DMF, 80 °C, 1 h, 72%.</p></p></figure><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Demethylation of Amide <b>24</b> with BBr<sub>3</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a final step, hit <b>1</b> and its analogs <b>41</b>–<b>54</b>, <b>56</b>, <b>64</b>, <b>66</b>–<b>78</b>, and <b>86</b>–<b>90</b> were obtained by <i>S</i>-alkylation of the phathalazinone intermediate <b>4</b> with the appropriate bromoalkylamide reagents (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a> and <a class="ref internalNav" href="#sch5" aria-label="5">5</a>a,b). In some cases, a small amount of <i>N</i>-alkylation of the phthalazinone intermediate <b>4</b> could be observed due to the tautomeric properties of the 3-mercapto-1,2,4-triazole ring.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In similar conditions, oxadiazole analogs <b>85</b> and <b>91</b> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>c) were prepared starting from the thiol <b>5</b>.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <i>S</i>-Alkylation Step of Thiol <b>4</b>, with the Bromoalkylamides <b>6</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <i>S</i>-Alkylation Step of Thiols <b>4</b> and <b>5</b> with Alkyl Halides</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Variations at the terminal arylamide part of some compounds were achieved starting from aryl ether or benzoate compounds. Following demethylation of compounds <b>51</b> and <b>74</b> in the presence of BBr<sub>3</sub>, phenol intermediates <b>57</b> and <b>79</b> could react with suitable alkylating agents to give the corresponding phenolic ether analogs <b>58</b>–<b>60</b> and <b>80</b>–<b>82</b> in good yields (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). On the other hand, benzoic acid derivatives <b>61</b>, <b>62</b>, and <b>83</b> were obtained from hydrolysis of the corresponding esters <b>52</b>, <b>53</b>, and <b>75</b> with LiOH (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Demethylation Step of Compounds <b>51</b> and <b>74</b>, To Access the Targeted Final Hydroxy Analogs <b>57</b> and <b>79</b> and Alkoxy Analogs <b>58–60</b> and <b>80–82</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0012.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Hydrolysis of Benzoate Derivatives <b>52</b>, <b>53</b>, and <b>75</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because the 1,2,3-triazole ring system has received considerable interest in medicinal chemistry due to its versatile potential to interact with biological systems through dipolar interactions and hydrogen bonding,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> we opted for the formation of this heterocycle to replace the terminal amide bond function or to be introduced into a long alkyl chain linker. For this purpose, we prepared the azide <b>40</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) and the alkyne <b>55</b>, which were involved in a Huisgen 1,3-dipolar cycloaddition under copper catalysis<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and gave access to compound <b>84</b> with 60% yield. Starting from commercially available 1-azidoadamantane, the intermediate <b>55</b> reacted in the same conditions to form compound <b>56</b>, the 1,2,3-triazole analog of <i>N</i>-1-adamantyl amide <b>54</b> (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>).</div><figure id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0013.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of the 1,2,3-Triazole Derivatives <b>56</b> and <b>84</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuSO<sub>4</sub>·5H<sub>2</sub>O (0.01 equiv), sodium ascorbate (0.1 equiv), <i>t</i>BuOH/H<sub>2</sub>O (1:1), 60 °C, 20 h, <b>56</b> (61%) and <b>84</b> (60%).</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">2.3 Structure–Activity Analyses</h3><div class="NLM_p">To date, to the best of our knowledge, no IL-15 selective inhibitor with low MW has been described in the literature. This work therefore opens the way to the first <i>in vitro</i> SAR study to provide crucial information on the key binding interactions of IL-15 with its IL-2Rβ binding site. Each fragment of compound <b>1</b> could be subjected to pertinent modifications, but among the available options, we focused this preliminary work on the study of the functional impact of the length of the alkyl linker and of the structure of the terminal amidic group. The effectiveness of the novel compounds was evaluated using the IL-15-dependent cell proliferation assay and, for the best of them, by SPR technology and the Stat5 phosphorylation assay.</div><div class="NLM_p">The binding properties of the compounds were first monitored by SPR. Given that the binding domains of IL-15 and IL-2 with IL-2Rβ show high similarity, we chose to study compound activity systematically on both cytokine systems to provide the opportunity to detect potential selective compounds rapidly. In the SPR assay, the compounds were flowed over a chip’s surface, on which RLI or IL-2 had previously been coupled. Binding of compounds induced a change in mass on the chip, which was detected by the change in reflectance units (RU). Direct interaction of compound <b>1</b> with immobilized RLI or IL-2 gave similar <i>K</i><sub>d</sub> values in the 10 μM range (48 and 10 μM, respectively). In the case of RLI, consisting of IL-15 bound to IL-15Rα, the binding of compound <b>1</b> could not have occurred on the IL-15 binding domain to IL-15Rα because the latter was no longer accessible.</div><div class="NLM_p">For further classic SAR exploration, we preferred to perform a functional and cellular assay with the aim of identifying a potential drug candidate. For this purpose, we first tested our hit <b>1</b> analogs, compounds <b>41</b>–<b>54</b> and <b>56</b>–<b>91</b>, for their potency in inhibiting cell proliferation induced by a fixed concentration (close to their respective EC<sub>50</sub> values) of RLI (100 pM) or IL-2 (1.5 nM) on 32Dβ cells that express IL-2Rβ/γ. RLI was preferred to IL-15 because of its better efficacy (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S3</a>).<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> In addition, the main compounds were checked for their lack of cytotoxicity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S4</a>).</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.3.1 Probing the Linker to Interact with a Lipophilic Pocket</h4><div class="NLM_p">Based on our binding model (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), it appeared that the main phthalazinone-triazole core of compound <b>1</b> was involved in major interactions with specific residues of the binding site, such as π–alkyl hydrophobic interactions with Ile68 and Leu69 and carbon HB with Asn65. Furthermore, the model revealed a large hydrophobic patch formed by residues Val3, Ile6, Val104, and Ile111 close to the predicted location of the terminal aromatic group of compound <b>1</b>, which could be targeted for compound optimization. We reasoned that considering the bis-cyclic aromatic part to be the main anchorage of the hit <b>1</b>, lengthening the alkyl chain could increase the affinity and activity through additive interactions with the lipophilic channel. We therefore prepared compounds <b>41</b>–<b>46</b>, which are analogs of compound <b>1</b> bearing an alkyl chain with 3–15 methylene groups.</div><div class="NLM_p">In the proliferation cellular assay, the IC<sub>50</sub> value followed an inverted bell-shaped curve when the length of the alkyl chain was increased (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S5</a>), decreasing from 17.3 μM (<i>n</i> = 1) to 1.9 μM (<i>n</i> = 7) and increasing back to 7.3 μM (<i>n</i> = 15) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Increasing the alkyl chain therefore led to a gain of 1 order of magnitude in activity potency and identified compounds <b>43</b>–<b>45</b> as potential leads (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). We prepared compound <b>46</b> with a long chain (<i>n</i> = 15) to test the limit of such chemical modification. Surprisingly, compound <b>46</b> kept the activity, suggesting a good adaptation of this long flexible lipophilic chain probably in a folded form. However, no IL-15 versus IL-2 selectivity could be observed at this stage, and the best IC<sub>50</sub> values of 1.9 and 1.1 μM for the inhibition of IL-15- and IL-2-induced cell proliferation, respectively, were obtained with compound <b>43</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Inhibition of 32Dβ Cell Proliferation with Compound <b>1</b> and Its Homologs <b>41–46</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center" char=".">RLI<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">IL-2<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">17.3</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">All values are the mean of two or more independent assays.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Inhibition of 32Dβ cell proliferation induced by RLI (0.1 nM).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Inhibition of 32Dβ cell proliferation induced by IL-2 (1.5 nM).</p></div></div></div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.3.2 SAR Study around the Terminal Amidic Part of the Molecules</h4><div class="NLM_p">The terminal amidic part of the molecules was predicted to form a stacking interaction between its substituted terminal phenyl ring and the Ser7 and Asp8 peptidic bond and an H bond between its amide function and the carboxyl function of Asp8 of IL-15. Accordingly, the <i>N</i>-methylation of the amide function (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compound <b>47</b>) decreased the inhibitory effect. Unexpectedly, the substitution of both 2,4-chloro substituents with various halogens such as bromide or fluoride (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compounds <b>48</b> and <b>49</b>) gave the same results. We next focused on the para position of the terminal phenyl group, which appeared not far from lipophilic residues such as Ile6 and Val104 in the structure of IL-15 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). We therefore introduced hydrophobic substituents such as iodide (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A, compound <b>50</b>) or alkoxy substituents with variable alkyl chains (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compounds <b>51</b>, <b>58</b>–<b>60</b>). To complete the series, we also selected the adamantane moiety as an interesting lipophilic and steric system to substitute the terminal phenyl group (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compound <b>54</b>). Uniformly, no improvement in the activity was observed compared to compound <b>1</b>, and neither with compound <b>56</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A), with a triazole ring in place of the amide function in <b>54</b>. Finally, to try to favor HB interaction with Lys11, carboxylic and ester functions were introduced into the ortho (compounds <b>52</b> and <b>61</b>) or meta (compounds <b>53</b> and <b>62</b>) positions of the aromatic phenyl cycle but such modifications were detrimental for the activity because no more effect was observed (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). In this series, all attempts to improve the biological results failed. Because the IC<sub>50</sub> value of the hit compound <b>1</b> was close to the limit of sensitivity of the cell proliferation assay, the SAR study of that series of compounds (<i>n</i> = 1) could not be refined up to 30 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of IL-15-dependent cell proliferation and Stat5 phosphorylation. (A–F) 32Dβ cell proliferation induced by a fixed concentration of RLI (100 pM) and increasing concentrations of indicated compounds was assessed by the Alamar Blue reduction assay. Data show the inhibitory effect of indicated compounds calculated as the percentage of reduction of the proliferative effect of RLI (100 pM). (G, H) Phosphorylation of Stat5 was evaluated in NK-92 cells stimulated for 1 h by a fixed concentration of IL-15 (50 pM) after a 30 min incubation with increasing concentrations of indicated compounds. Data show the inhibitory effect of indicated compounds calculated as the percentage of reduction of the p-Stat5 response induced by 50 pM of IL-15. All data are the mean ± SEM of at least 3 independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Study with Analogs of the Selected Compounds <b>1</b>, <b>43</b>, and <b>45</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0015.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0016.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">All values are the mean of at least two independent assays.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Inhibition of 32Dβ cell proliferation induced by RLI (100 pM).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Inhibition of 32Dβ cell proliferation induced by IL-2 (1.5 nM).</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Compound <b>63</b> was prepared by <i>N</i>-methylation of amide <b>43</b> in DMF, in the presence of NaH (1 equiv) and MeI (2 equiv).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Compound <b>65</b> was prepared by <i>S</i>-oxidation of thioether <b>64</b> in dichloromethane in the presence of 5 equiv of <i>m</i>CPBA.</p></div><div class="footnote" id="t2fn7"><sup>Table f</sup><p class="last">Compounds were tested in only one experiment in triplicate.</p></div><div class="footnote" id="t2fn6"><sup>Table g</sup><p class="last">ND, not determined; NE, no effect.</p></div></div><div></div></div><div class="NLM_p">We then performed modulations on compounds <b>43</b> (<i>n</i> = 7) and <b>45</b> (<i>n</i> = 10) by varying the terminal amidic part of the molecules. As both compounds had a longer aliphatic linker, it could be expected that this lipophilic part of the molecule would interact more efficiently with the hydrophobic channel formed by residues Val3, Ile111, Ile6, and Val104 of IL-15. The investigation first focused on the 2- and 4-chloro substituents of the phenyl group as explored with hit <b>1</b>. From the 2,4-dichlorophenyl analog <b>45</b> (<i>n</i> = 10), deletion of one chloro substituent in the para (compound <b>86</b>) or ortho (compound <b>87</b>) positions of the phenyl group afforded compounds that were three times less potent, which was not observed with the monochloro analog <b>71</b> of compound <b>43</b> (<i>n</i> = 7), which retained a good antiproliferative activity (IC<sub>50</sub> = 0.8 μM, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Substitution of the phenyl ring of <b>45</b> with hydrophobic and bulky groups, such as the naphthyl and adamantyl rings retained the activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, compounds <b>88</b> and <b>89</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C), but surprisingly, deletion of this hydrophobic amidic part of the molecule in compound <b>45</b> to give the <i>S</i>-decyl analog <b>90</b> did not dramatically affect the results (IC<sub>50</sub> around 10 μM, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C).</div><div class="NLM_p">We then turned our attention to the SAR on the terminal phenyl group of our best lead compound <b>43</b> (<i>n</i> = 7). Replacement of one or both chloro substituents with bromide or fluoride (compounds <b>64</b> and <b>66</b>), an apolar group such as methyl (compounds <b>67</b>), or a substituent such as methoxy (compounds <b>68</b> and <b>69</b>) was uniformly tolerated by both IL-15 and IL-2 systems, with IC<sub>50</sub> values in the micromolar range (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Deletion of the chloro substituent at the 2-position of the phenyl ring to give the 4-chloro phenyl compound <b>71</b> or analogs bearing apolar or polar systems (compounds <b>72</b>–<b>74</b>) also showed similar activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D). The azide analog <b>73</b> has been developed as a potential partner for a cross-linking study with the IL-15 protein (data not shown). At this stage, we could conclude that the terminal amidic part of the leads <b>43</b> and <b>45</b> bearing a long alkyl chain did not appear to be crucial for anchorage on the binding site. Nevertheless, simple <i>N</i>-methylation of the amide function of our lead compound <b>43</b> (compound <b>63</b>) as well as 2- and 4- mono- or disubstitution with a hydroxyl function (compounds <b>70</b>, <b>75</b>, and <b>79</b>), caused an approximately 10-fold decrease in the biological activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). These results observed with phenolic compounds suggested that binding to the protein was highly sensitive to acidic functions. This was confirmed with the ester analog <b>76</b>, whose acidic form <b>83</b> showed no effect. Moreover, the ethyl ester <b>76</b> was identified as one of the best products tested with an IC<sub>50</sub> value of 0.8 μM (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p last">Starting with the inactive phenol analog <b>79</b>, alkylation with short alkyl chains such as methyl, propyl, isopropyl, or isobutyl restored the activity (compounds <b>74</b>, <b>80</b>–<b>82</b>, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>E). Furthermore, as observed with compound <b>45</b>, substitution of the phenyl ring with a bulky lipophilic substituent such as naphthyl (compounds <b>77</b> and <b>88</b>) or adamantyl (compounds <b>78</b> and <b>89</b>) preserved the activity, and uniformly higher efficiency was observed with analogs with the seven-membered chain (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C).</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.3.3 Modification of the Mercapto Triazole Part of Compounds <b>43</b> and <b>45</b></h4><div class="NLM_p">Suspecting potential biological oxidative events in cellular assays, we reacted the dibromo compound <b>64</b> in a chemical oxidation step with <i>meta</i>-chloroperbenzoic acid to afford the sulfone derivative <b>65</b>. Interestingly, the same results were obtained with the alkylsulfide parent <b>64</b> and its sulfone <b>65</b>, on IL-15 as well as on IL-2. As observed in our binding model (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>), the sulfur atom is surrounded by two asparagine residues, Asn65 and Asn4, which constitute a favorable environment for the oxygen of <b>65</b> to make a HB.</div><div class="NLM_p last">However, in relation to the model, a carbon HB with Asn65 and the methyl group of the <i>N</i>-methyl triazole moiety was predicted. Consequently, we wanted to study the substitution of this <i>N</i>-methyl system with an oxygen atom and so prepared the oxadiazole analogs <b>85</b> and <b>91</b> of the corresponding triazole compounds <b>43</b> and <b>45</b>. No drastic decrease of the IC<sub>50</sub> values was observed, and oxadiazole <b>85</b> appeared as one of the best compounds tested, with an IC<sub>50</sub> of 0.8 μM on both interleukins (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>F). The formation of a HB bond between the amine function of Asn65 residue and the oxygen of the oxadiazole ring could explain this result. Because no IL-15 versus IL-2 selectivity could be observed, we did not go further with the oxadiazole series.</div></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.3.4 Measurement of Direct Interaction and Pharmacological Effect of Selected Compounds on IL-15 and IL-2 Systems</h4><div class="NLM_p">We further analyzed our best compounds using two supplementary cytokine specific assays. We first compared them based on their direct binding to RLI or IL-2 using the SPR technology and then measured their potency in reducing the phosphorylation of Stat5, a signal transducer that is activated when IL-15 or IL-2 binds to its respective receptor expressed at the surface of NK-92 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Figure S7</a>).</div><div class="NLM_p">The advantage of the p-Stat5 assay over the cell proliferation assay used in the first SAR study is that the readout is obtained over a short time (1 h), close to the initial cytokine receptor binding event, and does not result from the sum of several downstream signaling reactions, occurring in cascade or in parallel. Thus, the p-Stat5 assay represents a specific biological test more adapted to a fine study of SAR in a series of compounds.</div><div class="NLM_p">The great majority of the selected compounds displayed <i>K</i><sub>d</sub> values for RLI binding of around 10–20 μM, close to those for IL-2 binding, when measured (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The compound displaying a somewhat weaker affinity (78 μM) in this series (<i>n</i> = 7) was the adamantyl derivative <b>78</b>. This was probably due to the bulky nature of the tricyclic moiety, compared to the aromatic phenyl one. Interestingly, lengthening the central alkyl linker to give the adamantyl analog <b>89</b> (<i>n</i> = 10) decreased the <i>K</i><sub>d</sub> value to 16 μM, suggesting a better hydrophobic interaction with the binding site on IL-15, possibly near the hydrophobic patch formed with residues Val3, Ile111, Ile6, and Val104.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacological Data of Selected Potent Compounds<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0018.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">All values are the mean of two or more independent assays.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">ND = not determined.</p></div></div><div></div></div><div class="NLM_p">Regarding the <i>in vitro</i> functional p-Stat5 results, the IC<sub>50</sub> values measured were mainly around 1 order of magnitude lower than those found in the cell proliferation test (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). This could be explained by the shorter incubation time (1 h versus 2.5 days for p-Stat5 and cell proliferation, respectively), which could have a different impact on compound integrity and efficiency. Overall, these biological results in accordance with those previously obtained in the cell proliferation assay, confirmed the gain in efficacy by lengthening the central alkyl chain of compound <b>1</b> or <b>54</b> to afford the dichlorophenyl analogs <b>43</b> and <b>45</b> or the adamantyl analogs <b>78</b> and <b>89</b>, respectively (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>G). Here too, SAR studies with both series (<i>n</i> = 7 and <i>n</i> = 10), did not reveal a unique lead compound (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). However, the best results were obtained with the phenoxy derivatives <b>80</b> and <b>82</b> and the ethyl ester analog <b>76</b> with p-Stat5 inhibitory potencies of around 50 nM (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In the ether series, compounds with alkyl chains having fewer than three extended carbons with or without ramification, such as methoxy <b>74</b> and isopropoxy <b>81</b>, were the least efficient (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>H). The ester <b>76</b> could be classified as the best compound in this study with p-Stat5 inhibitory efficiencies of 57 and 43 nM with IL-15 and IL-2 respectively, and a cell proliferation IC<sub>50</sub> of 0.8 μM with both cytokines.</div><div class="NLM_p">Taken together, these results led to the discovery of the first small-molecule inhibitors of the IL-15 system showing efficacies in the 50 nM range in a p-Stat5 assay and in the micromolar range in a cell proliferation assay as observed with the ester <b>76</b> and the alkoxy derivatives <b>80</b> and <b>82</b>. These compounds also proved to be effective on the IL-2 system. It should be noted that similar affinity or activity values were described in earlier studies for nonpeptidic small-molecule inhibitors of IL-2, in that case targeting specifically the IL-2/IL-2Rα interface.<a onclick="showRef(event, 'ref15 ref16 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref40 ref41">(15, 16, 40, 41)</a></div><div class="NLM_p last">Ongoing clinical trials are being conducted with humanized Mik-Beta-1 antibody (Hu-Mik-Beta1) directed against IL-2Rβ, which targets both IL-15 and IL-2 systems. This antibody is currently being tested in patients with arthritis, celiac disease, multiple sclerosis, and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> (<a href="https://clinicaltrials.gov/" class="extLink">clinicaltrials.gov</a>) and has also been previously shown to prolong primate cardiac allograft survival.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Taking advantage of their combined profile, the kind of inhibitors described in this study may be of therapeutic value in pathologies where both cytokines have been shown to be involved such as RA,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> HAM/TSP, inflammatory bowel disease, or multiple sclerosis.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">3 Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03405" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03405" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the present study, we report the development process of hit optimization from structure-based drug virtual screening to small-molecule compounds blocking the interaction of IL-15 to its receptor with sub-micromolar efficiency. This is the first and successful attempt to target the IL-15 system by a PPI inhibitor approach, which opens the way for the identification of new classes of therapeutic drugs for IL-15 related pathologies such as RA or graft rejection. Binding and biological cell proliferation assays led to the selection of one hit among a number of compounds initially selected by virtual screening. This hit has an inhibitory activity in the 10 μM range and was used as a starting template for lead discovery. Pharmacomodulation studies around the linker chain and the terminal amidic part of the hit led to inhibitors with IC<sub>50</sub> values close to 50 nM in cell-based experiments, nevertheless showing the same activity on the IL-2 system. Having now identified the first class of small-molecule inhibitors of the IL-15/IL15R system, we are currently investigating the development of analogs with higher IL-15 selectivity, to rule out possible side effects to specific IL-2 blockade, such as the decrease of regulatory T cells.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">4 Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41843" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41843" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.1 Computational Study</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.1.1 Pharmacophore Modeling</h4><div class="NLM_p last">At the time of this work, the structure of IL-15 in complex with IL-2Rβ was not yet available. The X-ray crystal structure of IL-15 extracted from the structure of the IL-15/IL-15Rα complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q">2Z3Q</a>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was thus used. The protein structure was first prepared by adding the hydrogen atoms, removing the water molecules, and inserting the missing loop regions using the Prepare Protein tool within DS3.0. After a series of energy minimizations carried out with CHARMM force field and Steepest Descent algorithm implemented into DS3.0, the protein was used for generating a pharmacophore model using the Structure Based Pharmacophore tool within DS3.0. Pharmacophore models were created from the binding site of IL-15 with IL-15Rβ based on “hot spot” residues (Asp8, Asn65, and Leu69). The superimposition of IL-15 onto IL-2 in the tetrameric complex structure IL-2–IL-2Rα/β/γ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I">2B5I</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> had led us to consider an additional orientation for the side chain of residue Asn65 of IL-15, similar to that of its homologous IL-2 residue Asn88. Moreover, the X-ray crystal structure of IL-2–IL-2R complex shows two water molecules involved in the hydrogen bonding networks between Asp20 and Asn88 (IL-2 counterpart of Asp8 and Asn65 of IL-15) and the side chains of IL-2Rβ. Thus, two water molecules close to residues Asp8 and Asn65 of IL-15 were also taken into consideration. The pharmacophore model was built using hydrogen bond donor (HBD), hydrogen bond donor and acceptor (HBDA), and HY (hydrophobic) features on the basis of the four IL-15 residues, Asp8, Asn65, Ile68 and Leu69. Two HBD projections were centered on OD1 atoms within residues Asp8 and Asn65 (two orientations of its side chain considered) and a HBDA projection on OD2 atom within residue Asp8, and all were located within a sphere of 2.2 Å radius. The HY feature was manually created at distances of 5.062, 4.554, and 6.346 Å from carbon α (CA) atoms of residues Ile68, Leu69, and Asn65, respectively. Exclusion spheres of 1.6 Å radius were generated, centered on carbon β (CB) atoms of residues Asn1, Asn4, Ser7, Asp8, Thr62, Asn65, Ile68, Leu69, and Asn72 and on carbon γ (CG) atom of Lys11. Two HBDA projections were placed on water molecules 147 and 148. Finally, virtual screening was done using as main features HBD and HBDA projections on Asp8, the HY feature, and the exclusion spheres and as accessory features the HBD projection on Asn65 and HBDA projections on water molecules. A hit had to match at least the main features while the presence of the accessory features was not mandatory.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">4.1.2 Virtual Screening</h4><div class="NLM_p last">The chemical library for virtual screening was obtained by merging commercial (Chembridge, Maybridge, Preswick) and academic collections (the Diversity set II from the NCI and the French national chemical library Chimiothèque Nationale). Duplicate structures were removed and 3D coordinates (using Catalyst) were generated using the Prepare ligand tool within DS3.0. A multiconformation ligand database was then created using Catalyst within the Build 3D Database tool under DS3.0. The query was performed using the Search 3D Database tool with the FAST search method under DS3.0. Hits were screened for Fit values, and those with a Fit value more than 1 were then taken for molecular docking analysis.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.1.3 Molecular Docking</h4><div class="NLM_p last">Molecular docking studies were performed using LigandFit option of receptor–ligand interactions protocol section available in DS3.0. Initially the protein was prepared by adding the hydrogen atoms, removing the water molecules, and inserting the missing loop regions and then was minimized using CHARMM as described above. The protein molecule thus prepared and minimized was defined as the total receptor. Four docking conditions (4 targets: IL-15 protein with residue Asn65 side chain in its initial orientation (as referred to structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q">2Z3Q</a>) or in an orientation close to that of its IL-2 homologue Asn88 (from structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I">2B5I</a>), as well as each of these targets with 2 water molecules) were conducted in parallel. For each condition, the ligand molecules retained by the pharmacophore model were docked into a binding site facing residues Asn1, Asn4, Ser7, Asp8, Lys11, Thr62, Asn65, Ile68, Leu69, and Asn72 of IL-15 structures. The volumes of the binding site were 1396, 1538, 1481, and 1523 Å<sup>3</sup> and contained 11171, 12304, 11851, and 12188 points, respectively, to the 4 targets described above. Docking was performed using CFF as the energy grid. A penalty of 200 kcal/(mol·atom) was set up to reduce the dock score of poses that occurred outside of the binding site. The conformational search of the ligand poses was performed by the Monte Carlo trial method. Maximum internal energy was set at 10000 kcal/mol. A short rigid body minimization was then performed (steepest descent and Broyden–Fletcher–Goldfarb–Shanno (BFGS) minimizations). Twenty poses were saved for each ligand after docking, and 100 steps of BFGS rigid body minimization were then carried out. Scoring was performed with five scoring functions: LigScore1, Ligscore2,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> PLP1, PLP2,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and PMF.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> CFF force field was used for LigScore calculations. Among the 24115 compounds retained after the pharmacophore-based search, 7991 were actually docked to the targets. To improve the screening accuracy, a consensus strategy was adopted after dividing compounds in subsets based on MW (MW ≤600 and >600 Da) and number of rotatable bonds (rotatable bonds ≤5 and >5). Compounds with a consensus score equal to 5 (i.e., in the TOP 40% for each scoring function) were retained within each subset for each docking condition. All together, 1588 compounds were thereby retained. They were ranked by rescoring them against each of the 4 targets and summing the four consensus scores obtained (maximal score = 20). The top-ranked 20% were selected and represented 315 compounds, 240 of which were actually available and purchased for biological testing.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.1.4 Binding Mode and Molecular Interactions Analysis of Compound <b>1</b></h4><div class="NLM_p">In order to determine the potential binding mode of compound <b>1</b>, we performed a refinement step on the top 50 poses obtained from two more docking runs, one using LigandFit and the other using C-Docker, another docking program implemented under DS3.0. This refinement procedure consisted in a simulated annealing refinement (2000 steps at 700 K, 5000 steps at 300 K) followed by a final full force field minimization using CHARMM (100 steps of steepest descent followed by conjugate gradient with gradient tolerance of 0.01). The 100 poses retained with the two docking runs were compared in terms of interaction energy, and those with the most favorable binding were further visually validated for their proper docking. The top 10 poses belonged to the same cluster, and one of them has been selected.</div><div class="NLM_p last">Images for the <a class="ref internalNav" href="#fig1" aria-label="Figures 1">Figures 1</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> were captured from DS3.0 visualizer and treated with Adobe Photoshop CS4 software.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28">4.2 Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.2.1 General</h4><div class="NLM_p">Melting points were determined on a Stuart melting point SMP3 apparatus. All solvents used were reagent grade, and TLC was performed on silica-covered aluminum sheets (Kieselgel 60F<sub>254</sub>, MERCK). Eluted TLC was revealed using UV radiation (λ = 254 nm) or molybdate solution. Flash column chromatography was performed on silica gel 60 ACC 40–63 μm (SDS-CarloErba). NMR spectra were recorded on a BRUKER AC300 (300 MHz for <sup>1</sup>H and 75 MHz for <sup>13</sup>C) or on a BRUKER 400 (400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C) at room temperature on samples dissolved in an appropriate deuterated solvent. References of tetramethylsilane (TMS) for <sup>1</sup>H and deuterated solvent signal for <sup>13</sup>C were used. Chemical displacement values (δ) are expressed in parts per million (ppm) and coupling constants (<i>J</i>) in Hertz (Hz). Clearly identified proton and carbon were specified (for dihydrophthalazinone moiety as phthal and for triazole moiety as triaz). Low-resolution mass spectra (MS in Da unit) were recorded in the CEISAM laboratory on a Thermo-Finnigan DSQII quadripolar at 70 eV (CI with NH<sub>3</sub> gas) or on a Waters Xevo G2-XS QTOF. High-resolution mass spectrometry (HRMS in Da unit) analyses were recorded on an LC-Q-TOF (Synapt-G2 HDMS, Waters) in the IRS-UN center (Mass Spectrometry platform, Nantes) or on a MALDI -TOF-TOF apparatus (Autoflex III from Bruker) in the INRA center (BIBS platform, Nantes). The purity of the tested compounds was determined by analytical UPLC-MS (Acquity H-Class- Xevo G2-XS Qtof) using C18 reverse-phase column [BEH (1.7 μm, 2.1 mm × 50 mm)] and was over 95%. The compounds described in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> were checked for the presence of PAINS substructures as described by Baell and Holloway,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> using FAF-Drugs3<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> server, and no PAINS substructures were identified except in <b>73</b>, which was only developed for the purpose of carrying out cross-linking studies with IL-15 protein.</div><div class="NLM_p last">Synthesis and chemical characteristics of the halogenoalkylamides <b>6</b>–<b>39</b> and the azidoalkylamide <b>40</b> are detailed in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.2.2 General Synthetic Procedure 1 for the Synthesis of Bromoalkylamides</h4><div class="NLM_p last">The commercial bromoacid reagent (1 equiv) was dissolved in anhydrous DCM, and oxalyl chloride (1.2 equiv) was added at room temperature. A catalytic amount of DMF was then added. The mixture was stirred under argon atmosphere during 3 h. Carboxylic acid complete conversion to acyl chloride was determined by <sup>1</sup>H NMR in deuterated benzene after concentration in vacuum. The acyl chloride was taken up in anhydrous THF, and the amine (0.85 equiv) was then added at 0 °C, followed by triethylamine (2.5 equiv). After completion of the reaction, water was added, and the aqueous phase was extracted with Et<sub>2</sub>O (the aqueous layer was acidified to pH = 2 for compounds with phenol function). The organic phase was washed with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The expected bromoalkylamide product was then purified by flash column chromatography on silica gel.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.2.3 General Synthetic Procedure 2 for the S-Alkylation of 4-((5-Mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>) and 4-((5-Mercapto-1,3,4-oxadiazol-2-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>5</b>) with Halogenoalkyles or Halogenoalkylamides To Give Compounds <b>1</b>, <b>41</b>–<b>54</b>, <b>64</b>, <b>66</b>–<b>78</b>, and <b>86</b>–<b>91</b></h4><div class="NLM_p last">To a suspension of dry K<sub>2</sub>CO<sub>3</sub> (3 equiv, 3 mmol) in DMF (8 mL) was added thiol <b>4</b> (1 mmol). The mixture was stirred for 15 min, and a solution of bromoalkylamide (1.5 equiv) in CH<sub>2</sub>Cl<sub>2</sub> (1 mmol·mL<sup>–1</sup>) was added. The mixture was then stirred at room temperature until starting material disappeared (2–18 h). After completion of the reaction, a saturated solution of ammonium chloride was added. The mixture was extracted twice with ethyl acetate. The organic layer was washed several times with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified by flash chromatography on silica gel.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.2.4 <i>N</i>-(2,4-Dichlorophenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>1</b>)</h4><div class="NLM_p last">Following procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 2-bromo-<i>N</i>-(2,4-dichlorophenyl)acetamide (<b>6</b>, 3 mmol, 0.84 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>1</b> in 81% yield, as a white powder; mp 201.5–202 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.0 (bs, 1H, NH), 8.45 (dd, <i>J</i> = 7.8 and <i>J</i> = 1.1 Hz, 1H, H<sub>ar-Phthal</sub>), 8.23 (d, <i>J</i> = 8.8 Hz, 1H, H<sub>ar</sub>), 8.19 (dd, <i>J</i> = 7.8 and <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 7.82 (ddd, <i>J</i> = 7.9, <i>J</i> = 7.8 and <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 7.77 (ddd, <i>J</i> = 7.9, <i>J</i> = 7.8 and <i>J</i> = 1.1 Hz, 1H, H<sub>ar-Phthal</sub>), 7.31 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.18 (dd, <i>J</i> = 8.8 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 4.05 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>)) δ 167.1 (CONH), 159.5 (CONMe), 152.9 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.5 (C<sub>IV-C═N</sub>), 134.0 (C<sub>IV</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 129.6 (C<sub>IV</sub>), 129.1 (CH<sub>ar</sub>), 129.0 (C<sub>IV</sub>), 128.2 (C<sub>IV</sub>); 127.6 (CH<sub>ar</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 125.1 (CH<sub>ar-Phthal</sub>), 124.7 (C<sub>IV</sub>), 123.2 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 36.0 (CH<sub>2</sub>), 30.8 (NMe), 30.02 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>21</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 489.0662, found 489.0637.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.2.5 2-(3-Methyl-4-oxo-3,4-dihydrophthalazin-1-yl)acetohydrazide (<b>3</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h4><div class="NLM_p last">To a solution of ethyl [(<i>E</i>)-3-oxo-1,3-dihydroisobenzofuran-1-ylidene]acetate (<b>2-</b><i><b>E</b></i>, 13 mmol, 2.83 g) in EtOH (15 mL), was added dropwise methylhydrazine (13 mmol, 0.52 mL). The mixture was then stirred for 30 min, and hydrazine monohydrate was added dropwise (6 equiv, 78 mmol, 4.45 mL). The solution was finally heated at reflux during 3 h, and the resulting suspension was cooled to 20 °C and filtered. The white powder obtained was washed with Et<sub>2</sub>O to give 94% of hydrazide <b>3</b>, which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.36 (bs, 1H, NH), 8.28 (d, <i>J</i> = 7.6 Hz, 1H, H<sub>ar-Phthal</sub>), 7.92 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.85 (m, <i>J</i> = 4.3 Hz, 1H, H<sub>ar-Phthal</sub>), 4.27 (bs, 2H, NH<sub>2</sub>), 3.77 (s, 2H, CH<sub>2</sub>), 3.70 (s, 3H, NMe). HRMS (MALDI DHB, PEG 600) calcd for C<sub>11</sub>H<sub>13</sub>N<sub>4</sub>O<sub>2</sub> (M + H)<sup>+</sup> 233.1033, found 233.1035.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.2.6 4-((5-Mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>)</h4><div class="NLM_p last">To a suspension of hydrazide <b>3</b> (12 mmol, 2.8 g) in EtOH (28 mL) were added methylisothiocyanate (5 equiv, 60 mmol, 4.54 g) and triethylamine (5 equiv, 60 mmol, 8 mL), and the reaction mixture was heated to reflux during 8 h. The resulting suspension was cooled to 20 °C, filtered, and washed with Et<sub>2</sub>O to give compound <b>4</b> with 99% yield as a yellowish powder. This one was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.56 (bs, 1H, SH), 8.30 (m, 1H, H<sub>ar-Phthal</sub>), 7.97–7.84 (m, 3H, 3 × H<sub>ar-Phthal</sub>), 4.51 (s, 2H, CH<sub>2</sub>), 3.67 (s, 3H, NMe<sub>Phthal</sub>), 3.49 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.9 (C<sub>IV-SH</sub>), 158.4 (CONMe), 149.6 (C<sub>IV-C═N</sub>), 140.3 (C<sub>IV-C═N</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 128.7 (C<sub>IV</sub>), 127.1 (C<sub>IV</sub>), 126.0 (CH<sub>ar-Phthal</sub>), 125.6 (CH<sub>ar-Phthal</sub>), 39.0 (NMe<sub>Phthal</sub>), 30.2 (NMe), 28.3 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>13</sub>H<sub>14</sub>N<sub>5</sub>OS (M + H)<sup>+</sup> 288.0914, found 288.0919.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.2.7 4-((5-Mercapto-1,3,4-oxadiazol-2-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>5</b>)</h4><div class="NLM_p last">The compound was prepared as earlier described for the <i>N</i>-allyl analog.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> To a suspension of hydrazide <b>3</b> (1 mmol, 0.23 g) in CS<sub>2</sub> (10 mL) was added KOH (2.5 equiv, 2.5 mmol), and the reaction mixture was heated to reflux under vigorous stirring during 3 h. It was cooled to 10 °C, and the precipitate formed was filtered and washed with Et<sub>2</sub>O. The powder was stirred in hot ethanol and filtered to give the compound <b>5</b> with 65% yield as a gray powder. This one was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (m, 1H, H<sub>ar-Phthal</sub>), 7.98 (m, 3H, 3 × H<sub>ar-Phthal</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 3.70 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 178.2 (C<sub>IV-SH</sub>), 160.5 (CO), 158.3 (C<sub>IV-C═N</sub>), 139.7 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 128.5 (C<sub>IV</sub>), 127.1, (C<sub>IV</sub>) 126.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 45.4 (NMe), 29.1 (CH<sub>2</sub>). HRMS (ESI<sup>–</sup>): calcd for C<sub>12</sub>H<sub>9</sub>N<sub>4</sub>O<sub>2</sub>S (M-H)<sup>−</sup> 273.0446, found 273.0445.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.2.8 <i>N</i>-(2,4-Dichlorophenyl)-4-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)butanamide (<b>41</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 4-bromo-<i>N</i>-(2,4-dichlorophenyl)butanamide (<b>7</b>, 3 mmol), purification by column chromatography on silica gel (DCM/MeOH; 95:5) afforded compound <b>41</b> in 72% yield, as a white powder; mp 195–196 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (m, 1H, H<sub>ar-Phthal</sub>), 8.17 (m, 2H, H<sub>ar-Phthal</sub> and H<sub>ar</sub>), 8.01 (m, 1H, H<sub>ar</sub>), 7.77 (ddd, <i>J</i> = 8.2, <i>J</i> = 7.3, and <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 7.72 (ddd, <i>J</i> = 8.2, <i>J</i> = 7.8, and <i>J</i> = 1.3 Hz, 1H, H<sub>ar-Phthal</sub>), 7.31 (d, <i>J</i> = 2.3 Hz, 1H, H<sub>ar</sub>), 7.19 (dd, <i>J</i> = 8.9 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.44 (s, 2H, CH<sub>2</sub>), 3.77 (s, 3H, NMe<sub>Phthal</sub>), 3.55 (s, 3H, NMe), 3.27 (t, <i>J</i> = 7.1 Hz, 2H, SCH<sub>2</sub>), 2.61 (t, <i>J</i> = 7.1 Hz, 2H, CH<sub>2</sub>CO), 2.17 (tt, <i>J</i> = 7.1 Hz, <i>J</i> = 7.1 Hz, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.5 (CONH), 159.5 (CONMe), 152.2 (C<sub>IV-C═N</sub>), 151.5 (C<sub>IV-C═N</sub>), 140.7 (C<sub>IV-C═N</sub>), 133.4 (C<sub>IV</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.0 (C<sub>IV</sub>), 128.9 (C<sub>IV</sub>), 128.8 (C<sub>IV</sub>), 127.8 (CH<sub>ar</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.2 (CH<sub>ar-Phthal</sub>), 124.1 (C<sub>IV</sub>), 123.2 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 35.8 (CH<sub>2</sub>), 32.2 (CH<sub>2</sub>), 30.7 (NMe), 30.0 (CH<sub>2</sub>), 25.6 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>23</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>SNa (M + Na)<sup>+</sup> 539.0794, found 539.0819.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.2.9 <i>N</i>-(2,4-Dichlorophenyl)-6-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)hexanamide (<b>42</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 6-bromo-<i>N</i>-(2,4-dichlorophenyl)hexanamide (<b>9</b>, 3 mmol), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>42</b> in 56% yield, as a white powder; mp 184–185 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (m, 1H, H<sub>ar-Phthal</sub>), 8.27 (d, <i>J</i> = 8.9 Hz, 1H, H<sub>ar</sub>), 8.20 (m, 1H, H<sub>ar-Phthal</sub>), 7.78 (ddd, <i>J</i> = 7.8, <i>J</i> = 7.4 and <i>J</i> = 1.6 Hz, 1H, H<sub>ar-Phthal</sub>), 7.74 (ddd, <i>J</i> = 7.8 and <i>J</i> = 8.0 Hz, <i>J</i> = 1.3, 1H, H<sub>ar-Phthal</sub>), 7.67 (bs, 1H, NH), 7.33 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.21 (dd, <i>J</i> = 8.9 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.18 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>CO), 1.77 (m, 4H, 2 × CH<sub>2</sub>), 1.51 (m, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.2 (CONH), 159.5 (CONMe), 152.0 (C<sub>IV-C═N</sub>), 151.8 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.5 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.2 (C<sub>IV</sub>), 129.1(C<sub>IV</sub>), 128.8 (CH<sub>ar</sub>), 128.1 (C<sub>IV</sub>), 127.9 (CH<sub>ar</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 123.6 (C<sub>IV</sub>), 122.8 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.4 (CH<sub>2</sub>), 32.7 (CH<sub>2</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 29.2 (CH<sub>2</sub>), 28.0 (CH<sub>2</sub>), 24.8 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>25</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 545.1288, found 545.1281.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.2.10 <i>N</i>-(2,4-Dichlorophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>43</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2,4-dichlorophenyl)octanamide (<b>10</b>, 3 mmol, 1.09 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>43</b> in 53% yield, as a white powder; mp 165–166 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.31 (d, <i>J</i> = 9.0 Hz, 1H, H<sub>ar</sub>), 8.22 (m, 1H, H<sub>ar-Phthal</sub>), 7.80 (m, 1H, H<sub>ar-Phthal</sub>), 7.75 (m, 1H, H<sub>ar-Phthal</sub>), 7.60 (bs, 1H, NH), 7.35 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.23 (dd, <i>J</i> = 9.0 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.18 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.40 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>), 1.73 (m, 4H, 2 × CH<sub>2</sub>), 1.48–1.29 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.6 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.6 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 128.8 (CH<sub>ar</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 123.3 (C<sub>IV</sub>), 122.6 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.9 (CH<sub>2</sub>), 33.1 (CH<sub>2</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 29.5 (CH<sub>2</sub>), 29.0 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 25.4 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>27</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 573.1601, found 573.1583.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.2.11 <i>N</i>-(2,4-Dichlorophenyl)-10-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)decanamide (<b>44</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 10-bromo-<i>N</i>-(2,4-dichlorophenyl)decanamide (<b>11</b>, 3 mmol, 1.17 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>44</b> in 84% yield, as a white powder; mp 124–126 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (m, 1H, H<sub>ar-Phthal</sub>), 8.32 (d, <i>J</i> = 8.8 Hz, 1H, H<sub>ar</sub>), 8.21 (m, 1H, H<sub>ar-Phthal</sub>), 7.79 (m, 1H, H<sub>ar-Phthal</sub>), 7.74 (m, 1H, H<sub>ar-Phthal</sub>), 7.61 (bs, 1H, NH), 7.35 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.22 (dd, <i>J</i> = 8.9 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 1.70 (m, 4H, 2 × CH<sub>2</sub>), 1.40–1.29 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.5 (CONMe), 152.1 (C<sub>IV</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.6 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.8 (CH<sub>ar</sub>), 128.0 (C<sub>IV</sub>), 127.9 (CH<sub>ar-Phthal</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 123.3 (C<sub>IV</sub>), 122.6 (CH<sub>ar</sub>), 122.5 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.9 (CH<sub>2</sub>CO), 33.2 (SCH<sub>2</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 29.6 (CH<sub>2</sub>), 29.6–28.6 (6 × CH<sub>2</sub>), 25.5 (CH<sub>2</sub>) HRMS (ESI<sup>+</sup>): calcd for C<sub>29</sub>H<sub>35</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 601.1913, found 601.1902.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.2.12 <i>N</i>-(2,4-Dichlorophenyl)-11-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)undecanamide (<b>45</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 11-bromo-<i>N</i>-(2,4-dichlorophenyl)undecanamide (<b>12</b>, 3 mmol, 1.21 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>45</b> in 65% yield, as a white powder; mp 133–134 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (d, <i>J</i> = 7.5 Hz, 1H, H<sub>ar-Phthal</sub>), 8.32 (d, <i>J</i> = 8.8 Hz, 1H, CH<sub>ar</sub>), 8.21 (d, <i>J</i> = 7.9 Hz, 1H, H<sub>ar-Phthal</sub>), 7.79 (ddd, <i>J</i> = 8.2, <i>J</i> = 7.4, and <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 7.74 (ddd, <i>J</i> = 8.2, <i>J</i> = 7.8, and <i>J</i> = 1.2 Hz, 1H, H<sub>ar-Phthal</sub>), 7.60 (bs, 1H, NH), 7.35 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.22 (dd, <i>J</i> = 8.9 Hz, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>CO), 1.70 (m, 4H, 2 × CH<sub>2</sub>), 1.4–1.18 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.5 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.6 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.8 (CH<sub>ar</sub>), 128.0 (C<sub>IV</sub>), 127.9 (CH<sub>ar</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 123.3 (C<sub>IV</sub>), 122.5 (CH<sub>ar</sub>), 39.5 (NMe <sub>Phthal</sub>), 37.9 (<i>C</i>H<sub>2</sub>CO), 33.2 (SCH<sub>2</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 29.6–28.6 (6 × CH<sub>2</sub>), 25.5 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>30</sub>H<sub>37</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 615.2070, found 615.2076.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.2.13 <i>N</i>-(2,4-Dichlorophenyl)-16-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)hexadecanamide (<b>46</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 16-bromo-<i>N</i>-(2,4-dichlorophenyl)hexadecanamide (<b>13</b>, 3 mmol, 1.43 g), purification by column chromatography on silica gel (DCM/MeOH; 95:5) afforded compound <b>46</b> in 58% yield, as a white powder; mp 116–117.4 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.44 (m, 1H, H<sub>ar-Phthal</sub>), 8.36 (d, <i>J</i> = 8.9 Hz, 1H, CH<sub>ar</sub>), 8.24 (m, 1H, H<sub>ar-Phthal</sub>), 7.79 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.58 (bs, 1H, NH), 7.36 (d, <i>J</i> = 2.3 Hz, 1H, H<sub>ar</sub>), 7.23 (dd, <i>J</i> = 8.9 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.54 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.56 (s, 3H, NMe), 3.21 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 2.42 (t, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>CO), 1.73 (m, 4H, 2 × CH<sub>2</sub>), 1.4–1.23 (m, 18H, 9 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.3 (CONH), 159.3 (CONMe), 151.9 (C<sub>IV-C═N</sub>), 151.7 (C<sub>IV-C═N</sub>), 140.6 (C<sub>IV-C═N</sub>), 133.3 (C<sub>IV</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 131.7 (CH<sub>ar-Phthal</sub>), 128.9 (C<sub>IV</sub>), 128.8 (C<sub>IV</sub>), 128.5 (CH<sub>ar</sub>), 127.8 (C<sub>IV</sub>), 127.7 (CH<sub>ar</sub>), 126.9 (CH<sub>ar-Phthal</sub>), 125.2 (CH<sub>ar-Phthal</sub>), 123.1 (C<sub>IV</sub>), 122.3 (CH<sub>ar</sub>), 39.3 (NMe<sub>Phthal</sub>), 37.8 (<i>C</i>H<sub>2</sub>CO), 33.0 (SCH<sub>2</sub>), 30.5 (NMe), 30.0 (CH<sub>2</sub>), 29.5 (CH<sub>2</sub>), 29.4–29.3–29.2–29.1–29.0–28.6 (10 × CH<sub>2</sub>), 25.4 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>35</sub>H<sub>47</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 685.2853, found 685.2824.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.2.14 <i>N</i>-(2,4-Dichlorophenyl)-<i>N</i>-methyl-2-((4-methyl-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>47</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and <i>N</i>-(2,4-dichlorophenyl)-2-iodo-<i>N</i>-methylacetamide (<b>39</b>, 3 mmol, 1.02 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>47</b> in 52% yield, as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 7.7 and <i>J</i> = 1.4 Hz, 1H, H<sub>ar-Phthal</sub>), 8.17 (dd, <i>J</i> = 7.4 and <i>J</i> = 1.1 Hz, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.51 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.25 (m, 2H, 2 × H<sub>ar</sub>), 4.45 (m, 2H, CH<sub>2</sub>), 3.95 (AB system, <i>J</i> = 15.4 Hz, 1H, C<i>H</i>H′), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.66 (AB system, <i>J</i> = 15.6 Hz, 1H, CH<i>H</i>′), 3.53 (s, 3H, NMe<sub>Triaz</sub>), 3.28 (s, 3H, CONMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1 (CONH), 159.6 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 151.0 (C<sub>IV-C═N</sub>), 140.7 (C<sub>IV-C═N</sub>), 138.8 (C<sub>IV</sub>), 135.8 (C<sub>IV</sub>), 133.9 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 131.0 (CH<sub>ar</sub>), 130.9 (CH<sub>ar</sub>), 129.2 (CH<sub>ar</sub>), 129.1 (C<sub>IV</sub>), 129.1 (C<sub>IV</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 39.5 (NMe<sub>Phthal</sub>), 36.9 (NMe), 36.7 (CH<sub>2</sub>), 30.9 (NMe), 30.1 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>22</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>NaS (M + Na)<sup>+</sup> 525.0643, found 525.0649.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.2.15 <i>N</i>-(2,4-Dibromophenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>48</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 2-bromo-<i>N</i>-(2,4-dibromophenyl)acetamide (<b>14</b>, 3 mmol, 1.15 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>48</b> in 75% yield, as a white powder; mp 224–225 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.76 (bs, 1H, NH), 8.45 (m, 1H, H<sub>ar-Phthal</sub>), 8.19 (m, 1H, H<sub>ar-Phthal</sub>), 8.12 (d, <i>J</i> = 8.84 Hz, 1H, H<sub>ar</sub>), 7.79 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.68 (d, <i>J</i> = 2.20 Hz, 1H, H<sub>ar</sub>), 7.37 (dd, <i>J</i> = 8.90 and <i>J</i> = 2.2 Hz, 1H, H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 4,07 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.58 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 167.1 (CONH), 159.5 (CONMe), 152.9 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.5 (C<sub>IV-C═N</sub>), 135.6 (C<sub>IV</sub>), 134.9 (CH<sub>ar</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.2 (CH<sub>ar-Phthal</sub>), 131.1 (CH<sub>ar</sub>), 129.0 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 125.1 (CH<sub>ar-Phthal</sub>), 124.0 (CH<sub>ar</sub>), 117.4 (C<sub>IV</sub>), 115.0 (C<sub>IV</sub>), 39.6 (NMe<sub>Phthal</sub>), 36.0 (CH<sub>2</sub>), 30.9 (NMe), 30.0 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>21</sub>H<sub>19</sub>Br<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 576.9651, found 576.9640.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.2.16 <i>N</i>-(2,4-Difluorophenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>49</b>)</h4><div class="NLM_p last">Following procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 2 mmol, 0.58 g) and 2-bromo-<i>N</i>-(2,4-Difluorophenyl)acetamide (<b>15</b>, 5 mmol, 1.2 g), purification by column chromatography on silica gel (DCM/MeOH; 99:1) afforded compound <b>49</b> in 21% yield, as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.28 (bs, 1H, NH), 8.45 (dd, <i>J</i> = 7.9 and <i>J</i> = 1.16 Hz, 1H, H<sub>ar-Phthal</sub>), 8.21 (d, <i>J</i> = 7.94 Hz, 1H, H<sub>ar-Phthal</sub>), 8.15 (m, 1H, H<sub>ar</sub>), 7.81 (m, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 1H, H<sub>ar-Phthal</sub>), 6.81 (m, 1H, H<sub>ar</sub>), 6.79 (m, 1H, H<sub>ar</sub>), 4.51 (s, 2H, CH<sub>2</sub>), 3.97 (s, 2H, CH<sub>2</sub>), 3.8 (s, 3H, NMe<sub>Phthal</sub>), 3.58 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.9 (CONH), 159.5 (CONMe), 158.9 (dd, <i>J</i><sub>CF</sub> = 244 Hz, <i>J</i><sub>CF</sub> = 11 Hz, C<sub>IV</sub>), 153.3 (dd, <i>J</i><sub>CF</sub> = 247 Hz, <i>J</i><sub>CF</sub> = 11.5 Hz, C<sub>IV</sub>), 152.8 (C<sub>IV-C═N</sub>), 152.5 (C<sub>IV-C═N</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 129 (C<sub>IV</sub>), 128.2 (C<sub>IV</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 125.1 (CH<sub>ar-Phthal</sub>), 123.2 (d, <i>J</i><sub>CF</sub> = 8.94 Hz, CH<sub>ar</sub>), 122.9 (dd; <i>J</i><sub>CF</sub> = 11.7 Hz, <i>J</i><sub>CF</sub> = 3.8 Hz, C<sub>IV</sub>), 111.1 (dd, <i>J</i><sub>CF</sub> = 21.63 Hz, <i>J</i><sub>CF</sub> = 3.36 Hz, CH<sub>ar</sub>), 103.7 (dd, <i>J</i><sub>CF</sub> = 27.28 Hz, <i>J</i><sub>CF</sub> = 23.11 Hz, CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 36.1 (CH<sub>2</sub>), 31.0 (NMe), 30.0 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>21</sub>H<sub>19</sub>F<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 457.1255, found 457.1250.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.2.17 <i>N</i>-(4-Iodophenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>50</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 0.5 mmol, 0.15 g) and 2-bromo-<i>N</i>-(4-iodophenyl)acetamide (<b>16</b>, 1.1 equiv, 0.6 mmol), purification by stirring the precipitate in dichloromethane followed by filtration afforded <b>50</b> in 52% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.53 (s, 1 H, NH), 8.29 (m, 1H, H<sub>ar-Phthal</sub>), 8.05 (m, 1H, H<sub>ar-Phthal</sub>), 7.88 (m, 2H, H<sub>ar-Phthal</sub>), 7.63 (m, 2H, H<sub>ar</sub>), 7.39 (m, 2H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 4.02 (s, 2H, CH<sub>2</sub>CO), 3.65 (s, 3H, NMe<sub>Phthal</sub>), 3.59 (s, 3H, NMe). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.1 (CONH), 158.4 (CONMe), 153.0 (C<sub>IV-C═N</sub>), 149.1 (C<sub>IV-C═N</sub>), 141.1 (C<sub>IV-C═N</sub>), 138.7 (C<sub>IV</sub>), 137.3 (CH<sub>ar</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 128.9 (C<sub>IV</sub>), 127.2 (C<sub>IV</sub>), 126.0 (CH<sub>ar-Phthal</sub>), 125.8 (CH<sub>ar-Phthal</sub>), 121.2 (CH<sub>ar</sub>), 87.0 (C<sub>IV-C–I</sub>), 38.9 (NMe<sub>Phthal</sub>), 37.7 (CH<sub>2</sub>CO), 30.6 (NMe), 28.8 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>) calcd for C<sub>21</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub>SINa (M + Na)<sup>+</sup> 569.0227, found 569.0228.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">4.2.18 <i>N</i>-(4-Methoxyphenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>51</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 2-bromo<i>-N</i>-(4-methoxyphenyl)acetamide (<b>17</b>, 1.5 mmol, 0.36 g), purification by column chromatography on silica gel (DCM/MeOH; 97:3) afforded compound <b>51</b> in 80% yield, as a white powder; mp 246–247 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.05 (bs, 1H, NH), 8.45 (dd, <i>J</i> = 7.4 Hz, <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 8.17 (dd, <i>J</i> = 7.4 Hz, <i>J</i> = 1.2 Hz, 1H, H<sub>ar-Phthal</sub>), 7.81 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.44 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.80 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 3.91 (s, 2H, CH<sub>2</sub>); 3.80 (s, 3H, NMe <sub>Phthal</sub>), 3.76 (s, 3H, OMe); 3.59 (s, 3H, NMe). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.3 (CONH), 159.5 (CONMe), 156.4 (C<sub>IV</sub>), 152.8 (C<sub>IV-C═N</sub>), 152.8 (C<sub>IV-C═N</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 131.5 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 125.0 (CH<sub>ar-Phthal</sub>), 121.5 (2 × CH<sub>ar</sub>), 114.1 (2 × CH<sub>ar</sub>), 55.6 (OMe), 39.6 (NMe <sub>Phthal</sub>), 36.3 (CH<sub>2</sub>), 31.0 (NMe), 29.9 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>22</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub>NaS (M + Na)<sup>+</sup> 473.1372, found 473.1363.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">4.2.19 Ethyl 2-(2-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazine-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamido)benzoate (<b>52</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and ethyl 3-(2-bromoacetamido)benzoate (<b>18</b>, 2 mmol, 0.58 g), purification by column chromatography on silica gel (DCM/MeOH; 97:3) afforded compound <b>52</b> in 61% yield, as a white powder; mp 165–166 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.52 (bs, 1H, NH), 8.59 (dd, <i>J</i> = 8.53 and <i>J</i> = 0.92 Hz, 1H, H<sub>ar</sub>), 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (m, 1H, H<sub>ar-Phthal</sub>), 7.99 (dd, <i>J</i> = 8.05 and <i>J</i> = 1.59 Hz, H<sub>ar</sub>), 7.75 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.50 (m, 1H, H<sub>ar</sub>), 7.09 (m, 1H, H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 4.30 (q, <i>J</i> = 8.14 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 4.16 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe <sub>Phthal</sub>), 3.64 (s, 3H, NMe), 1.38 (t, <i>J</i> = 8.0 Hz, 3H, CH<sub>2</sub>C<i>H</i><sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.1 (<i>C</i>OOEt), 165.9 (CONH), 159.6 (CONMe), 152.5 (C<sub>IV-C═N</sub>), 150.5 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV</sub>), 140.7 (C<sub>IV-C═N</sub>), 134.5 (CH<sub>ar</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 130.9 (CH<sub>ar</sub>), 129.1 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 123.2 (CH<sub>ar</sub>), 120.7 (CH<sub>ar</sub>), 116.0 (C<sub>IV</sub>), 61.6 (<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 39.5 (NMe<sub>Phthal</sub>), 38.3 (CH<sub>2</sub>), 31.0 (NMe), 30.2 (CH<sub>2</sub>), 14.3 (CH<sub>2</sub><i>C</i>H<sub>3</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>24</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>NaS (M + Na)<sup>+</sup> 515.1472, found 515.1462.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">4.2.20 Ethyl 3-(2-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazine-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamido)benzoate (<b>53</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g), and ethyl 3-(2-bromoacetamido)benzoate (<b>19</b>, 1.5 mmol, 0.42 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>53</b> in 68% yield, as a white powder; mp 211–212 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.36 (bs, 1H, NH), 8.45 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (m, 2H, H<sub>ar</sub> and H<sub>ar-Phthal</sub>), 7.79 (m, 4H, 2 × H<sub>ar</sub> and 2 × H<sub>ar-Phthal</sub>), 7.34 (dd, 2H, <i>J</i> = 8.0 Hz, 1H, H<sub>ar</sub>), 4.5 (s, 2H, CH<sub>2</sub>), 4.36 (q, <i>J</i> = 8.14 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.95 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe <sub>Phthal</sub>), 3.64 (s, 3H, NMe), 1.38 (t, <i>J</i> = 7.16 Hz, 3H, CH<sub>2</sub>C<i>H</i><sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 166.8 (<i>C</i>ONH), 166.4 (COOEt or CONH), 159.6 (CONMe or COOEt), 152.8 (C<sub>IV-C═N</sub>), 152.7 (C<sub>IV-C═N</sub>), 140.72 (C<sub>IV-C═N</sub>), 138.4 (C<sub>IV</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 131.5 (C<sub>IV</sub>), 129.1 (C<sub>IV</sub>), 129.0 (CH<sub>ar</sub>), 128.2 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 125.5 (CH<sub>ar</sub>), 125.0 (CH<sub>ar-Phthal</sub>), 124.4 (CH<sub>ar</sub>), 121 (CH<sub>ar</sub>), 61.2 (<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 39.6 (NMe <sub>Phthal</sub>), 36.5 (CH<sub>2</sub>), 31.0 (NMe), 29.9 (CH<sub>2</sub>), 14.5 (CH<sub>2</sub><i>C</i>H<sub>3</sub>). HRMS (MALDI, DHB, PEG 600) calcd for C<sub>24</sub>H<sub>24</sub>N<sub>6</sub>O<sub>4</sub>NaS (M + Na)<sup>+</sup> 515.1472, found 515.1467.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">4.2.21 <i>N</i>-((3s,5s,7s)-Adamantan-1-yl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>54</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 2-bromo-<i>N</i>-(adamantyl)acetamide (<b>20</b>, 3 mmol, 1.05 g), purification by column chromatography on silica gel (DCM/MeOH; 95:5) afforded compound <b>54</b> in 81% yield, as a white powder; mp 134–136 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 7.2 and <i>J</i> = 1.1 Hz, 1H, H<sub>ar-Phthal</sub>), 8.46 (dd, <i>J</i> = 7.2 and <i>J</i> = 1.1 Hz, 1H, H<sub>ar-Phthal</sub>), 7.77 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.23 (bs, 1H, NH), 4.47 (s, 2H, CH2), 3.78 (s, 3H, NMe<sub>Phthal</sub>), 3.66 (m, 2H, CH<sub>2</sub>), 3.57 (s, 3H, NMe), 1.99 (bs, 3H, 3 × CH), 1.91 (m, 6H, 3 × CH<sub>2-adam</sub>), 1.56 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.8 (CONH), 159.3 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 152.1 (C<sub>IV-C═N</sub>), 140.2 (C<sub>IV-C═N</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 128.9 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 124.9 (CH<sub>ar-Phthal</sub>), 52.2 (C<sub>IV-adam</sub>), 41.2 (3 × CH<sub>2</sub>), 39.4 (NMe<sub>Phthal</sub>), 37.7 (CH<sub>2</sub>), 36.3 (3 × CH<sub>2</sub>), 30.8 (NMe), 29.8 (SCH<sub>2</sub>), 29.4 (3 × CH). HRMS (ESI<sup>+</sup>): calcd for C<sub>25</sub>H<sub>31</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 479.2229, found 479.2231.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">4.2.22 2-Methyl-4-((4-methyl-5-(prop-2-yn-1-ylthio)-4<i>H</i>-1,2,4-triazol-3-yl)methyl)phthalazin-1(2<i>H</i>)-one (<b>55</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 2 mmol, 0.58 g) and propargyl bromide (5 equiv, 10 mmol from a 80% solution in toluene), purification by column chromatography on silica gel (DCM/MeOH; 97:3) afforded compound <b>55</b> in 85% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 8.19 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 7.80 (d, <i>J</i> = 7.6 Hz, 1H, H<sub>ar-Phthal</sub>), 7.75 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 4.50 (s, 2H, CH<sub>2</sub>), 3.87 (d, <i>J</i> = 2.6 Hz, 2H, SCH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.62 (s, 3H, NMe), 2.17 (t, <i>J</i> = 2.6 Hz, CH). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 159.7 (CO), 152.7 (C<sub>IV-C═N</sub>), 150.1 (C<sub>IV-C═N</sub>), 140.7 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 78.6 (C<sub>IV</sub>), 72.7 (CH), 39.5 (NMe<sub>Phthal</sub>), 31.1 (NMe), 30.3 (CH<sub>2</sub>), 22.6 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>16</sub>H<sub>16</sub>N<sub>5</sub>OS (M + H)<sup>+</sup> 326.1076, found 326.1070.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">4.2.23 4-((5-(((1-((1<i>S</i>,3<i>S</i>)-Adamantan-1-yl)-1<i>H</i>-1,2,3-triazol-4-yl)methyl)thio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>56</b>)</h4><div class="NLM_p last">To a solution of alkyne <b>55</b> (0.21 mmol, 68 mg) and 1-azidoadamantane (0.21 mmol, 60 mg) in <i>t</i>BuOH/H<sub>2</sub>O (1:1) were added sodium ascorbate (0.1 equiv, 110 μL of a 0.2 M water solution) and CuSO<sub>4</sub>·5H<sub>2</sub>O (0.01 equiv, 10 μL of a 0.2 M water solution). After stirring at 60 °C during 20 h, a saturated solution of Na<sub>2</sub>CO<sub>3</sub> was added, and the aqueous phase was extracted with dichloromethane. The organic phase was washed with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel (DCM/petroleum ether; 90:10) to give compound <b>56</b> with 61% yield as a white powder; mp 197–198 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 7.8 Hz, 1H, H<sub>ar-Phthal</sub>), 8.20 (d, <i>J</i> = 7.8 Hz, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.69 (s, 1H, CH<sub>Triaz</sub>), 4.51 (s, 2H, SCH<sub>2</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.52 (s, 3H, NMe), 2.15 (m, 3H, 3 × CH), 2.15 (m, 6H, 3 × CH<sub>2</sub>), 1.76 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 159.5 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 151.6 (C<sub>IV-C═N</sub>), 142.4 (C<sub>IV-C═C</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 128.2 (C<sub>IV</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 119.9 (<i>C</i>H═C), 59.8 (C<sub>IV</sub>), 43.1 (3 × CH<sub>2</sub>), 39.6 (NMe <sub>Phthal</sub>), 36.0 (3 × CH<sub>2</sub>), 30.9 (NMe), 30.0 (CH<sub>2</sub>), 29.6 (3 × CH), 27.8 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>26</sub>H<sub>31</sub>N<sub>8</sub>OS (M + H)<sup>+</sup> 503.2336, found 503.2336.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">4.2.24 <i>N</i>-(4-Hydroxyphenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>57</b>)</h4><div class="NLM_p last">To a solution of <i>N</i>-(4-methoxyphenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>51</b>, 1 equiv) in anhydrous DCM (0.01 mmol·mL<sup>–1</sup>) under argon atmosphere at 0 °C was added dropwise a solution of boron tribromide (6 equiv of a 1 M solution in DCM). The mixture was stirred at room temperature overnight. The mixture was then quenched by slow addition of MeOH at 0 °C and concentrated. The crude powder was purified by flash column chromatography on silica gel (CHCl<sub>3</sub>/MeOH; 95:5) to give <b>57</b> in 84% yield as a beige powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1H, NH), 9.35 (bs, 1H, OH), 8.29 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 8.05 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 7.97–7.83 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.29 (d, <i>J</i> = 8.8 Hz, 2H, H<sub>ar</sub>), 6.68 (d, <i>J</i> = 8.8 Hz, 2H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 3.96 (s, 2H, CH<sub>2</sub>), 3.65 (s, 3H, NMe <sub>Phthal</sub>), 3.59 (s, 3H, NMe). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.0 (CONH), 158.4 (CONMe), 153.6 (C<sub>IV</sub>), 152.9 (C<sub>IV-C═N</sub>), 149.4 (C<sub>IV-C═N</sub>), 141.1 (C<sub>IV-C═N</sub>), 133.1 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 130.4 (C<sub>IV</sub>), 128.9 (C<sub>IV</sub>), 127.2 (C<sub>IV</sub>), 126.1 (CH<sub>ar-Phthal</sub>), 125.8 (CH<sub>ar-Phthal</sub>), 120.9 (2 × CH<sub>ar</sub>), 115.1 (2 × CH<sub>ar</sub>), 38.8 (NMe<sub>Phthal</sub>), 37.7 (CH<sub>2</sub>), 30.5 (NMe), 28.7 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>21</sub>H<sub>21</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 437.1396, found 437.1390.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">4.2.25 2-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)-<i>N</i>-(4-propoxyphenyl)acetamide (<b>58</b>)</h4><div class="NLM_p last">To a solution of phenol <b>57</b> (1 equiv) in anhydrous DMF (0.05 mmol·mL<sup>–1</sup>) under argon atmosphere at room temperature was added 1-bromopropane (5 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (5 equiv). The mixture was then stirred at 60 °C overnight. The mixture was quenched at 0 °C by addition of a saturated solution of ammonium chloride and extracted twice with AcOEt, washed 5 times with a saturated solution of NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash column chromatography on silica gel (DCM/MeOH; 97:3) to give <b>58</b> in 69% yield as a beige powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 10.03 (s, 1H, NH), 8.45 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 8.15 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 7.87–7.72 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.41 (d, <i>J</i> = 8.9 Hz, 2H, 2 × H<sub>ar</sub>), 6.78 (d, <i>J</i> = 8.9 Hz, 2H, 2 × H<sub>ar</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.90 (s, 2H, SCH<sub>2</sub>), 3.86 (t, <i>J</i> = 6.6 Hz, 2H, OCH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.58 (s, 3H, NMe), 1.77 (quint, <i>J</i> = 7.1 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.00 (t, <i>J</i> = 7.4 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 166.2 (CONH), 159.5 (CONMe), 155.9 (C<sub>IV</sub>), 152.7 (C<sub>IV-C═N</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 131.3 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 125.0 (CH<sub>ar-Phthal</sub>), 121.4 (2 × CH<sub>ar</sub>), 114.8 (2 × CH<sub>ar</sub>), 69.9 (OCH<sub>2</sub>), 39.6 (NMe <sub>Phthal</sub>), 36.3 (CH<sub>2</sub>), 31.0 (NMe), 29.8 (CH<sub>2</sub>), 22.7 (<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 10.6 (CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 479.1865, found 479.1847.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">4.2.26 <i>N</i>-(4-Isopropoxyphenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>59</b>)</h4><div class="NLM_p last">To a solution of phenol <b>57</b> (1 equiv) in anhydrous DMF (0.05 mmol·mL<sup>–1</sup>) under argon atmosphere was added 2-bromopropane (5 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (5 equiv). The mixture was then stirred at 60 °C overnight and quenched at 0 °C by addition of a saturated solution of ammonium chloride. The mixture was extracted twice with AcOEt, washed 5 times with a saturated solution of NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash column chromatography on silica gel (DCM/MeOH; 97:3) to give <b>59</b> in 63% yield as a beige powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.99 (s, 1H, NH), 8.43 (d, <i>J</i> = 7.6 Hz, 1H, H<sub>ar-Phthal</sub>), 8.13 (d, <i>J</i> = 7.7 Hz, 1H H<sub>ar-Phthal</sub>), 7.82–7.72 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.39 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.76 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.48–4.41 (m, 3H, CH and CH<sub>2</sub>), 3.90 (s, 2H, SCH<sub>2</sub>), 3.77 (s, 3H, NMe<sub>Phthal</sub>), 3.57 (s, 3H, NMe), 1.28 (d, <i>J</i> = 6.1 Hz, 6H, 2 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.1 (CONH), 159.4 (CONMe), 154.7 (C<sub>IV</sub>), 152.7 (C<sub>IV-C═N</sub>), 152.6 (C<sub>IV-C═N</sub>), 140.3 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.4 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 124.9 (CH<sub>ar-Phthal</sub>), 121.4 (2 × CH<sub>ar</sub>), 116.4 (2 × CH<sub>ar</sub>), 70.4 (CH), 39.5 (NMe<sub>Phthal</sub>), 36.5 (CH<sub>2</sub>), 30.9 (NMe), 29.8 (CH<sub>2</sub>), 22.1 (2 × CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>24</sub>H<sub>26</sub>N<sub>6</sub>O<sub>3</sub>NaS (M + Na)<sup>+</sup> 501.1685, found 501.1666.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">4.2.27 <i>N</i>-(4-Isobutoxyphenyl)-2-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamide (<b>60</b>)</h4><div class="NLM_p last">To a solution of phenol <b>57</b> (1 equiv) in anhydrous DMF (0.05 mmol·mL<sup>–1</sup>) under argon atmosphere at room temperature was added 1-iodo-2-methylpropane (10 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (10 equiv). The mixture was then stirred at 60 °C overnight and quenched at 0 °C by addition of a saturated solution of ammonium chloride. The mixture was extracted twice with AcOEt, washed 5 times with a saturated solution of NaCl, dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by flash column chromatography on silica gel (DCM/MeOH; 97:3) to give <b>60</b> in 69% yield as a yellowish brown powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.97 (s, 1H, NH), 8.45 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 8.16 (d, <i>J</i> = 7.7 Hz, 1H, H<sub>ar-Phthal</sub>), 7.85–7.75 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.41 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.78 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.90 (s, 2H, SCH<sub>2</sub>), 3.79 (s, 3H, NMe <sub>Phthal</sub>), 3.67 (d, <i>J</i> = 6.6 Hz, 2H, OCH<sub>2</sub>), 3.58 (s, 3H, NMe), 2.04 (m, 1H, CH), 1.00 (d, <i>J</i> = 6.6 Hz, 6H, 2 × CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.2 (CONH), 159.5 (CONMe), 156.2 (C<sub>IV</sub>), 152.7 (2 × C<sub>IV-C═N</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 131.3 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.2 (C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 125.0 (CH<sub>ar-Phthal</sub>), 121.5 (2 × CH<sub>ar</sub>), 114.9 (2 × CH<sub>ar</sub>), 74.9 (OCH<sub>2</sub>), 39.5 (NMe <sub>Phthal</sub>), 36.4 (CH<sub>2</sub>), 31.0 (NMe), 29.9 (CH<sub>2</sub>), 28.4 (CH), 19.4 (2 × CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>25</sub>H<sub>28</sub>N<sub>6</sub>O<sub>3</sub>NaS (M + Na)<sup>+</sup> 515.1841, found 515.1825.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">4.2.28 2-(2-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazine-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamido) Benzoic Acid (<b>61</b>)</h4><div class="NLM_p last">To a suspension of the ester <b>52</b> (0.3 mmol, 0.15 g) in dioxane (5 mL), LiOH (10 equiv, 1 M solution in water) was added, and the mixture was stirred until starting material disappeared. The reaction was diluted with water (15 mL) and acidified to pH = 2. Concentration under reduced pressure gave a precipitate, which was filtered and washed with Et<sub>2</sub>O, to give the pure compound <b>61</b> in 60% yield as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.79 (bs, 1H, NH), 8.43 (d, <i>J</i> = 8.5 Hz, 1H, H<sub>ar</sub>), 8.28 (m, 1H, H<sub>ar-Phthal</sub>), 8.02 (m, 1H, H<sub>ar-Phthal</sub>), 7.96 (dd, <i>J</i> = 7.9 and <i>J</i> = 1.5 Hz, 1H, H<sub>ar</sub>), 7.86 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.55 (ddd, <i>J</i> = 8.9, <i>J</i> = 7.9 and <i>J</i> = 1.6 Hz, 1H, H<sub>ar</sub>), 7.15 (ddd, <i>J</i> = 8.4 Hz, <i>J</i> = 7.7 and <i>J</i> = 1.4 Hz, 1H, H<sub>ar</sub>), 4.52 (s, 2H, CH<sub>2</sub>), 4.11 (s, 2H, CH<sub>2</sub>), 3.62 (s, 3H, NMe<sub>Phthal</sub>), 3.60 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 169.2 (COOH), 166.1 (CONH), 159.4 (CONMe), 152.9 (C<sub>IV-C═N</sub>), 148.9 (C<sub>IV-C═N</sub>), 141.1 (C<sub>IV-C═N</sub>), 140.2 (C<sub>IV</sub>), 133.7 (CH<sub>ar</sub>), 133.1 (CH<sub>ar-Phthal</sub>), 131.8 (CH<sub>ar-Phthal</sub>), 131.1 (CH<sub>ar</sub>), 128.8 (C<sub>IV</sub>), 127.2 (C<sub>IV</sub>), 126.0 (CH<sub>ar-Phthal</sub>), 125.7 (CH<sub>ar-Phthal</sub>), 123.0 (CH<sub>ar</sub>), 119.8 (CH<sub>ar</sub>), 117.3 (C<sub>IV</sub>), 38.8 (NMe<sub>Phthal</sub>), 37.5 (CH<sub>2</sub>), 30.5 (NMe), 28.6 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>6</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 465.1340, found 465.1344.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.2.29 3-(2-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazine-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)acetamido) Benzoic Acid (<b>62</b>)</h4><div class="NLM_p last">To a suspension of the ester <b>53</b> (0.3 mmol, 0.15 g) in dioxane (5 mL), LiOH (10 equiv, 1 M solution in water) was added, and the mixture was stirred until starting material disappeared. The reaction was diluted with water (15 mL) and acidified to pH = 2. Concentration under reduced pressure gave a precipitate, which was filtered and washed with Et<sub>2</sub>O, to give the pure compound <b>62</b> in 30% yield as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (bs, 1H, NH), 8.28 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (s, 1H, H<sub>ar</sub>), 8.05 (m, 1H, H<sub>ar-Phthal</sub>), 7.87 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.72 (ddd, <i>J</i> = 8.13, <i>J</i> = 2.26 and <i>J</i> = 1.09 Hz, 1H, H<sub>ar</sub>), 7.63 (m, 1H, H<sub>ar</sub>), 7.42 (t, <i>J</i> = 7.9 Hz, 1H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 4.04 (s, 2H, CH<sub>2</sub>), 3.65 (s, 3H, NMe<sub>Phthal</sub>), 3.60 (s, 3H, NMe). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.0 (COOH), 166.0 (CONH), 158.4 (CONMe), 152.9 (C<sub>IV-C═N</sub>), 149.2 (C<sub>IV-C═N</sub>), 141.1 (C<sub>IV-C═N</sub>), 138.9 (C<sub>IV</sub>), 133.1 (CH<sub>ar-Phthal</sub>), 131.8 (CH<sub>ar-Phthal</sub>), 131.4 (C<sub>IV</sub>), 129.0 (CH<sub>ar</sub>), 128.8 (C<sub>IV</sub>), 127.1 (C<sub>IV</sub>), 126.0 (CH<sub>ar-Phthal</sub>), 125.7 (CH<sub>ar-Phthal</sub>), 124.3 (CH<sub>ar</sub>), 123.1 (CH<sub>ar</sub>), 119.8 (CH<sub>ar</sub>), 38.8 (NMe<sub>Phthal</sub>), 37.7 (CH<sub>2</sub>), 30.5 (NMe), 28.7 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>22</sub>H<sub>20</sub>N<sub>6</sub>O<sub>4</sub>NaS (M + Na)<sup>+</sup> 487.1159, found 487.1154.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.2.30 <i>N</i>-(2,4-Dichlorophenyl)-<i>N</i>-methyl-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>63</b>)</h4><div class="NLM_p last">To a solution of <b>43</b> (0.1 g, 0.17 mmol) in anhydrous DMF (3 mL) was added NaH (1.2 equiv of a 60% suspension in oil) at 0 °C. Pure MeI (2 equiv, 22 μL) was then added, and after stirring during 2 h, the reaction was quenched with a saturated solution of NH<sub>4</sub>Cl, extracted twice with dichloromethane, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure. Purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>63</b> in 74% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.43 (dd, <i>J</i> = 7.5 and <i>J</i> = 1.7 Hz, 1H, H<sub>ar-Phthal</sub>), 8.24 (dd, <i>J</i> = 7.3 and <i>J</i> = 1.3 Hz, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.51 (d, <i>J</i> = 2.3 Hz, 1H, H<sub>ar</sub>), 7.32 (dd, <i>J</i> = 8.3 and <i>J</i> = 2.3 Hz, 1H, H<sub>ar</sub>), 7.19 (d, <i>J</i> = 8.3 Hz, 1H, H<sub>ar</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.15 (m, 5H, NMeCO and CH<sub>2</sub>S), 1.93 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CONH), 1.64 (m, 4H, 2 × CH<sub>2</sub>), 1.24 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ ppm 173.0 (CH<sub>2</sub><i>C</i>ONMe), 159.6 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 140.1 (C<sub>IV</sub>), 134.8 (C<sub>IV</sub>), 134.1 (C<sub>IV</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 130.8 (CH<sub>ar</sub>), 130.7 (CH<sub>ar</sub>), 128.7 (CH<sub>ar</sub>), 128.16 (C<sub>IV</sub>), 127.7 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 39.5 (NMe<sub>Phthal</sub>), 35.9 (SCH<sub>2</sub>), 33.9 (CH<sub>2</sub>CO), 33.1 (NMe<sub>Triaz</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 20.5 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 28.5 (CH<sub>2</sub>), 25.0 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>28</sub>H<sub>33</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 587.1763, found 587.1755.</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">4.2.31 <i>N</i>-(2,4-Dibromorophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>64</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2,4-dibromophenyl)octanamide (<b>21</b>, 3 mmol, 1.36 g) purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>64</b> in 85% yield, as a white powder; mp 153.5 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.44 (m, 1H, H<sub>ar-Phthal</sub>), 8.23 (m, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phtha</sub>), 7.66 (d, <i>J</i> = 2.2 Hz, 1H, H<sub>ar</sub>), 7.62 (bs, 1H, NH), 7.41 (dd, <i>J</i> = 8.7 and <i>J</i> = 2.2 Hz, 1H, H<sub>ar</sub>), 4.51 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.55 (s, 3H, NMe), 3.20 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.40 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.81–1.63 (m, 4H, 2 × CH<sub>2</sub>), 1.46–1.34 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.2 (CONH), 159.4 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 151.7 (C<sub>IV-C═N</sub>), 140.5 (C<sub>IV-C═N</sub>), 134.0 (C<sub>IV</sub>), 134.3 (CH<sub>ar</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 131.8 (CH<sub>ar-Phthal</sub>), 131.3 (CH<sub>ar</sub>), 129.9 (C<sub>IV</sub>), 127.9 (C<sub>IV</sub>), 127.0 (CH<sub>ar-Phthal</sub>), 125.2 (CH<sub>ar-Phthal</sub>), 122.9 (C<sub>IV</sub>), 39.4 (NMe<sub>Phthal</sub>), 37.7 (SCH<sub>2</sub>), 32.9 (<i>C</i>H<sub>2</sub>CO), 30.6 (NMe), 29.9 (CH<sub>2</sub>), 29.3 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 25.2 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600) calcd for C<sub>27</sub>H<sub>31</sub>Br<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 661.0590, found 661.0609.</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">4.2.32 <i>N</i>-(2,4-Dibromophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)sulfonyl)octanamide (<b>65</b>)</h4><div class="NLM_p last">To a solution of thioether <b>64</b> in DCM (0.01 M) was added portionwise <i>meta-</i>chloroperbenzoic acid (5 equiv). After completion of the reaction, the mixture was washed several times with a saturated solution of Na<sub>2</sub>CO<sub>3</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The solid residue was purified by column chromatography on silica gel (DCM/MeOH; 98:2) to give compound <b>65</b> in 74% yield, as a white powder; mp 175–176 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.47 (m, 1H, H<sub>ar-Phthal</sub>), 8.26 (m, 1H, H<sub>ar-Phthal</sub>), 8.13 (m, 1H, H<sub>ar-Phthal</sub>), 7.82 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.67 (d, <i>J</i> = 2.2 Hz, 1H, H<sub>ar</sub>), 7.56 (bs, 1H, NH), 7.42 (dd, <i>J</i> = 8.7 and <i>J</i> = 2.2 Hz, 1H, H<sub>ar</sub>), 4.55 (s, 2H, CH<sub>2</sub>), 3.97 (s, 3H, NMe<sub>Phthal</sub>), 3.79 (s, 3H, NMe), 3.62 (m, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.95 (m, 2H, CH<sub>2</sub>), 1.73 (m, 2H, CH<sub>2</sub>), 1.52 (m, 2H, CH<sub>2</sub>), 1.38 (m, 4H, 2 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.0 (CONH), 159.3 (CONMe), 153.9 (C<sub>IV-C═N</sub>), 152.4 (C<sub>IV-C═N</sub>), 139.7 (C<sub>IV-C═N</sub>), 134.9 (C<sub>IV</sub>), 134.3 (CH<sub>ar</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 131.4 (CH<sub>ar</sub>), 128.7 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 124.7 (CH<sub>ar-Phthal</sub>), 122.9 (C<sub>IV</sub>), 54.8 (SO<sub>2</sub>CH<sub>2</sub>), 39.4 (NMe<sub>Phthal</sub>), 37.7 (COCH<sub>2</sub>), 32.2 (NMe), 29.2 (CH<sub>2</sub>), 28.7 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 27.95 (CH<sub>2</sub>), 25.1 (CH<sub>2</sub>), 21.9 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>27</sub>H<sub>31</sub>Br<sub>2</sub>N<sub>6</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 693.0489, found 693.0492.</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">4.2.33 <i>N</i>-(2,4-Difluorophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>66</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2,4-difluorophenyl)octanamide (<b>22</b>, 3 mmol, 1.00 g) purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>66</b> in 72% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.41 (m, 1H, H<sub>ar-Phthal</sub>), 8.16 (m, 2H, H<sub>ar-Phthal</sub> and H<sub>ar</sub>), 7.77 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 6.82 (m, 2H, 2 × H<sub>ar</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.77 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.15 (t, <i>J</i> = 7.03 Hz, 2H, SCH<sub>2</sub>), 2.26 (t, <i>J</i> = 7.73 Hz, 2H, CH<sub>2</sub>CO), 1.68 (m, 4H, 2 × CH<sub>2</sub>), 1.45–1.25 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.7 (CONH), 159.6 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 129.0 (C<sub>IV</sub>), 127.9 (C<sub>IV</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.2 (CH<sub>ar-Phthal</sub>), 123.4 (d, <i>J</i><sub>CF</sub> = 8.94 Hz, CH<sub>ar</sub>), 111.2 (d, <i>J</i><sub>CF</sub> = 21.63 Hz, CH<sub>ar</sub>), 103.6 (t, <i>J</i><sub>CF</sub> = 27.28 Hz, CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.2 (CH<sub>2</sub>), 33.5 (CH<sub>2</sub>), 30.7 (NMe), 30.0 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 29.2–27.7 (3 × CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>27</sub>H<sub>31</sub>F<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 541.2192, found 541.2196.</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.2.34 <i>N</i>-(2-Chloro-4-methylphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>67</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g), and 8-bromo-<i>N</i>-(2-chloro-4-methylphenyl)octanamide (<b>23</b>, 3 mmol, 1.04 g) purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>67</b> in 74% yield, as a white powder; mp 151–152 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.23 (m, 1H, H<sub>ar-Phthal</sub>), 8.19 (d, <i>J</i> = 8.4 Hz, 1H, H<sub>ar</sub>), 7.77 (m, 2H, 2 × H<sub>ar-Phtha</sub>), 7.54 (bs, 1H, NH), 7.16 (d, <i>J</i> = 1.24 Hz, 1H, H<sub>ar</sub>), 7.05 (dd, <i>J</i> = 8.4 and <i>J</i> = 1.9 Hz, 1H, H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.18 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.37 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 2.29 (s, 3H, CH<sub>3</sub>), 1.72 (m, 4H, 2 × CH<sub>2</sub>), 1.46–1.34 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.1 (CONH), 159.4 (CONMe), 152.0 (C<sub>IV-C═N</sub>), 151.8 (C<sub>IV-C═N</sub>), 140.6 (C<sub>IV-C═N</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 132.0 (C<sub>IV</sub>), 131.8 (CH<sub>ar-Phthal</sub>), 129.2 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.3 (CH<sub>ar</sub>), 127.9 (C<sub>IV</sub>), 127.0 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.7 (C<sub>IV</sub>), 39.3 (NMe<sub>Phthal</sub>), 37.8 (SCH<sub>2</sub>), 33.0 (CH<sub>2</sub>CO), 30.6 (NMe), 30.0 (CH<sub>2</sub>), 29.3 (CH<sub>2</sub>), 29.0 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>), 20.6 (CH<sub>3</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>28</sub>H<sub>34</sub>ClN<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 553.2147, found 553.2165.</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">4.2.35 <i>N</i>-(2,4-Difluorophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>68</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g), and 8-bromo-<i>N</i>-(2,4-dimethoxyphenyl)octanamide (<b>24</b>, 3 mmol, 1.07 g) purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>68</b> in 74% yield, as a white powder; mp 118–120 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 9.2 and <i>J</i> = 1.6 Hz, 1H, H<sub>ar-Phthal</sub>), 8.23 (m, 2H, H<sub>ar</sub> and H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.54 (bs, 1H, NH), 6.45 (m, 2H, 2 × H<sub>ar</sub>), 4.52 (s, 2H, CH<sub>2</sub>), 3.84 (s, 3H, OMe), 3.8 (s, 3H, NMe<sub>Phthal</sub>), 3.78 (s, 3H, OMe), 3.55 (s, 3H, NMe), 3.20 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.34 (t, <i>J</i> = 7.35 Hz, 2H, CH<sub>2</sub>CO), 1.78–1.61 (m, 4H, 2 × CH<sub>2</sub>), 1.46–1.25 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 170.9 (CONH), 159.5 (CONMe), 156.3 (C<sub>IV</sub>), 152.4 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.2 (C<sub>IV</sub>), 140.6 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 127.9 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.4 (CH<sub>ar</sub>), 120.7 (C<sub>IV</sub>), 103.8 (CH<sub>ar</sub>), 98.7 (CH<sub>ar</sub>), 55.8 (OMe), 55.7 (OMe), 39.5 (NMe<sub>Phthal</sub>), 37.9 (<i>C</i>H<sub>2</sub>CO), 33.2 (SCH<sub>2</sub>), 30.9 (NMe), 29.9 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 28.5 (CH<sub>2</sub>), 25.6 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>29</sub>H<sub>37</sub>N<sub>6</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 565.2592, found 565.2574.</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">4.2.36 <i>N</i>-(2-Hydroxy-4-methoxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>69</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2-hydroxy-4-methoxyphenyl)octanamide (<b>26</b>, 1.5 mmol, 0.52 g) purification by column chromatography on silica gel (DCM/MeOH; 95:5 to 90:10) afforded compound <b>69</b> in 48% yield, as a white powder; mp 154–155 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.67 (s, H, OH), 8.44 (m, 1H, H<sub>ar-Phthal</sub>), 8.10 (dd, 1H, <i>J</i> = 6.4 and <i>J</i> = 1.7 Hz, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.08 (d, <i>J</i> = 8.7 Hz, 1H, H<sub>ar</sub>), 6.56 (d, <i>J</i> = 2.7 Hz, 1H, H<sub>ar</sub>), 6.32 (dd, <i>J</i> = 8.7 and <i>J</i> = 2.8 Hz, 1H, H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 3.78 (s, 3H, NMe<sub>Phthal</sub>), 3.73 (s, 3H, OMe), 3.59 (s, 3H, NMe), 3.19 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.43 (t, <i>J</i> = 7.35 Hz, 2H, CH<sub>2</sub>CO), 1.72 (m, 4H, 2 × CH<sub>2</sub>), 1.45–1.34 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.3 (CONH), 159.4 (CONMe), 158.6 (C<sub>IV</sub>), 152.9 (C<sub>IV-C═N</sub>), 150.2 (C<sub>IV-C═N</sub>), 140.1 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 128.7 (C<sub>IV</sub>), 127.9 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 124.8 (CH<sub>ar-Phthal</sub>), 123.1 (CH<sub>ar</sub>), 119.6 (C<sub>IV</sub>), 106.2 (CH<sub>ar</sub>), 104.2 (CH<sub>ar</sub>), 55.4 (OMe), 39.4 (NMe<sub>Phthal</sub>), 36.4 (<i>C</i>H<sub>2</sub>CO), 32.7 (SCH<sub>2</sub>), 30.9 (NMe), 28.5 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 27.4 (CH<sub>2</sub>), 27.3 (CH<sub>2</sub>), 25.2 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>28</sub>H<sub>35</sub>N<sub>6</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 551.2435, found 551.2441.</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">4.2.37 <i>N</i>-(2,4-Dihydroxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>70</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2,4-dihydroxy-phenyl)octanamide (<b>25</b>, 2 mmol, 0.66 g) purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>70</b> in 40% yield, as a pink powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.54 (bs, 1H, NH), 9.13 (s, 1H, OH), 9.08 (s, 1H, OH), 8.30 (d, <i>J</i> = 7.5 Hz, 1H, H<sub>ar-Phthal</sub>), 8.06 (d, <i>J</i> = 7.5 Hz, 1H, H<sub>ar-Phthal</sub>), 7.89 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.20 (d, <i>J</i> = 8.6 Hz, 1H, H<sub>ar</sub>), 6.28 (d, <i>J</i> = 2.6 Hz, 1H, H<sub>ar</sub>), 6.17 (dd, <i>J</i> = 8.6 and <i>J</i> = 2.7 Hz, 1H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 3.66 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.06 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.29 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 1.64–1.51 (m, 4H, 2 × CH<sub>2</sub>), 1.39–1.24 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.5 (CONH), 158.3 (C<sub>IV</sub>), 154.9 (C<sub>IV</sub>), 152.5 (C<sub>IV-C═N</sub>), 149.5 (C<sub>IV</sub>), 146.6 (C<sub>IV</sub>), 141.04 (C<sub>IV-C═N</sub>), 133.0 (CH<sub>ar-Phthal</sub>), 131.75 (CH<sub>ar-Phthal</sub>), 128.7 (C<sub>IV</sub>), 127.8 (C<sub>IV</sub>), 125.9 (CH<sub>ar-Phthal</sub>), 125.6 (CH<sub>ar-Phthal</sub>), 123.9 (C<sub>IV</sub>), 117.9 (C<sub>IV</sub>), 105.8 (CH<sub>ar</sub>), 103.3 (CH<sub>ar</sub>), 38.7 (NMe<sub>Phthal</sub>), 35.4 (<i>C</i>H<sub>2</sub>CO), 32.6 (SCH<sub>2</sub>), 30.2 (NMe), 28.9 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 28 (CH<sub>2</sub>), 27.6 (CH<sub>2</sub>), 25.1 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>27</sub>H<sub>33</sub>N<sub>6</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 537.2279, found 537.2302.</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">4.2.38 <i>N</i>-(4-Chlorophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>71</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 0.7 mmol, 0.20 g) and 8-bromo-<i>N</i>-(4-chlorophenyl)octanamide (<b>27</b>, 0.84 mmol, 0.28 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>71</b> in 31% yield, as a yellowish powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.47 (br s, 1H, NH), 8.42 (m, 1H, H<sub>ar-Phthal</sub>), 8.13 (m, 1H, H<sub>ar-Phthal</sub>), 7.76 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.54 (d, <i>J</i> = 8.8 Hz, 2H, 2 × H<sub>ar</sub>), 7.19 (d, <i>J</i> = 8.8 Hz, 2H, 2 × H<sub>ar</sub>), 4.50 (s, 2H, CH<sub>2</sub>), 3.78 (s, 3H, NMe<sub>Phthal</sub>), 3.56 (s, 3H, NMe), 3.15 (t, <i>J</i> = 7.27, 2H, SCH<sub>2</sub>), 2.30 (t, <i>J</i> = 7.37, 2H, CH<sub>2</sub>CO), 1.61–1.72 (m, 4H, 2 × CH<sub>2</sub>), 1.25–1.61 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 172.0 (CONH), 159.5 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 152.1 (C<sub>IV-C═N</sub>), 140.5 (C<sub>IV</sub>), 137.3 (C<sub>IV</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.1 (CH<sub>ar-Phthal</sub>), 128.9 (CH<sub>ar</sub>), 128.7 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.1 (CH<sub>ar-Phthal</sub>), 121.1 (CH<sub>ar</sub>), 39.6 (NMe<sub>Phthal</sub>), 37.5 (CH<sub>2</sub>CO), 33.0 (SCH<sub>2</sub>), 31.0 (NMe), 29.9 (CH<sub>2</sub>), 29.2 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 25.2 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>27</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>SCl (M + H)<sup>+</sup> 539.1990, found 539.1999.</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">4.2.39 <i>N</i>-(4-Iodophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>72</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 0.43 mmol, 0.12 g), and 8-bromo-<i>N</i>-(4-iodophenyl)octanamide (<b>28</b>, 1.1 equiv, 0.20 g). The crude precipitate was taken up in dichloromethane, and the product was filtrered and washed with petroleum ether to give <b>72</b> in 49% yield, as a white powder; mp 120–121 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.95 (s, 1H, NH), 8.34 (m, 1H, H<sub>ar-Phthal</sub>), 8.1 (m, 1H, H<sub>ar-Phthal</sub>), 7.9 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.60 (m, 2H, 2 × H<sub>ar</sub>), 7.41 (m, 2H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 3.66 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.05 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.27 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.60–1.55 (m, 4H, 2 × CH<sub>2</sub>), 1.35–1.26 (m, 6H, CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.4 (CONH), 158.4 (CONMe), 152.6 (C<sub>IV-C═N</sub>), 149.6 (C<sub>IV-C═N</sub>), 141.2 (C<sub>IV-C═N</sub>), 139.1 (C<sub>IV</sub>), 137.3 (CH<sub>ar</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 128.9 (C<sub>IV</sub>), 127.2 (C<sub>IV</sub>), 126.1 (CH<sub>ar-Phthal</sub>), 125.7 (CH<sub>ar-Phthal</sub>), 121.2 (CH<sub>ar</sub>), 86.2 (C<sub>IV-C–I</sub>), 38.9 (NMe<sub>Phthal</sub>), 36.4 (CH<sub>2</sub>CO), 32.7 (SCH<sub>2</sub>), 30.4 (NMe), 29.0 (CH<sub>2</sub>), 28.7 (CH<sub>2</sub>), 28.5 (CH<sub>2</sub>), 28.2 (CH<sub>2</sub>), 27.7 (CH<sub>2</sub>), 24.9 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>27</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>SI (M + H)<sup>+</sup> 631.1346, found 631.1319.</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">4.2.40 <i>N</i>-(4-Azidophenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>73</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(4-azidophenyl)octanamide (<b>32</b>, 1.5 mmol, 0.51 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>73</b> in 87% yield, as a white powder; mp 96.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.19 (m, 1H, H<sub>ar-Phthal</sub>), 7.95 (bs, 1H, NH), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.57 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.93 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.78 (s, 3H, NMe<sub>Phthal</sub>), 3.57 (s, 3H, NMe), 3.16 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.30 (t, <i>J</i> = 7.7 Hz, 2H, CH<sub>2</sub>CO), 1.73–1.65 (m, 4H, 2 × CH<sub>2</sub>), 1.43–1.28 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.7 (CONH), 159.6 (CONMe), 152.2 (C<sub>IV</sub>), 152.1 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 135.6 (C<sub>IV</sub>), 135.5 (CH<sub>ar</sub>)133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.4 (2 × CH<sub>ar</sub>), 119.5 (2 × CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.6 (<i>C</i>H<sub>2</sub>CO), 33.1 (SCH<sub>2</sub>), 30.8 (NMe), 30.2 (CH<sub>2</sub>), 29.3 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.2 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>27</sub>H<sub>32</sub>N<sub>9</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 546.2400, found 546.2403.</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">4.2.41 <i>N</i>-(4-Methoxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>74</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(4-methoxyphenyl)octanamide (<b>29</b>, 3 mmol, 1.00 g), purification by column chromatography on silica gel (DCM/MeOH; 96:4) afforded compound <b>74</b> in 89% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (m, 1H, H<sub>ar-Phthal</sub>), 7.82–7.72 (m, 3H, NH and 2 × H<sub>ar-Phthal</sub>), 7.44 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.81 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.76 (s, 3H, OMe), 3.55 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.28 (t, <i>J</i> = 7.8 Hz, 2H, CH<sub>2</sub>CO), 1.75–1.61 (m, 4H, 2 × CH<sub>2</sub>), 1.46–1.20 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.6 (CONMe), 156.3 (C<sub>IV</sub>), 152.1 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.6 (C<sub>IV</sub>), 129.1 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.8 (2 × CH<sub>ar</sub>), 114.2 (2 × CH<sub>ar</sub>), 55.6 (OMe), 39.5 (NMe<sub>Phthal</sub>), 37.5 (<i>C</i>H<sub>2</sub>CO), 33.1 (SCH<sub>2</sub>), 30.8 (NMe), 30.2 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 25.5 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>28</sub>H<sub>35</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 535.2491, found 535.2500.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">4.2.42 <i>N</i>-(2-Hydroxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>75</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(2-hydroxyphenyl)octanamide (<b>30</b>, 2 mmol, 0.63 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>75</b> in 65% yield, as a white powder; mp 180.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (dd, <i>J</i> = 7.6 and <i>J</i> = 1.2 Hz, 1H, H<sub>ar-Phthal</sub>), 8.08 (d, 1H, H<sub>ar-Phthal</sub>), 7.76 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.40 (d, <i>J</i> = 8 Hz, 1H, 2 × H<sub>ar</sub>), 6.96 (t, <i>J</i> = 8.2 Hz, 1H, H<sub>ar</sub>), 6.88 (d, <i>J</i> = 8 Hz, 1H, H<sub>ar</sub>), 6.77 (t, <i>J</i> = 7.3 Hz, 1H, H<sub>ar</sub>), 4.45 (s, 2H, CH<sub>2</sub>), 3.74 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.11 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.36 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.66 (m, 4H, 2 × CH<sub>2</sub>), 1.44–1.32 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.2 (CONH), 159.6 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.7 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 128.7 (C<sub>IV</sub>), 127.7 (C<sub>IV</sub>), 126.9 (CH<sub>ar</sub>), 126.1 (C<sub>IV</sub>), 125.7 (CH<sub>ar-Phthal</sub>), 124.8 (CH<sub>ar-Phthal</sub>), 121.6 (CH<sub>ar</sub>), 120.0 (CH<sub>ar</sub>), 117.7 (CH<sub>ar</sub>), 39.3 (NMe<sub>Phthal</sub>), 36.6 (<i>C</i>H<sub>2</sub>CO), 32.9 (SCH<sub>2</sub>), 30.7 (NMe), 29.4 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>27</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 521.2329, found 521.2353.</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">4.2.43 Ethyl 3-(8-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamido)benzoate (<b>76</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and ethyl 3-(8-bromo octanamido)benzoate (<b>31</b>, 3 mmol, 1.11 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>76</b> in 72% yield, as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.39 (m, 1H, H<sub>ar-Phthal</sub>), 8.34 (bs, 1H, NH), 8.16 (m, 1H, H<sub>ar-Phthal</sub>), 8.06 (s, 1H, H<sub>ar</sub>), 7.94 (d, <i>J</i> = 7.8 Hz, 1H, H<sub>ar</sub>), 7.74 (m, 3H, H<sub>ar</sub> and 2 × H<sub>ar-Phthal</sub>), 7.33 (t, <i>J</i> = 7.9 Hz, 1H, H<sub>ar</sub>), 4.50 (s, 2H, CH<sub>2</sub>), 4.32 (q, <i>J</i> = 7.0 Hz, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.78 (s, 3H, NMe-<sub>Phthal</sub>), 3.57 (s, 3H, NMe), 3.16 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.35 (t, <i>J</i> = 7.4 Hz 2H, CH2CO), 1.69 (m, 4H, 2 × CH<sub>2</sub>), 1.37 (t, <i>J</i> = 7.1 Hz, 3H, CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.4–1.30 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.1 (CONH), 166.4 (<i>C</i>OOEt), 159.5 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 152.1 (C<sub>IV-C═N</sub>), 140.7 (C<sub>IV-C═N</sub>), 138.8 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.2 (C<sub>IV</sub>), 129.1 (C<sub>IV</sub>), 129.0 (CH<sub>ar</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.2 (CH<sub>ar-Phthal</sub>), 124.9 (CH<sub>ar</sub>), 124.4 (CH<sub>ar</sub>), 120.7 (CH<sub>ar</sub>), 61.1 (<i>C</i>H<sub>2</sub>CH<sub>3</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.6 (CH<sub>2</sub>CO), 33.1 (SCH<sub>2</sub>), 30.8 (NMe), 30.0 (CH<sub>2</sub>), 29.4 (2 × CH<sub>2</sub>), 28.7 (CH<sub>2</sub>), 28.2 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>), 25.3 (2 × CH<sub>2</sub>), 14.4 (CH<sub>2</sub><i>C</i>H<sub>3</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>3O</sub>H<sub>37</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 577.2592, found 577.2608.</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">4.2.44 8-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)-<i>N</i>-(naphthalen-1-yl)octanamide (<b>77</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 0.7 mmol, 0.20 g) and 8-bromo-<i>N</i>-(1-naphthalen-1-yl)octanamide (<b>33</b>, 0.84 mmol, 0.29 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>77</b> in 44% yield, as a yellowish powder; mp 162–163 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.37 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (bs, 1H, NH), 8.05 (m, 1H, H<sub>ar-Phthal</sub>), 7.9–7.65 (m, 6H, 6 × Har), 7.43 (m, 3H, 3 × Har), 4.39 (s, 2H, CH<sub>2</sub>), 3.75 (s, 3H, NMe<sub>Phthal</sub>), 3.51 (s, 3H, NMe), 3.22 (t, <i>J</i> = 7.1 Hz, 2H, SCH<sub>2</sub>), 2.53 (t, <i>J</i> = 7.3 Hz, 2H, CH<sub>2</sub>CO), 1.82–1.73 (m, 4H, 2 × CH<sub>2</sub>), 1.48–1.41 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 172.3 (CONH), 159.4 (CONMe), 152.3 (C<sub>IV</sub>), 151.8 (C<sub>IV</sub>), 140.3 (C<sub>IV</sub>), 134.1 (C<sub>IV</sub>), 133.3 (CH<sub>ar</sub>), 132.6 (CH<sub>ar</sub>), 131.9 (CH<sub>ar</sub>), 128.8 (CH<sub>ar</sub>), 128.6 (CH<sub>ar</sub>), 127.8 (CH<sub>ar-Phthal</sub>), 127.5 (CH<sub>ar-Phthal</sub>), 127.0 (CH<sub>ar-Phthal</sub>), 126.1 (CH<sub>ar</sub>), 125.9 (CH<sub>ar</sub>), 125.7 (CH<sub>ar</sub>), 125.0 (CH<sub>ar</sub>), 121.4 (CH<sub>ar</sub>), 121.2 (CH<sub>ar</sub>), 39.4 (NMe<sub>Phthal</sub>), 37.4 (<i>C</i>H<sub>2</sub>CO), 32.9 (SCH<sub>2</sub>), 30.7 (NMe), 29.5 (CH<sub>2</sub>), 29.2 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 25.5 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>31</sub>H<sub>35</sub>N<sub>9</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 555.2537, found 555.2545.</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">4.2.45 <i>N</i>-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>78</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>4</b>, 1 mmol, 0.29 g) and 8-bromo-<i>N</i>-(adamantan-1-yl)octanamide (<b>34</b>, 3 mmol, 1.06 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>78</b> in 75% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.37 (m, 1H, H<sub>ar-Phthal</sub>), 8.18 (m, 1H, H<sub>ar-Phthal</sub>), 7.76 (m, 1H, H<sub>ar-Phthal</sub>), 7.71 (m, 1H, H<sub>ar-Phthal</sub>), 5.26 (bs, 1H, NH), 4.44 (s, 2H, CH<sub>2</sub>), 3.75 (s, 3H, NMe<sub>Phthal</sub>), 3.51 (s, 3H, NMe), 3.12 (t, <i>J</i> = 7.1 Hz, 2H, SCH<sub>2</sub>), 2.00 (m, 5H, CH<sub>2</sub>CO and 3 × CH<sub>adam</sub>), 1.94 (m, 6H, 3 × CH<sub>2-adam</sub>), 1.65 (m, 2H, CH<sub>2</sub>), 1.61 (m, 6H, 3 × CH<sub>2-adam</sub>), 1.51 (m, 2H, CH<sub>2</sub>), 1.42–1.13 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 172.4 (CONH), 159.5 (CONMe), 151.9 (C<sub>IV-C═N</sub>), 151.8 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 127.8 (C<sub>IV</sub>), 127.0 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 51.7 (C<sub>IV-adam</sub>), 41.7 (3 × CH<sub>2 adam</sub>), 39.8 (NMe<sub>Phthal</sub>), 37.6 (CH<sub>2</sub>), 36.4 (3 × CH<sub>2 adam</sub>), 33.0 (SCH<sub>2</sub>), 30.6 (NMe), 30.2 (CH<sub>2</sub>), 30.3–27.6 (3 × CH<sub>2</sub>), 29.4 (3 × CH<sub>adam</sub>), 29.3 (CH<sub>2</sub>), 25.7 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>31</sub>H<sub>43</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 563.3163, found 563.3163.</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">4.2.46 <i>N</i>-(4-Hydroxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>79</b>)</h4><div class="NLM_p last">To a solution of benzamide <b>74</b> (1 equiv) in anhydrous DCM (0.01 mmol·mL<sup>–1</sup>) under argon atmosphere at 0 °C was added dropwise a solution of boron tribromide in DCM (8 equiv). The mixture was then stirred at room temperature overnight. The mixture was quenched by slow addition of MeOH at 0 °C and concentrated. The crude powder was purified by flash column chromatography on silica gel (CHCl<sub>3</sub>/MeOH; 95:5) to give <b>79</b> in 94% yield as a beige powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.56 (s, 1H, OH), 8.31 (dd, <i>J</i> = 7.6 and <i>J</i> = 1.3 Hz, 1H, H<sub>ar-Phthal</sub>), 8.07 (d, <i>J</i> = 7.6 Hz, 1H, H<sub>ar-Phthal</sub>), 7.98–7.87 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.34 (d, <i>J</i> = 8.9 Hz, 2H, 2 × H<sub>ar</sub>), 6.66 (d, <i>J</i> = 8.9 Hz, 2 × H<sub>ar</sub>), 4.70 (s, 2H, CH<sub>2</sub>), 3.65 (s, 3H, NMe<sub>Phthal</sub>), 3.64 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.22 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.65 (quint, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>C<i>H</i><sub>2</sub>), 1.55 (quint, <i>J</i> = 7.0 Hz, 2H, CH<sub>2</sub>), 1.42–1.34 (m, 2H, CH<sub>2</sub>), 1.32–1.24 (m, 4H, 2 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 170.4 (CONH), 158.4 (CONMe), 153.0 (C<sub>IV</sub>), 152.9 (C<sub>IV-C═N</sub>), 151.6 (C<sub>IV-C═N</sub>), 139.9 (C<sub>IV-C═N</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.0 (C<sub>IV</sub>), 128.6 (C<sub>IV</sub>), 127.2 (C<sub>IV</sub>), 126.1 (CH<sub>ar-Phthal</sub>), 125.5 (CH<sub>ar-Phthal</sub>), 120.8 (2 × CH<sub>ar</sub>), 114.9 (2 × CH<sub>ar</sub>), 38.8 (NMe<sub>Phthal</sub>), 36.1 (CH<sub>2</sub>), 32.7 (CH<sub>2</sub>), 31.2 (NMe), 28.8 (CH<sub>2</sub>), 28.5 (CH<sub>2</sub>), 28.1 (2 × CH<sub>2</sub>), 27.6 (CH<sub>2</sub>), 25.1 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>27</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 521.2335, found 521.2349.</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">4.2.47 8-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)-<i>N</i>-(4-propoxyphenyl)octanamide (<b>80</b>)</h4><div class="NLM_p last">To a solution of phenol <b>79</b> (1 equiv) in anhydrous DMF (0.04 mmol·mL<sup>–1</sup>) under argon atmosphere was added dropwise 1-bromopropane (5 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (5 equiv). The mixture was then stirred at 60 °C overnight and quenched at 0 °C by addition of a saturated solution of ammonium chloride. The aqueous phase was extracted twice with AcOEt, and the organic phase was washed 5 times with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash column chromatography on silica gel (DCM/MeOH; 95:5) to give <b>80</b> in 59% yield as a white powder; mp 117–118 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 6.8 and <i>J</i> = 2.3 Hz, 1H, H<sub>ar-Phthal</sub>), 8.18 (dd, <i>J</i> = 6.1 and <i>J</i> = 2.1 Hz, 1H, H<sub>ar-Phthal</sub>), 7.84 (bs, 1H, NH), 7.81–7.71 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.42 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.80 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 3.86 (t, <i>J</i> = 6.6 Hz, 2H, OCH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.55 (s, 3H, NMe), 3.15 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.28 (t, <i>J</i> = 7.7 Hz, 2H, COCH<sub>2</sub>), 1.83–1.73 (m, 2H, CH<sub>2</sub>), 1.72–1.62 (m, 4H, 2 × CH<sub>2</sub>), 1.42–1.26 (m, 6H, 3 × CH<sub>2</sub>), 1.00 (t, <i>J</i> = 7.5 Hz, 3H, CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.6 (CONMe), 155.8 (C<sub>IV</sub>), 152.1 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.4 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.7 (2 × CH<sub>ar</sub>), 114.8 (2 × CH<sub>ar</sub>), 69.9 (OCH<sub>2</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.5 (CH<sub>2</sub>), 33.1 (CH<sub>2</sub>), 30.8 (NMe), 30.1 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 25.5 (CH<sub>2</sub>), 22.7 (CH<sub>2</sub>), 10.6 (CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>30</sub>H<sub>39</sub>N<sub>6</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 563.2804; found 563.2793.</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">4.2.48 <i>N</i>-(4-Isopropoxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>81</b>)</h4><div class="NLM_p last">To a solution of phenol <b>79</b> (1 equiv) in anhydrous DMF (0.04 mmol·mL<sup>–1</sup>) under argon atmosphere was added dropwise 2-bromopropane (5 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (5 equiv). The mixture was then stirred at 60 °C overnight and quenched at 0 °C by addition of a saturated solution of ammonium chloride. The aqueous phase was extracted twice with AcOEt, and the organic phase was washed 5 times with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography on silica gel (DCM/MeOH; 95:5) to give <b>81</b> in 90% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 6.9 and <i>J</i> = 2.3 Hz, 1H, H<sub>ar-Phthal</sub>), 8.19 (d, <i>J</i> = 6.9 Hz, 1H, H<sub>ar-Phthal</sub>), 7.81–7.71 (m, 3H, NH and 2 × H<sub>ar-Phthal</sub>), 7.42 (d, <i>J</i> = 8.9 Hz, 2H, 2 × Har), 6.80 (d, <i>J</i> = 8.9 Hz, 2H, 2 × Har), 4.51–4.42 (m, 3H, CH<sub>2</sub> and CH), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.55 (s, 3H, NMe), 3.15 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.28 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 1.73–1.62 (m, 4H, 2 × CH<sub>2</sub>), 1.41–1.27 (m, 12H, 3 × CH<sub>2</sub> and 2 × CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.6 (CONMe), 154.5 (C<sub>IV</sub>), 152.0 (2 × C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.4 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.7 (2 × CH<sub>ar</sub>), 116.5 (2 × CH<sub>ar</sub>), 70.4 (CH–O), 39.5 (NMe<sub>Phthal</sub>), 37.5 (CH<sub>2</sub>), 33.1 (CH<sub>2</sub>), 30.8 (NMe), 30.2 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 25.5 (CH<sub>2</sub>), 22.2 (2 × CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>30</sub>H<sub>38</sub>N<sub>6</sub>NaO<sub>3</sub>S (M + Na)<sup>+</sup> 585.2624, found 585.2631.</div></div><div id="sec4_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">4.2.49 <i>N</i>-(4-Isobutoxyphenyl)-8-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamide (<b>82</b>)</h4><div class="NLM_p last">To a solution of phenol <b>79</b> (1 equiv) in anhydrous DMF (0.04 mmol·mL<sup>–1</sup>) under argon atmosphere was added dropwise 1-iodo-2-methylpropane (10 equiv) followed by K<sub>2</sub>CO<sub>3</sub> (10 equiv). The mixture was then stirred at 60 °C overnight and quenched at 0 °C by addition of a saturated solution of ammonium chloride. The aqueous phase was extracted twice with AcOEt, and the organic phase was washed 5 times with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude product was purified by flash chromatography on silica gel (DCM/MeOH; 97:3) to give <b>82</b> in 83% yield as a beige powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 6.9 and <i>J</i> = 2.3 Hz, 1H, H<sub>ar-Phthal</sub>), 8.18 (d, <i>J</i> = 6.6 Hz, 1H, H<sub>ar-Phthal</sub>), 7.85 (bs, 1H, NH), 7.80–7.71 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.41 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 6.79 (d, <i>J</i> = 9.0 Hz, 2H, 2 × H<sub>ar</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.66 (d, <i>J</i> = 7.2 Hz, 2H, OCH<sub>2</sub>), 3.55 (s, 3H, NMe), 3.15 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.28 (t, <i>J</i> = 7.2 Hz, 2H, CH<sub>2</sub>CO), 1.99 (m, 1H, CH), 1.74–1.59 (m, 4H, 2 × CH<sub>2</sub>), 1.43–1.25 (m, 6H, 3 × CH<sub>2</sub>), 0.99 (d, <i>J</i> = 6.7 Hz, 6H, 2 × CH<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.6 (CONMe), 156.0 (C<sub>IV</sub>), 152.0 (2 × C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.0 (CH<sub>ar-Phthal</sub>), 131.4 (C<sub>IV</sub>), 129.0 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.7 (2 × CH<sub>ar</sub>), 114.8 (2 × CH<sub>ar</sub>), 74.8 (OCH<sub>2</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.5 (CH<sub>2</sub>CO), 33.1 (SCH<sub>2</sub>), 30.7 (NMe), 30.1 (CH<sub>2</sub>), 29.4 (CH<sub>2</sub>), 28.8 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 28.4 (CH), 28.1 (CH<sub>2</sub>), 25.4 (CH<sub>2</sub>), 19.4 (2 × CH<sub>3</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>31</sub>H<sub>40</sub>N<sub>6</sub>O<sub>3</sub>NaS (M + Na)<sup>+</sup> 599.2780, found 599.2800.</div></div><div id="sec4_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">4.2.50 3-(8-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)octanamido) Benzoic Acid (<b>83</b>)</h4><div class="NLM_p last">To a suspension of the ester <b>76</b> (0.3 mmol, 0.10 g) in dioxane (5 mL), LiOH (10 equiv, 1 M solution in water) was added, and the mixture was stirred until starting material disappeared. The reaction was diluted with water (15 mL) and acidified to pH = 2. Elimination of volatiles under reduced pressure gave a precipitate, which was filtered and washed with Et<sub>2</sub>O to give the pure compound <b>83</b> in 50% yield as a white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1H, NH), 8.3 (m, 1H, H<sub>ar-Phthal</sub>), 8.22 (s, 1H H<sub>ar</sub>), 8.06 (m, 1H, H<sub>ar-Phthal</sub>), 8.06 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.79 (d, <i>J</i> = 8.1 Hz, 1H, H<sub>ar</sub>), 7.59 (d, 1H, <i>J</i> = 8.1 Hz, 1H, H<sub>ar</sub>), 7.39 (t, <i>J</i> = 8.1 Hz, 1H, H<sub>ar</sub>), 4.53 (s, 2H, CH<sub>2</sub>), 3.66 (s, 3H, NMe<sub>Phthal</sub>), 3.55 (s, 3H, NMe), 3.06 (t, <i>J</i> = 7.2 Hz, 2H, SCH<sub>2</sub>), 2.30 (t, <i>J</i> = 7.3 Hz 2H, CH<sub>2</sub>CO), 1.67–1.56 (m, 4H, 2 × CH<sub>2</sub>), 1.38–1.20 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 172.3 (CONH), 158.3 (CONMe), 152.5 (C<sub>IV-C═N</sub>), 149.5 (C<sub>IV-C═N</sub>), 141.04 (C<sub>IV-C═N</sub>), 139.3 (C<sub>IV</sub>), 133.0 (CH<sub>ar-Phthal</sub>), 131.7 (CH<sub>ar-Phthal</sub>), 128.2 (2 × CH<sub>ar</sub>), 127.1 (C<sub>IV</sub>), 125.8 (C<sub>IV</sub>), 125.6 (CH<sub>ar-Phthal</sub>), 125.6 (CH<sub>ar</sub>), 123.6 (CH<sub>ar</sub>), 122.8 (C<sub>IV</sub>), 119.67 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 36.2 (CH<sub>2</sub>CO), 32.6 (SCH<sub>2</sub>), 30.2 (NMe), 28.9 (CH<sub>2</sub>), 28.6 (CH<sub>2</sub>), 28.3 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 27.5 (CH<sub>2</sub>), 24.79 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>28</sub>H<sub>32</sub>N<sub>6</sub>O<sub>2</sub>NaS (M + Na)<sup>+</sup> 571.2098, found 571.2121.</div></div><div id="sec4_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">4.2.51 <i>N</i>-(2,4-Dichlorophenyl)-5-(4-(((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)pentanamide (<b>84</b>)</h4><div class="NLM_p last">To a solution of alkyne <b>55</b> (0.21 mmol, 68 mg) and azide <b>40</b> (0.21 mmol, 60 mg) in <i>t</i>BuOH/H<sub>2</sub>O (1.1) were added sodium ascorbate (0.1 equiv, 110 μL of a 0.2 M water solution) and CuSO<sub>4</sub>·5H<sub>2</sub>O (0.01 equiv, 10 μL of a 0.2 M water solution). After stirring at 60 °C during 20 h, a saturated solution of Na<sub>2</sub>CO<sub>3</sub> was added, and the aqueous phase was extracted with dichloromethane. The organic layer was washed with brine, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The residue was then purified by column chromatography on silica gel (DCM/petroleum ether; 99:1 to 96:4) to give compound <b>84</b> with 60% yield as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 7.5 and <i>J</i> = 1.5 Hz, 1H, H<sub>ar-Phthal</sub>), 8.22 (d, <i>J</i> = 8.8 Hz, 1H, H<sub>ar</sub>), 8.21 (m, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 3H, 2 × H<sub>ar-Phthal</sub> and H<sub>ar</sub>), 7.69 (s, 1H, CH<sub>Triaz</sub>), 7.34 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.20 (dd, <i>J</i> = 8.9 Hz and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 4.28 (t, <i>J</i> = 7.4 Hz, 2H, NCH<sub>2</sub>), 3.78 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 2.41 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 1.92 (m, 6H, 3 × CH<sub>2</sub>), 1.68 (m, 2H, CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 170.3 (CONH), 159.4 (CONMe), 152.3 (C<sub>IV-C═N</sub>), 143.5 (C<sub>IV-C═N</sub>), 140.4 (C<sub>IV-C═N</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 133.2 (CH<sub>arl</sub>, 131.8 (CH<sub>ar-Phthal</sub>), 128.8 (CH), 128.7 (CH<sub>ar</sub>), 127.9 (CH<sub>ar</sub>), 127.8 (CH<sub>ar</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.0 (C<sub>IV</sub>), 123.4 (CH), 123.3 (CH<sub>ar</sub>), 122.7 (CH<sub>ar</sub>), 49.8 (CH<sub>2</sub>–Ntriaz), 39.4 (NMe <sub>Phthal</sub>), 36.5 (<i>C</i>H<sub>2</sub>CO), 30.7 (NMe), 29.7 (CH<sub>2</sub>), 27.2 (CH<sub>2</sub>S), 22.0 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>27</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 612.1458, found 612.1460.</div></div><div id="sec4_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">4.2.52 <i>N</i>-(2,4-Dichlorophenyl)-8-((5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1,3,4-oxadiazol-2-yl)thio)octanamide (<b>85</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-1,3,4-oxadiazol-2-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>5</b>, 0.55 mmol, 0.15 g) and 8-bromo-<i>N</i>-(2,4-dichlorophenyl)octanamide (<b>10</b>, 0.66 mmol, 0.24 g), purification by column chromatography on silica gel (DCM/ethyl acetate; 90:10) afforded <b>85</b> in 20% yield, as a beige powder; mp 61–63 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.30 (d, <i>J</i> = 8.5 Hz, 1H, H<sub>ar</sub>), 7.72–7.85 (m, 3H, 3 × H<sub>ar-Phthal</sub>), 7.60 (bs, 1H, NH), 7.34 (d, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 7.21 (dd, <i>J</i> = 8.6 and <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.48 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.17 (t, <i>J</i> = 7.5 Hz, 2H, SCH<sub>2</sub>), 2.39 (t, <i>J</i> = 7.2 Hz, 2H, CH<sub>2</sub>CO), 1.79–1.65 (m, 4H, 2 × CH<sub>2</sub>), 1.45–1.28 (m, 6H, 3 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.3 (CONH), 165.6 (C<sub>IV-C═N</sub>), 164.1 (C<sub>IV-C═N</sub>), 159.5 (CONMe), 139.2 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar</sub>), 133.3 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.0, 128.8, 128.7, 127.9 (2 × CH<sub>ar-</sub>, CH<sub>ar-Phthal</sub>, C<sub>IV</sub>), 127.4 (CH<sub>ar-Phthal</sub>), 124.3 (CH<sub>ar-Phthal</sub>), 123.2 (C<sub>IV</sub>), 122.5 (CH<sub>ar</sub>), 39.5 (CH<sub>3</sub>), 37.8 (<i>C</i>H<sub>2</sub>CO), 32.5 (SCH<sub>2</sub>), 29.9 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 29.0 (CH<sub>2</sub>), 28.7 (CH<sub>2</sub>), 28.4 (CH<sub>2</sub>), 25.3 (CH<sub>2</sub>). HRMS (ESI<sup>+</sup>): calcd for C<sub>26</sub>H<sub>28</sub>Cl<sub>2</sub>N<sub>5</sub>O<sub>3</sub>S (M + H)<sup>+</sup> 560.1284, found 560.1286.</div></div><div id="sec4_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">4.2.53 <i>N</i>-(2-Chlorophenyl)-11-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)undecanamide (<b>86</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g), and 11-bromo-<i>N</i>-(2-chlorophenyl)undecanamide (<b>35</b>, 3 mmol, 1.12 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>86</b> in 42% yield, as a white powder; mp 129–130 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.42 (dd, <i>J</i> = 7.5 Hz and <i>J</i> = 1.0 Hz, 1H, H<sub>ar-Phthal</sub>), 8.35 (d, 1H, CH<sub>ar</sub>), 8.21 (m, 1H, H<sub>ar-Phthal</sub>), 7.75 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 77.65 (bs, 1H, NH), 7.33 (dd, <i>J</i> = 7.3 and <i>J</i> = 1.3 Hz, 1H, H<sub>ar</sub>), 7.24 (t, <i>J</i> = 8.2 Hz, 1H, H<sub>ar</sub>), 7.01 (t, <i>J</i> = 8 Hz, 1H, H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.70 (m, 4H, 2 × CH<sub>2</sub>), 1.32 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 171.5 (CONH), 159.5 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 151.8 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 134.7 (C<sub>IV</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub> and CH<sub>ar</sub>), 127.9 (C<sub>IV</sub>), 127.8 (C<sub>IV</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 124.5 (CH<sub>ar</sub>), 122.7 (C<sub>IV</sub>), 121.8 (CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.9 (CH<sub>2</sub>CO), 33.2 (SCH<sub>2</sub>), 30.7 (NMe), 30.2 (CH<sub>2</sub>), 29.6 (CH<sub>2</sub>), 29.6–28.6 (6 × CH<sub>2</sub>), 25.6 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>30</sub>H<sub>38</sub>ClN<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 581.2460, found 581.2449.</div></div><div id="sec4_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">4.2.54 <i>N</i>-(4-Chlorophenyl)-11-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)undecanamide (<b>87</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g) and 11-bromo-<i>N</i>-(4-chlorophenyl)undecanamide (<b>36</b>, 3 mmol, 1.12 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>87</b> in 54% yield, as a white powder; mp 168–169 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.17 (m, 1H, H<sub>ar-Phthal</sub>), 7.94 (bs, 1H, NH), 7.75 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.49 (d, <i>J</i> = 7.5 Hz, 2H, 2 × H<sub>ar</sub>), 7.22 (d, <i>J</i> = 8.9 Hz, 2H, 2 × H<sub>ar</sub>), 4.47 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 2.32 (t, <i>J</i> = 7.5 Hz, 2H, CH<sub>2</sub>CO), 1.69 (m, 4H, 2 × CH<sub>2</sub>), 1.43–1.15 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.8 (CONH), 159.6 (CONMe), 152.2 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 137.7 (C<sub>IV</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 132 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 120 (2 × CH<sub>ar</sub>), 128.1 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.3 (CH<sub>ar-Phthal</sub>), 121.2 (2 × CH<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.7 (<i>C</i>H<sub>2</sub>CO), 33.3 (SCH<sub>2</sub>), 30.8 (NMe), 30.1 (CH<sub>2</sub>), 29.5 (CH<sub>2</sub>), 29.6–28.6 (6 × CH<sub>2</sub>), 25.6 (CH<sub>2</sub>).. HRMS (MALDI, DHB, PEG 600): calcd for C<sub>30</sub>H<sub>38</sub>ClN<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 581.2460, found 581.2434.</div></div><div id="sec4_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">4.2.55 11-((4-Methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)-<i>N</i>-(naphthalen-1-yl)undecanamide (<b>88</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g) and 11-bromo-<i>N</i>-(naphthalen-1-yl)undecanamide (<b>37</b>, 3 mmol, 1.95 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>88</b> in 65% yield, as a white powder; mp 136–137 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 (m, 1H, H<sub>ar-Phthal</sub>), 8.11 (m, 1H, H<sub>ar-Phthal</sub>), 8.00–7.79 (m, 3H, 3 × H<sub>ar</sub>), 7.74 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 7.65 (m, 1H, H<sub>ar</sub>), 7.45 (m, 3H, 3 × H<sub>ar</sub>), 4.40 (s, 2H, CH<sub>2</sub>), 3.77 (s, 3H, NMe<sub>Phthal</sub>), 3.51 (s, 3H, NMe), 3.17 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 2.53 (m, 2H, CH<sub>2</sub>CO), 1.91–1.63 (m, 4H, 2 × CH<sub>2</sub>), 1.50–1.04 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.2 (CONH), 159.6 (CONMe), 152.2 (C<sub>IV-C═N</sub>), 152.0 (C<sub>IV-C═N</sub>), 140.8 (C<sub>IV-C═N</sub>), 134.3 (C<sub>IV-napht</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 132.7 (C<sub>IV-napht</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.0 (C<sub>IV</sub>), 128.8 (CH<sub>ar-napht</sub>), 128.0 (C<sub>IV</sub>), 127.5, 127.2, 126.2, 126.0, 125.8, 125.3, 121.4, 124.0 (8 × C<sub>ar</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.7 (CH<sub>2</sub>CO), 33.3 (SCH<sub>2</sub>), 30.7 (NMe), 30.1 (CH<sub>2</sub>), 29.6 (CH<sub>2</sub>), 29.5–28.4 (5 × CH<sub>2</sub>), 25.9 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600) calcd for C<sub>34</sub>H<sub>41</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 597.3006, found 597.2998.</div></div><div id="sec4_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">4.2.56 <i>N</i>-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-Adamantan-1-yl)-11-((4-methyl-5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-4<i>H</i>-1,2,4-triazol-3-yl)thio)undecanamide (<b>89</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g) and <i>N</i>-((3<i>S</i>,5<i>S</i>,7<i>S</i>)-adamantan-1-yl)-11-bromoundecanamide (<b>38</b>, 3 mmol, 1.17 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>89</b> in 75% yield, as a white powder. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H, H<sub>ar-Phthal</sub>), 8.23 (m, 1H, H<sub>ar-Phthal</sub>), 7.78 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 4.96 (br, 1H, NH), 4.48 (s, 2H, CH<sub>2</sub>), 3.80 (s, 3H, NMe<sub>Phthal</sub>), 3.54 (s, 3H, NMe), 3.18 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.05 (m, 5H, CH<sub>2</sub> and 3 × CH<sub>adam</sub>), 1.98 (m, 6H, 3 × CH<sub>2-adam</sub>), 1.71 (m, 2H, CH<sub>2</sub>), 1.67 (m, 6H, 3 × CH<sub>2-adam</sub>), 1.56 (m, 2H, CH<sub>2</sub>), 1.39 (m, 2H, CH<sub>2</sub>), 1.25 (m, 10H, 5 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.4 (CONH), 159.6 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.5 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.1 (C<sub>IV</sub>), 128.0 (C<sub>IV</sub>), 127.2 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 51.9 (C<sub>IV-adam</sub>), 41.8 (3 × CH<sub>2-adam</sub>), 39.5 (NMe<sub>Phthal</sub>), 37.9 (CO<i>C</i>H<sub>2</sub>), 36.5 (3 × CH<sub>2-adam</sub>), 33.3 (SCH<sub>2</sub>), 30.7 (C<sub>IV</sub>), 30.3 (NMe), 29.6 (CH<sub>2</sub>), 29.5–28.8 (7 × CH<sub>2</sub>), 25.9 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>34</sub>H<sub>49</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 605.3632, found 605.3623.</div></div><div id="sec4_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">4.2.57 4-((5-(Decylthio)-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>90</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-4-methyl-4<i>H</i>-1,2,4-triazol-3-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>1</b>, 1 mmol, 0.29 g), and 1-bromodecane (3 mmol, 0.66 g), purification by column chromatography on silica gel (DCM/MeOH; 98:2) afforded compound <b>90</b> in 84% yield, as a white powder; mp 108–109 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.42 (m, 1H, H<sub>ar-Phthal</sub>), 8.22 (m, 1H, H<sub>ar-Phthal</sub>), 7.76 (m, 2H, 2 × H<sub>ar-Phthal</sub>), 4.46 (s, 2H, CH<sub>2</sub>), 3.79 (s, 3H, NMe<sub>Phthal</sub>), 3.53 (s, 3H, NMe), 3.18 (t, <i>J</i> = 7.4 Hz, 2H, SCH<sub>2</sub>), 1.71 (m, 2H, SCH<sub>2</sub>C<i>H</i><sub>2</sub>), 1.39 (m, 2H, C<i>H</i><sub>2</sub>CH<sub>3</sub>), 1.32–1.16 (m, 12H, 6 × CH<sub>2</sub>), 0.85 (t, <i>J</i> = 6.7 Hz, CH<sub>3</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.6 (CONMe), 152.1 (C<sub>IV-C═N</sub>), 151.9 (C<sub>IV-C═N</sub>), 140.9 (C<sub>IV-C═N</sub>), 133.4 (CH<sub>ar-Phthal</sub>), 131.9 (CH<sub>ar-Phthal</sub>), 129.2 (C<sub>IV</sub>), 128.1 (C<sub>IV</sub>), 127.1 (CH<sub>ar-Phthal</sub>), 125.4 (CH<sub>ar-Phthal</sub>), 39.5 (NMe<sub>Phthal</sub>), 33.3 (SCH<sub>2</sub>), 32.0–29.0 (5 × CH<sub>2</sub>), 30.7 (NMe), 29.6 (SCH<sub>2</sub><i>C</i>H<sub>2</sub>), 28.8 (CH<sub>2</sub>), 22.8 (CH<sub>2</sub>), 14.2 (CH<sub>3</sub>). HRMS (ESI<sup>+</sup>) calcd for C<sub>23</sub>H<sub>34</sub>N<sub>5</sub>OS (M + H)<sup>+</sup> 428.2478, found 428.2467.</div></div><div id="sec4_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86">4.2.58 <i>N</i>-(2,4-Dichlorophenyl)-11-((5-((3-methyl-4-oxo-3,4-dihydrophthalazin-1-yl)methyl)-1,3,4-oxadiazol-2-yl)thio)undecanamide (<b>91</b>)</h4><div class="NLM_p last">Following general procedure 2 and starting from 4-((5-mercapto-1,3,4-oxadiazol-2-yl)methyl)-2-methylphthalazin-1(2<i>H</i>)-one (<b>5</b>, 1 mmol, 0.27 g), and 11-bromo-<i>N</i>-(2,4-dichlorophenyl)undecanamide (<b>12</b>, 3 mmol, 1.21 g), purification by column chromatography on silica gel (DCM/MeOH; 90:10) afforded compound <b>91</b> in 65% yield, as a white powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.47 (m, 1H, H<sub>ar-Phthal</sub>), 8.34 (d, <i>J</i> = 8.8 Hz, 1H, H<sub>ar</sub>), 7.86–7.57 (m, 3H, 2 × H<sub>ar-Phthal</sub> and H<sub>ar</sub>), 7.57 (bs, 1H, NH), 7.36 (d, <i>J</i> = 2.3 Hz, 1H, H<sub>ar</sub>), 7.24 (dd, <i>J</i> = 8.9 Hz, <i>J</i> = 2.4 Hz, 1H, H<sub>ar</sub>), 4.49 (s, 2H, CH<sub>2</sub>), 3.82 (s, 3H, NMe<sub>Phthal</sub>), 3.19 (t, <i>J</i> = 7.3 Hz, 2H, SCH<sub>2</sub>), 2.41 (t, <i>J</i> = 7.4 Hz, 2H, CH<sub>2</sub>CO), 1.79–1.69 (m, 4H, 2 × CH<sub>2</sub>), 1.4–1.27 (m, 12H, 6 × CH<sub>2</sub>). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 171.3 (CONH), 165.6 (C<sub>IV-C═N</sub>), 163.9 (C<sub>IV-C═N</sub>), 159.4 (CONMe), 139.1 (C<sub>IV-C═N</sub>), 133.4 (C<sub>IV</sub>), 133.2 (CH<sub>ar-Phthal</sub>), 131.8 (CH<sub>ar-Phthal</sub>), 128.9 (C<sub>IV</sub>), 128.8 (C<sub>IV</sub>), 128.6 (CH<sub>ar</sub>), 128.0 (C<sub>IV</sub>), 127.9 (CH<sub>ar</sub>), 127.3 (CH<sub>ar-Phthal</sub>), 124.2 (CH<sub>ar-Phthal</sub>), 122.3 (C<sub>IV</sub>), 39.4 (NMe<sub>Phthal</sub>), 37.8 (CH<sub>2</sub>CO), 33.5 (SCH<sub>2</sub>), 29.8 (CH<sub>2</sub>), 29.2 (CH<sub>2</sub>), 29.2 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 29.0 (CH<sub>2</sub>), 28.1 (CH<sub>2</sub>), 28.5 (6 × CH<sub>2</sub>), 25.4 (CH<sub>2</sub>). HRMS (MALDI, DHB, PEG 600): calcd for C<sub>30</sub>H<sub>37</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub>S (M + H)<sup>+</sup> 615.2070, found 615.2076.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87">4.3 Biological Assays</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88">4.3.1 Cell Lines, Recombinant Proteins, and Antibodies</h4><div class="NLM_p last">The 32Dβ and NK-92 cell lines were used in that study and cultured as described previously.<a onclick="showRef(event, 'ref38 ref52'); return false;" href="javascript:void(0);" class="ref ref38 ref52">(38, 52)</a> Recombinant human IL-15 and recombinant murine IL-3 were obtained from Peprotech, Inc., and recombinant human IL-2 was from Chiron. RLI was produced as described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Recombinant IL-2Rβ (224-2B-025/CF) was purchased from R&D Systems. CF1 antibody was from Beckman Coulter.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89">4.3.2 SPR Experiment</h4><div class="NLM_p last">The SPR experiments were performed at 25 °C with a BIAcore 3000 biosensor (GE Healthcare, Chalfont St Giles, UK). Recombinant IL-15, RLI, or IL-2 was covalently immobilized to CM5 sensor chips using the amine coupling method in accordance with the manufacturer’s instructions, and the binding of compounds at 100 μM or at increasing concentrations prepared in PBS or 1% or 5% DMSO was monitored. Analysis of sensorgrams was performed using BIAeval 4.1 software.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90">4.3.3 HTRF Assays</h4><div class="NLM_p last">HTRF assays were performed using as donor molecule Lumi4-Tb-NHS cryptate (Tb) conjugated to CF1 mouse anti-human IL-2Rβ mAb and as acceptor molecule D2 conjugated to streptavidin (streptavidin–D2) (HTRF Dye labeling kits, Cisbio). The donor excitation at 320 nm leads to energy emission at 620 nm that induces in close proximity (<i>d</i> < 10 nm) excitation of the acceptor and energy emission at 665 nm. The assays were carried out in a white 384-well Small Volume HiBase polystyrene microplate (Greiner) at room temperature. After a 30 min preincubation period of biotinylated human IL-15 (Fluorokine, R&D Systems) with compounds, recombinant human IL-2Rβ was added for an additional 30 min incubation time. Finally, the donor CF1–Tb and the acceptor streptavidin–D2 were added to the mixture and incubated for 30 min. Final concentrations were 100 μM for compounds and 20 nM for biotinylated IL-15, IL-2Rβ, CF1–Tb, and streptavidin–D2 in PBS, 0.1% BSA, 1% DMSO. Fluorescence signals were read with a Mithras reader (Berthold) at excitation 320 nm and emission 620 and 665 nm, and the HTRF was calculated as normalized fluorescence transfer value (Δ<i>F</i>):<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/jm-2017-00485r_m001.gif" alt="" /></img></span></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91">4.3.4 Proliferation Assays</h4><div class="NLM_p last">The proliferation response of 32Dβ cells to RLI was assessed by Alamar blue reduction assay (AbDSerotec). Cells were starved in the culture medium without cytokine for 4 h. Cells (1 × 10<sup>4</sup>) were cultured for 2.5 days in the medium supplemented with 100 pM RLI or 1.5 nM IL-2, previously preincubated for 30 min with fixed or increasing concentrations of compounds or the vehicle (culture medium, DMSO 0.1%, final concentration). Alamar blue (10 μL) was added to each well, and after a 6 h-incubation period at 37 °C, the emitted fluorescence at 590 nm under excitation at 560 nm was measured using Fluoroskan Ascent FL reader (Thermo Electro Corporation). Compounds were tested in triplicate in at least three independent experiments.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92">4.3.5 P-STAT5 Assays</h4><div class="NLM_p last">Exponentially growing NK-92 cells were washed and serum-starved overnight to reduce basal phosphorylation. Cells (2 × 10<sup>5</sup>) were then stimulated at 37 °C for 1 h with fixed or increasing concentrations of IL-15 or IL-2 that have or have not been preincubated for 30 min with increasing concentrations of chemical compounds or the vehicle (PBS, BSA 0.1% DMSO 0.6%, final concentration). At the end of the stimulation, cells were lysed, and Stat5 phosphorylation was measured according to the manufacturer’s instructions using p-Stat5 AlphaScreen Surefire kit (PerkinElmer Life Sciences). Compounds were tested in duplicate in at least three independent experiments.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93">4.3.6 Cytotoxicity Assay</h4><div class="NLM_p last">The cytotoxicity of the main compounds was evaluated on 32Dβ cells using the CytoTox-FluorTM Cytoxicity Assay kit from Promega. Briefly, 1 × 10<sup>4</sup> cells were plated in 100 μL and cultured in the medium supplemented with vehicle (culture medium, DMSO 0.1%, final concentration) or compounds at a concentration of 11 μM for 3 h. The bis-AAF-R110 substrate was then added in each well, and the dead-cell protease activity was detected 30 min later by measuring the fluorescence signals with a Mithras reader (Berthold) at excitation 485 nm and emission 520 nm. Conditions with medium and with medium supplemented with digitonin were used for negative and positive controls, respectively. Compounds were tested in triplicate in two independent experiments.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00485">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10282" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10282" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00485" class="ext-link">10.1021/acs.jmedchem.7b00485</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Docking scores of compounds selected from virtual screening, <i>in vitro</i> inhibitory effect of 5 compounds selected from virtual screening, dose–response curves of the effect of cytokines on 32Dβ cell proliferation, evaluation of the cytotoxicity of some compounds, SAR of <b>1</b> and its homologues <b>41</b>–<b>46</b>, SAR of <b>1</b> and its analogs <b>47</b>–<b>54</b> and <b>56</b>–<b>62</b>, dose–response curves of the effect of cytokines on p-Stat5 in NK-92 cells, synthesis and chemical characteristics of the halogenoalkylamides <b>6</b>–<b>39</b> and the azidoalkylamide <b>40</b>, and NMR spectra of the tested compounds <b>1</b> and <b>41</b>–<b>91</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf">jm7b00485_si_001.pdf (15.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_002.csv">jm7b00485_si_002.csv (6.14 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00485" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnès Quéméner</span> - <span class="hlFld-Affiliation affiliation">CRCINA,
INSERM, CNRS, University of Nantes, Nantes 44007, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4026-8496" title="Orcid link">http://orcid.org/0000-0002-4026-8496</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6100060f04124f1014040c040f041321140f08174c0f000f1504124f0713"><span class="__cf_email__" data-cfemail="93f2f4fdf6e0bde2e6f6fef6fdf6e1d3e6fdfae5befdf2fde7f6e0bdf5e1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monique Mathé-Allainmat</span> - <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5e333130372f2b3b70333f2a363b1e2b30372873303f302a3b2d70382c"><span class="__cf_email__" data-cfemail="600d0f0e091115054e0d0114080520150e09164d0e010e1405134e0612">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike Maillasson</span> - <span class="hlFld-Affiliation affiliation">CRCINA,
INSERM, CNRS, University of Nantes, Nantes 44007, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurence Arzel</span> - <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Sicard</span> - <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romy Vomiandry</span> - <span class="hlFld-Affiliation affiliation">CRCINA,
INSERM, CNRS, University of Nantes, Nantes 44007, France</span>; 
    <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erwan Mortier</span> - <span class="hlFld-Affiliation affiliation">CRCINA,
INSERM, CNRS, University of Nantes, Nantes 44007, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Dubreuil</span> - <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yannick Jacques</span> - <span class="hlFld-Affiliation affiliation">CRCINA,
INSERM, CNRS, University of Nantes, Nantes 44007, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacques Lebreton</span> - <span class="hlFld-Affiliation affiliation">CEISAM,
CNRS, Faculty of Sciences, University of
Nantes, Nantes 44322, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d85e12512-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are deeply indebted to the Ministère de l’Enseignement Supérieur et de la Recherche, the Institut National de la Santé Et de la Recherche Médicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), the Université de Nantes, and Biogenouest (Network of Technological Platform) for their support. This work was funded by the programs CIMATH2 (Ciblage Moléculaire et Applications Thérapeutiques 2) and PIRAMID (Protein-protein Interactions in Rational Approaches for Medicinal Innovative Drugs) supported by La Région Pays de la Loire. R.V. was supported by a fellowship from La Région Pays de la Loire. We thank CHEM-Symbiose and IMPACT facilities for technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i96" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i96"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i97" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i97"> Abbreviations Used</h2><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">Interleukin</p></td></tr><tr><td class="NLM_term">R</td><td class="NLM_def"><p class="first last">receptor</p></td></tr><tr><td class="NLM_term">Stat</td><td class="NLM_def"><p class="first last">signal transducers and activators of transcription</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">PPIs</td><td class="NLM_def"><p class="first last">protein–protein interactions</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time resolved fluorescence</p></td></tr><tr><td class="NLM_term">Tb</td><td class="NLM_def"><p class="first last">Lumi4-Tb-NHS cryptate</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hydrogen bond</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32435" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32435" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 52 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Grabstein, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanebeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenborn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahdieh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giri, J. G.</span><span> </span><span class="NLM_article-title">Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1126/science.8178155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1126%2Fscience.8178155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=965-968&author=K.+H.+Grabsteinauthor=J.+Eisenmanauthor=K.+Shanebeckauthor=C.+Rauchauthor=S.+Srinivasanauthor=V.+Fungauthor=C.+Beersauthor=J.+Richardsonauthor=M.+A.+Schoenbornauthor=M.+Ahdiehauthor=L.+Johnsonauthor=M.+R.+Aldersonauthor=J.+D.+Watsonauthor=D.+M.+Andersonauthor=J.+G.+Giri&title=Cloning+of+a+T+cell+growth+factor+that+interacts+with+the+beta+chain+of+the+interleukin-2+receptor&doi=10.1126%2Fscience.8178155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.8178155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8178155%26sid%3Dliteratum%253Aachs%26aulast%3DGrabstein%26aufirst%3DK.%2BH.%26aulast%3DEisenman%26aufirst%3DJ.%26aulast%3DShanebeck%26aufirst%3DK.%26aulast%3DRauch%26aufirst%3DC.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DFung%26aufirst%3DV.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DSchoenborn%26aufirst%3DM.%2BA.%26aulast%3DAhdieh%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DAlderson%26aufirst%3DM.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BM.%26aulast%3DGiri%26aufirst%3DJ.%2BG.%26atitle%3DCloning%2520of%2520a%2520T%2520cell%2520growth%2520factor%2520that%2520interacts%2520with%2520the%2520beta%2520chain%2520of%2520the%2520interleukin-2%2520receptor%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D965%26epage%3D968%26doi%3D10.1126%2Fscience.8178155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Burton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">4935</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1073/pnas.91.11.4935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.91.11.4935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4935-4939&author=J.+D.+Burtonauthor=R.+N.+Bamfordauthor=C.+Petersauthor=A.+J.+Grantauthor=G.+Kurysauthor=C.+K.+Goldmanauthor=J.+Brennanauthor=E.+Roesslerauthor=T.+A.+Waldmann&title=A+lymphokine%2C+provisionally+designated+interleukin+T+and+produced+by+a+human+adult+T-cell+leukemia+line%2C+stimulates+T-cell+proliferation+and+the+induction+of+lymphokine-activated+killer+cells&doi=10.1073%2Fpnas.91.11.4935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.11.4935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.11.4935%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BD.%26aulast%3DBamford%26aufirst%3DR.%2BN.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DGrant%26aufirst%3DA.%2BJ.%26aulast%3DKurys%26aufirst%3DG.%26aulast%3DGoldman%26aufirst%3DC.%2BK.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DRoessler%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DA%2520lymphokine%252C%2520provisionally%2520designated%2520interleukin%2520T%2520and%2520produced%2520by%2520a%2520human%2520adult%2520T-cell%2520leukemia%2520line%252C%2520stimulates%2520T-cell%2520proliferation%2520and%2520the%2520induction%2520of%2520lymphokine-activated%2520killer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D4935%26epage%3D4939%26doi%3D10.1073%2Fpnas.91.11.4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kirman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O. H.</span><span> </span><span class="NLM_article-title">Increased numbers of interleukin-15-expressing cells in active ulcerative colitis</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=8792700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A280%3ADyaK28zosVynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1996&pages=1789-1794&author=I.+Kirmanauthor=O.+H.+Nielsen&title=Increased+numbers+of+interleukin-15-expressing+cells+in+active+ulcerative+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Increased numbers of interleukin-15-expressing cells in active ulcerative colitis</span></div><div class="casAuthors">Kirman I; Nielsen O H</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1789-94</span>
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    </div><div class="casAbstract">OBJECTIVES:  Interleukin-15 (IL-15) is a novel cytokine sharing many of the activities of IL-2.  The goal of this study was to evaluate intracellular and serum IL-15 in ulcerative colitis (UC) and Crohn's disease (CD).  METHODS:  Intracellular expression of IL-15 in peripheral blood mononuclear cells (PBMC) from UC patients, CD patients, and controls was studied using cell permeabilization and staining with monoclonal antibodies.  Serum levels of IL-15 were detected using ELISA.  RESULTS:  Percentage of IL-15 expressing PBMC was increased in UC patients and in five of six of CD patients with moderate and severe disease activity compared with controls.  The number of IL-15 expressing cells in patients with active inflammatory bowel disease (IBD) declined within 2 wk of treatment.  Serum IL-15 reached detectable levels in 62.5% of UC patients with moderate and severe disease activity but not in UC patients with slight disease activity or in remission, neither in CD patients nor in controls.  In vitro lipopolysaccharide (LPS)-induced activation of PBMC from controls was associated with up-regulation of intracellular IL-15 expression (p < 0.01) and release of IL-15.  CONCLUSIONS:  UC patients with moderate and severe disease activity have increased percentage of IL-15 expressing PBMC, which might be induced by in vivo cell activation and can lead to elevation of released IL-15 in serum.  Increased IL-15 expression after in vitro LPS stimulation of control PBMC suggests a nonspecific production of this cytokine during the immunoinflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlQEHGUcd1P_6xYuD7tu2XfW6udTcc2ebB87FLe6V9Irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zosVynsg%253D%253D&md5=a7eb0037a53c79b627bdd0f859528c77</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirman%26aufirst%3DI.%26aulast%3DNielsen%26aufirst%3DO.%2BH.%26atitle%3DIncreased%2520numbers%2520of%2520interleukin-15-expressing%2520cells%2520in%2520active%2520ulcerative%2520colitis%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D1996%26volume%3D91%26spage%3D1789%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ruckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadullah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budagian, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trombotto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulfone-Paus, S.</span><span> </span><span class="NLM_article-title">Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">2240</span><span class="NLM_x">–</span> <span class="NLM_lpage">2250</span><span class="refDoi"> DOI: 10.4049/jimmunol.165.4.2240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4049%2Fjimmunol.165.4.2240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2000&pages=2240-2250&author=R.+Ruckertauthor=K.+Asadullahauthor=M.+Seifertauthor=V.+M.+Budagianauthor=R.+Arnoldauthor=C.+Trombottoauthor=R.+Pausauthor=S.+Bulfone-Paus&title=Inhibition+of+keratinocyte+apoptosis+by+IL-15%3A+a+new+parameter+in+the+pathogenesis+of+psoriasis%3F&doi=10.4049%2Fjimmunol.165.4.2240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.165.4.2240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.165.4.2240%26sid%3Dliteratum%253Aachs%26aulast%3DRuckert%26aufirst%3DR.%26aulast%3DAsadullah%26aufirst%3DK.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DBudagian%26aufirst%3DV.%2BM.%26aulast%3DArnold%26aufirst%3DR.%26aulast%3DTrombotto%26aufirst%3DC.%26aulast%3DPaus%26aufirst%3DR.%26aulast%3DBulfone-Paus%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520keratinocyte%2520apoptosis%2520by%2520IL-15%253A%2520a%2520new%2520parameter%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%253F%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D165%26spage%3D2240%26epage%3D2250%26doi%3D10.4049%2Fjimmunol.165.4.2240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamihira, S.</span><span> </span><span class="NLM_article-title">Pathological roles of interleukin-15 in adult T-cell leukemia</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.3109/10428199909145703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.3109%2F10428199909145703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10512161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=37-45&author=Y.+Yamadaauthor=S.+Kamihira&title=Pathological+roles+of+interleukin-15+in+adult+T-cell+leukemia&doi=10.3109%2F10428199909145703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological roles of interleukin-15 in adult T-cell leukemia</span></div><div class="casAuthors">Yamada, Yasuaki; Kamihira, Shimeru</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 63 refs.  Interleukin-15 (IL-15) is a 14-kDa glycoprotein belonging to the same 4 helix bundle-cytokine family as IL-2.  Although the biol. activity of IL-15 in vitro has been studied extensively, its physiol. role is still obscure.  The receptors for IL-15 and IL-2 consist of 3 subunits, an unique α chain and shared β and γ chains.  Since β and γ chains transduce the signals from the receptors, both cytokines share similar biol. functions, although IL-15 and IL-2 do not have sequence homol.  The α chains function to increase binding affinity for each cytokines.  Adult T-cell leukemia (ATL) cells constitutively express the IL-2 receptor (IL-2R) α and expression is believed to be essential in the early stages of disease development.  We have recently shown that ATL cells also express the complete form of IL-15R including the α chain, and that ATL cells proliferate in response to exogenous IL-15.  Since the mRNA of IL-15 is ubiquitous and is detected in many tissues and cells, it is possible that IL-15R stimulation is involved in the development and progression of ATL.  Here, we review recent studies on IL-15 and IL-15R and their assocn. with ATL and other lymphoproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOIWYHWXxkw7Vg90H21EOLACvtfcHk0ljy9k9dRdq_Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFal&md5=81f029fcd2b05e33dba25b3ce1449648</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3109%2F10428199909145703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428199909145703%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DKamihira%26aufirst%3DS.%26atitle%3DPathological%2520roles%2520of%2520interleukin-15%2520in%2520adult%2520T-cell%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1999%26volume%3D35%26spage%3D37%26epage%3D45%26doi%3D10.3109%2F10428199909145703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span> </span><span class="NLM_article-title">Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/S0167-5699(97)01205-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0167-5699%2897%2901205-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9509762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlWlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=75-79&author=I.+B.+McInnesauthor=F.+Y.+Liew&title=Interleukin+15%3A+a+proinflammatory+role+in+rheumatoid+arthritis+synovitis&doi=10.1016%2FS0167-5699%2897%2901205-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis</span></div><div class="casAuthors">McInnes, Iain B.; Liew, Foo Y.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-79</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 32 refs.  In rheumatoid arthritis (RA), locally produced interleukin 15 (IL-15) can recruit and activate synovial T cells, which then amplify and perpetuate inflammation through induction of monocyte-derived tumor necrosis factor α (TNF-α) via a cell-contact-dependent mechanism.  Thus, IL-15 could play a pivotal role in disease pathogenesis, acting upstream of TNF-α in orchestrating the induction of a cascade of inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_p7D8AlaibVg90H21EOLACvtfcHk0ljy9k9dRdq_Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlWlsL0%253D&md5=1b4b3ff0ee5d2ed41ff8dfcdab73f9a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2897%2901205-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252897%252901205-X%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26atitle%3DInterleukin%252015%253A%2520a%2520proinflammatory%2520role%2520in%2520rheumatoid%2520arthritis%2520synovitis%26jtitle%3DImmunol.%2520Today%26date%3D1998%26volume%3D19%26spage%3D75%26epage%3D79%26doi%3D10.1016%2FS0167-5699%2897%2901205-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Pavlakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehlau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span> </span><span class="NLM_article-title">Intragraft IL-15 transcripts are increased in human renal allograft rejection</span> <span class="citation_source-journal">Transplantation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1097/00007890-199608270-00020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1097%2F00007890-199608270-00020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1996&pages=543-545&author=M.+Pavlakisauthor=J.+Strehlauauthor=M.+Lipmanauthor=M.+Shapiroauthor=W.+Maslinskiauthor=T.+B.+Strom&title=Intragraft+IL-15+transcripts+are+increased+in+human+renal+allograft+rejection&doi=10.1097%2F00007890-199608270-00020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00007890-199608270-00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007890-199608270-00020%26sid%3Dliteratum%253Aachs%26aulast%3DPavlakis%26aufirst%3DM.%26aulast%3DStrehlau%26aufirst%3DJ.%26aulast%3DLipman%26aufirst%3DM.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26atitle%3DIntragraft%2520IL-15%2520transcripts%2520are%2520increased%2520in%2520human%2520renal%2520allograft%2520rejection%26jtitle%3DTransplantation%26date%3D1996%26volume%3D62%26spage%3D543%26epage%3D545%26doi%3D10.1097%2F00007890-199608270-00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Manfro, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy-Chaudhury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span> </span><span class="NLM_article-title">Interleukin-15 gene transcripts are present in rejecting islet allografts</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1016/S0041-1345(96)00410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0041-1345%2896%2900410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9123207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK2sXit12gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=1077-1078&author=R.+C.+Manfroauthor=P.+Roy-Chaudhuryauthor=X.+X.+Zhengauthor=J.+Steigerauthor=P.+W.+Nickersonauthor=Y.+Liauthor=W.+Maslinskiauthor=T.+B.+Strom&title=Interleukin-15+gene+transcripts+are+present+in+rejecting+islet+allografts&doi=10.1016%2FS0041-1345%2896%2900410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-15 gene transcripts are present in rejecting islet allografts</span></div><div class="casAuthors">Manfro, R. C.; Roy-Chaudhury, P.; Zheng, X. X.; Steiger, J.; Nickerson, P. W.; Li, Y.; Maslinski, W.; Strom, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">1077-1078</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Greater interleukin-15 gene expression was present in murine pancreatic islet allografts than in murine syngeneic islet grafts.  Furthermore, interleukin-15 gene expression was greater in allografts in interleukin-2-deficient (knockout) mice than in allografts in interleukin-2 wild type mice.  Apparently, factors other than interleukin-2 are able to mediate allograft rejection in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxr4zLqC_UvLVg90H21EOLACvtfcHk0ljy9k9dRdq_Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit12gurY%253D&md5=48e38f6eef507be17b8407068c8c6f30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2896%2900410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252896%252900410-1%26sid%3Dliteratum%253Aachs%26aulast%3DManfro%26aufirst%3DR.%2BC.%26aulast%3DRoy-Chaudhury%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DSteiger%26aufirst%3DJ.%26aulast%3DNickerson%26aufirst%3DP.%2BW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26atitle%3DInterleukin-15%2520gene%2520transcripts%2520are%2520present%2520in%2520rejecting%2520islet%2520allografts%26jtitle%3DTransplant.%2520Proc.%26date%3D1997%26volume%3D29%26spage%3D1077%26epage%3D1078%26doi%3D10.1016%2FS0041-1345%2896%2900410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ruchatz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span> </span><span class="NLM_article-title">Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5654</span><span class="NLM_x">–</span> <span class="NLM_lpage">5660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5654-5660&author=H.+Ruchatzauthor=B.+P.+Leungauthor=X.+Q.+Weiauthor=I.+B.+McInnesauthor=F.+Y.+Liew&title=Soluble+IL-15+receptor+%CE%B1-chain+administration+prevents+murine+collagen-induced+arthritis%3A+a+role+for+IL-15+in+development+of+antigen-induced+immunopathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuchatz%26aufirst%3DH.%26aulast%3DLeung%26aufirst%3DB.%2BP.%26aulast%3DWei%26aufirst%3DX.%2BQ.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26atitle%3DSoluble%2520IL-15%2520receptor%2520%25CE%25B1-chain%2520administration%2520prevents%2520murine%2520collagen-induced%2520arthritis%253A%2520a%2520role%2520for%2520IL-15%2520in%2520development%2520of%2520antigen-induced%2520immunopathology%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5654%26epage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ferrari-Lacraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, T.</span><span> </span><span class="NLM_article-title">Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">5818</span><span class="NLM_x">–</span> <span class="NLM_lpage">5826</span><span class="refDoi"> DOI: 10.4049/jimmunol.173.9.5818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4049%2Fjimmunol.173.9.5818" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=5818-5826&author=S.+Ferrari-Lacrazauthor=E.+Zanelliauthor=M.+Neubergauthor=E.+Donskoyauthor=Y.+S.+Kimauthor=X.+X.+Zhengauthor=W.+W.+Hancockauthor=W.+Maslinskiauthor=X.+C.+Liauthor=T.+B.+Stromauthor=T.+Moll&title=Targeting+IL-15+receptor-bearing+cells+with+an+antagonist+mutant+IL-15%2FFc+protein+prevents+disease+development+and+progression+in+murine+collagen-induced+arthritis&doi=10.4049%2Fjimmunol.173.9.5818"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.173.9.5818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.173.9.5818%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari-Lacraz%26aufirst%3DS.%26aulast%3DZanelli%26aufirst%3DE.%26aulast%3DNeuberg%26aufirst%3DM.%26aulast%3DDonskoy%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%2BC.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DMoll%26aufirst%3DT.%26atitle%3DTargeting%2520IL-15%2520receptor-bearing%2520cells%2520with%2520an%2520antagonist%2520mutant%2520IL-15%252FFc%2520protein%2520prevents%2520disease%2520development%2520and%2520progression%2520in%2520murine%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D5818%26epage%3D5826%26doi%3D10.4049%2Fjimmunol.173.9.5818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span> </span><span class="NLM_article-title">Interleukin-15 receptor-directed immunotoxins atteunuate disease severity in rat adjuvant arthritis</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1535</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span><span class="refDoi"> DOI: 10.1016/j.molimm.2010.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.molimm.2010.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=20188418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Kgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=1535-1543&author=D.+Wangauthor=X.+Dengauthor=X.+Lengauthor=X.+Mao&title=Interleukin-15+receptor-directed+immunotoxins+atteunuate+disease+severity+in+rat+adjuvant+arthritis&doi=10.1016%2Fj.molimm.2010.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-15 receptor-directed immunotoxins attenuate disease severity in rat adjuvant arthritis</span></div><div class="casAuthors">Wang, Deling; Deng, Xianglei; Leng, Xiaoyan; Mao, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1535-1543</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors previously constructed two Pseudomonas exotoxin (PE)-based immunotoxins, IL15-PEΔ293 (IT1) and IL15M-PEΔ293 (IT2), for eliminating interleukin-15 receptor (IL-15R)-overexpressing cells.  These two immunotoxins were generated by fusing either wild-type human IL-15 or an antagonist mutant IL-15 (IL-15M) to a modified form of PE.  In this study the anti-arthritic effect of IT1 and IT2 was investigated using the rat model of adjuvant arthritis (AA).  The authors found that both IT1 and IT2 could specifically target IL-15R-pos. cells and induce apoptosis.  After AA induction, treatment with either IT1 or IT2 resulted in profound improvement of the disease, with redns. in levels of synovial mononuclear leukocytes and certain inflammatory factors.  Clin. and histol. comparisons, together with the analyses of mRNA expression and the signal transducer and activator of transcription-3 (STAT-3) phosphorylation, revealed that the two immunotoxins decreased joint inflammation in AA rats to a similar extent.  These data suggest that eliminating IL-15R-bearing cells via immunotoxins may be a promising approach for RA treatment.  In addn., wild-type IL-15-based immunotoxins can be as effective as antagonist mutant IL-15-based immunotoxins in preventing joint inflammation assocd. with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWucqvyNO9JrVg90H21EOLACvtfcHk0liIg33sVMKE_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Kgsr8%253D&md5=b95a72cf23d905a84fae7016c5ff993c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2010.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2010.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLeng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DInterleukin-15%2520receptor-directed%2520immunotoxins%2520atteunuate%2520disease%2520severity%2520in%2520rat%2520adjuvant%2520arthritis%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D47%26spage%3D1535%26epage%3D1543%26doi%3D10.1016%2Fj.molimm.2010.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yang, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span> </span><span class="NLM_article-title">Therapeutic potential of IL-15 in rheumatoid arthritis</span> <span class="citation_source-journal">Hum. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1016/j.humimm.2015.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.humimm.2015.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=26429323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2htLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=812-818&author=X.+K.+Yangauthor=W.+D.+Xuauthor=R.+X.+Lengauthor=Y.+Liangauthor=Y.+Y.+Liuauthor=X.+Y.+Fangauthor=C.+C.+Fengauthor=R.+Liauthor=H.+Cenauthor=H.+F.+Panauthor=D.+Q.+Ye&title=Therapeutic+potential+of+IL-15+in+rheumatoid+arthritis&doi=10.1016%2Fj.humimm.2015.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of IL-15 in rheumatoid arthritis</span></div><div class="casAuthors">Yang, Xiao-Ke; Xu, Wang-Dong; Leng, Rui-Xue; Liang, Yan; Liu, Yan-Yan; Fang, Xin-Yu; Feng, Chen-Chen; Li, Rui; Cen, Han; Pan, Hai-Feng; Ye, Dong-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Human Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">812-818</span>CODEN:
                <span class="NLM_cas:coden">HUIMDQ</span>;
        ISSN:<span class="NLM_cas:issn">0198-8859</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic, destructive inflammatory autoimmune disease.  Cytokine-mediated immunity has been found to play an important role in the pathogenesis of autoimmune diseases including RA.  Recently, much attention has been paid on the role of IL-15, which is a member of the 4 α-helix bundle cytokine family.  IL-15 was detected in serum and synovial fluid from RA patients and arthritis mice models.  Moreover, administration of IL-15 leads to the development of severe inflammatory arthritis, suggesting that IL-15 may be therapeutically relevant in RA.  Therefore, targeting IL-15 may be significantly important and valuable.  In this article, we discuss the biol. features and effects of IL-15 and summarize recent advances on the pathol. roles of IL-15 in RA and treatment for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWgvwmK6HqmbVg90H21EOLACvtfcHk0lhbEqC_mO6IRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2htLzI&md5=4307d67f06360dd3c3e03e9b0a4853f0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.humimm.2015.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humimm.2015.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BK.%26aulast%3DXu%26aufirst%3DW.%2BD.%26aulast%3DLeng%26aufirst%3DR.%2BX.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DFang%26aufirst%3DX.%2BY.%26aulast%3DFeng%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DCen%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DH.%2BF.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26atitle%3DTherapeutic%2520potential%2520of%2520IL-15%2520in%2520rheumatoid%2520arthritis%26jtitle%3DHum.%2520Immunol.%26date%3D2015%26volume%3D76%26spage%3D812%26epage%3D818%26doi%3D10.1016%2Fj.humimm.2015.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8259</span><span class="refDoi"> DOI: 10.1039/C5CS00252D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1039%2FC5CS00252D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=26248294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8238-8259&author=C.+Shengauthor=G.+Dongauthor=Z.+Miaoauthor=W.+Zhangauthor=W.+Wang&title=State-of-the-art+strategies+for+targeting+protein-protein+interactions+by+small-molecule+inhibitors&doi=10.1039%2FC5CS00252D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors</span></div><div class="casAuthors">Sheng, Chunquan; Dong, Guoqiang; Miao, Zhenyuan; Zhang, Wannian; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8238-8259</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Targeting protein-protein interactions (PPIs) has emerged as a viable approach in modern drug discovery.  However, the identification of small mols. enabling us to effectively interrupt their interactions presents significant challenges.  In the recent past, significant advances have been made in the development of new biol. and chem. strategies to facilitate the discovery process of small-mol. PPI inhibitors.  This review aims to highlight the state-of-the-art technologies and the achievements made recently in this field.  The "hot spots" of PPIs have been proved to be crit. for small mols. to bind.  Three strategies including screening, designing, and synthetic approaches have been explored for discovering PPI inhibitors by targeting the "hot spots".  Although the classic high throughput screening approach can be used, fragment screening, fragment-based drug design and newly improved virtual screening are demonstrated to be more effective in the discovery of PPI inhibitors.  In addn. to screening approaches, design strategies including anchor-based and small mol. mimetics of secondary structures involved in PPIs have become powerful tools as well.  Finally, constructing new chem. spaced libraries with high diversity and complexity is becoming an important area of interest for PPI inhibitors.  The successful cases from the recent five year studies are used to illustrate how these approaches are implemented to uncover and optimize small mol. PPI inhibitors and notably some of them have become promising therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGresOJEXOV1r7Vg90H21EOLACvtfcHk0lhbEqC_mO6IRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mtb3J&md5=770274ca159e2a9e01e4c1a42b4c2c28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC5CS00252D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00252D%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DState-of-the-art%2520strategies%2520for%2520targeting%2520protein-protein%2520interactions%2520by%2520small-molecule%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8238%26epage%3D8259%26doi%3D10.1039%2FC5CS00252D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuenemann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzoni-Giovanelli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagorce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, M. A.</span><span> </span><span class="NLM_article-title">Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1002/minf.201400040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fminf.201400040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=25254076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=414-437&author=B.+O.+Villoutreixauthor=M.+A.+Kuenemannauthor=J.+L.+Poyetauthor=H.+Bruzzoni-Giovanelliauthor=C.+Labbeauthor=D.+Lagorceauthor=O.+Sperandioauthor=M.+A.+Miteva&title=Drug-Like+Protein-Protein+Interaction+Modulators%3A+Challenges+and+Opportunities+for+Drug+Discovery+and+Chemical+Biology&doi=10.1002%2Fminf.201400040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Villoutreix, Bruno O.; Kuenemann, Melaine A.; Poyet, Jean-Luc; Bruzzoni-Giovanelli, Heriberto; Labbe, Celine; Lagorce, David; Sperandio, Olivier; Miteva, Maria A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">414-437</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Fundamental processes in living cells are largely controlled by macromol. interactions and among them, protein-protein interactions (PPIs) have a crit. role while their dysregulations can contribute to the pathogenesis of numerous diseases.  Although PPIs were considered as attractive pharmaceutical targets already some years ago, they have been thus far largely unexploited for therapeutic interventions with low mol. wt. compds.  Several limiting factors, from technol. hurdles to conceptual barriers, are known, which, taken together, explain why research in this area has been relatively slow.  However, this last decade, the scientific community has challenged the dogma and became more enthusiastic about the modulation of PPIs with small drug-like mols.  In fact, several success stories were reported both, at the preclin. and clin. stages.  In this review article, written for the 2014 International Summer School in Chemoinformatics (Strasbourg, France), we discuss in silico tools (essentially post 2012) and databases that can assist the design of low mol. wt. PPI modulators (these tools can be found at www.vls3d.com).  We first introduce the field of protein-protein interaction research, discuss key challenges and comment recently reported in silico packages, protocols and databases dedicated to PPIs.  Then, we illustrate how in silico methods can be used and combined with exptl. work to identify PPI modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppampn_mwHg7Vg90H21EOLACvtfcHk0lhbEqC_mO6IRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCmur4%253D&md5=768a72c4cbebea40e9451b4f6048f41c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fminf.201400040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201400040%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26aulast%3DKuenemann%26aufirst%3DM.%2BA.%26aulast%3DPoyet%26aufirst%3DJ.%2BL.%26aulast%3DBruzzoni-Giovanelli%26aufirst%3DH.%26aulast%3DLabbe%26aufirst%3DC.%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26atitle%3DDrug-Like%2520Protein-Protein%2520Interaction%2520Modulators%253A%2520Challenges%2520and%2520Opportunities%2520for%2520Drug%2520Discovery%2520and%2520Chemical%2520Biology%26jtitle%3DMol.%2520Inf.%26date%3D2014%26volume%3D33%26spage%3D414%26epage%3D437%26doi%3D10.1002%2Fminf.201400040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Raimundo, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oslob, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braisted, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waal, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkin, M. R.</span><span> </span><span class="NLM_article-title">Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3111</span><span class="NLM_x">–</span> <span class="NLM_lpage">3130</span><span class="refDoi"> DOI: 10.1021/jm049967u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049967u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3111-3130&author=B.+C.+Raimundoauthor=J.+D.+Oslobauthor=A.+C.+Braistedauthor=J.+Hydeauthor=R.+S.+McDowellauthor=M.+Randalauthor=N.+D.+Waalauthor=J.+Wilkinsonauthor=C.+H.+Yuauthor=M.+R.+Arkin&title=Integrating+fragment+assembly+and+biophysical+methods+in+the+chemical+advancement+of+small-molecule+antagonists+of+IL-2%3A+an+approach+for+inhibiting+protein-protein+interactions&doi=10.1021%2Fjm049967u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm049967u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049967u%26sid%3Dliteratum%253Aachs%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DHyde%26aufirst%3DJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DWaal%26aufirst%3DN.%2BD.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26atitle%3DIntegrating%2520fragment%2520assembly%2520and%2520biophysical%2520methods%2520in%2520the%2520chemical%2520advancement%2520of%2520small-molecule%2520antagonists%2520of%2520IL-2%253A%2520an%2520approach%2520for%2520inhibiting%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3111%26epage%3D3130%26doi%3D10.1021%2Fjm049967u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kalsoom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaukat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdalla, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesaik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaheer-ul-Haq</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, F. L.</span><span> </span><span class="NLM_article-title">In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5751</span><span class="refDoi"> DOI: 10.1007/s00044-013-0564-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1007%2Fs00044-013-0564-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=5739-5751&author=S.+Kalsoomauthor=U.+Rashidauthor=A.+Shaukatauthor=O.+M.+Abdallaauthor=K.+Hussainauthor=W.+Khanauthor=S.+Nazirauthor=M.+A.+Mesaikauthor=+Zaheer-ul-Haqauthor=F.+L.+Ansari&title=In+vitro+and+in+silico+exploration+of+IL-2+inhibition+by+small+drug-like+molecules&doi=10.1007%2Fs00044-013-0564-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules</span></div><div class="casAuthors">Kalsoom, Saima; Rashid, Umer; Shaukat, Awais; Abdalla, Omer Mohamed; Hussain, Khalida; Khan, Waqasuddin; Nazir, Samina; Mesaik, Mohammad Ahmad; Zaheer-ul-Haq; Ansari, Farzana Latif</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5739-5751</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Interleukin-2 (IL-2) is an immunoregulatory cytokine produced by T lymphocytes in response to antigen.  It is a potent growth and differentiation factor for several cell-types and is structurally related to the four-helix bundle family of cytokines.  Here, we report IL-2 inhibitory potential and computational studies on different series of chalcones, benzothiazepines, semicarbazones, and dihydropyrimidines.  These compds. were synthesized in wet lab and were then tested for their potency as IL-2 inhibitors through in vitro T cell proliferation, IL-2 cytokine prodn. as well as their effect on oxidative burst.  Compds. that showed significant suppressive activity were further evaluated for their cytotoxicity on normal two cell lines.  Most of the chalcones were found to have a powerful inhibitory effect on T-lymphocytes proliferation and cytokine prodn.  Among the aza heterocycles benzothiazepines, benzoxazepines, and benzodiazepinones were found to be the strongest IL-2 inhibitors.  Mol. docking and MD simulation studies were carried out to correlate exptl. and theor. results whereby a good correlation was obsd. which indicated that computational studies could provide an alternate tool for the identification and designing of more potent IL-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor7PYLP79sU7Vg90H21EOLACvtfcHk0li2VdfrB_w25w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVegtbw%253D&md5=97c062e0ab3537daf5c9fee7af2c6fa0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00044-013-0564-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-013-0564-x%26sid%3Dliteratum%253Aachs%26aulast%3DKalsoom%26aufirst%3DS.%26aulast%3DRashid%26aufirst%3DU.%26aulast%3DShaukat%26aufirst%3DA.%26aulast%3DAbdalla%26aufirst%3DO.%2BM.%26aulast%3DHussain%26aufirst%3DK.%26aulast%3DKhan%26aufirst%3DW.%26aulast%3DNazir%26aufirst%3DS.%26aulast%3DMesaik%26aufirst%3DM.%2BA.%26aulast%3DZaheer-ul-Haq%26aulast%3DAnsari%26aufirst%3DF.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520silico%2520exploration%2520of%2520IL-2%2520inhibition%2520by%2520small%2520drug-like%2520molecules%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D5739%26epage%3D5751%26doi%3D10.1007%2Fs00044-013-0564-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span> </span><span class="NLM_article-title">Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e78619</span><span class="refDoi"> DOI: 10.1371/journal.pone.0078619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1371%2Fjournal.pone.0078619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e78619&author=T.+Zhangauthor=X.+Baiauthor=X.+Mao&title=Systemic+delivery+of+small+interfering+RNA+targeting+the+interleukin-2%2F15+receptor+%CE%B2+chain+prevents+disease+progression+in+experimental+arthritis&doi=10.1371%2Fjournal.pone.0078619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078619%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DSystemic%2520delivery%2520of%2520small%2520interfering%2520RNA%2520targeting%2520the%2520interleukin-2%252F15%2520receptor%2520%25CE%25B2%2520chain%2520prevents%2520disease%2520progression%2520in%2520experimental%2520arthritis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De78619%26doi%3D10.1371%2Fjournal.pone.0078619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Pettit, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabstein, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gombotz, W. R.</span><span> </span><span class="NLM_article-title">Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span><span class="refDoi"> DOI: 10.1074/jbc.272.4.2312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.272.4.2312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=2312-2318&author=D.+K.+Pettitauthor=T.+P.+Bonnertauthor=J.+Eisenmanauthor=S.+Srinivasanauthor=R.+Paxtonauthor=C.+Beersauthor=D.+Lynchauthor=B.+Millerauthor=J.+Yostauthor=K.+H.+Grabsteinauthor=W.+R.+Gombotz&title=Structure-function+studies+of+interleukin+15+using+site-specific+mutagenesis%2C+polyethylene+glycol+conjugation%2C+and+homology+modeling&doi=10.1074%2Fjbc.272.4.2312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.4.2312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.4.2312%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DD.%2BK.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DEisenman%26aufirst%3DJ.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DPaxton%26aufirst%3DR.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DB.%26aulast%3DYost%26aufirst%3DJ.%26aulast%3DGrabstein%26aufirst%3DK.%2BH.%26aulast%3DGombotz%26aufirst%3DW.%2BR.%26atitle%3DStructure-function%2520studies%2520of%2520interleukin%252015%2520using%2520site-specific%2520mutagenesis%252C%2520polyethylene%2520glycol%2520conjugation%252C%2520and%2520homology%2520modeling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D2312%26epage%3D2318%26doi%3D10.1074%2Fjbc.272.4.2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bernard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermot-Desroches, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijdeness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slootstra, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Identification of an interleukin-15α receptor-binding site on human interleukin-15</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24313</span><span class="NLM_x">–</span> <span class="NLM_lpage">24322</span><span class="refDoi"> DOI: 10.1074/jbc.M312458200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M312458200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24313-24322&author=J.+Bernardauthor=C.+Harbauthor=E.+Mortierauthor=A.+Quemenerauthor=R.+H.+Meloenauthor=C.+Vermot-Desrochesauthor=J.+Wijdenessauthor=P.+van+Dijkenauthor=J.+Grotzingerauthor=J.+W.+Slootstraauthor=A.+Pletauthor=Y.+Jacques&title=Identification+of+an+interleukin-15%CE%B1+receptor-binding+site+on+human+interleukin-15&doi=10.1074%2Fjbc.M312458200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312458200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312458200%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DJ.%26aulast%3DHarb%26aufirst%3DC.%26aulast%3DMortier%26aufirst%3DE.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DMeloen%26aufirst%3DR.%2BH.%26aulast%3DVermot-Desroches%26aufirst%3DC.%26aulast%3DWijdeness%26aufirst%3DJ.%26aulast%3Dvan%2BDijken%26aufirst%3DP.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DSlootstra%26aufirst%3DJ.%2BW.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520an%2520interleukin-15%25CE%25B1%2520receptor-binding%2520site%2520on%2520human%2520interleukin-15%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24313%26epage%3D24322%26doi%3D10.1074%2Fjbc.M312458200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Pulliam, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzhachenko, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adunyah, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, A.</span><span> </span><span class="NLM_article-title">Common gamma chain cytokines in combinatorial immune strategies against cancer</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.imlet.2015.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.imlet.2015.11.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2016&pages=61-72&author=S.+R.+Pulliamauthor=R.+V.+Uzhachenkoauthor=S.+E.+Adunyahauthor=A.+Shanker&title=Common+gamma+chain+cytokines+in+combinatorial+immune+strategies+against+cancer&doi=10.1016%2Fj.imlet.2015.11.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2015.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2015.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPulliam%26aufirst%3DS.%2BR.%26aulast%3DUzhachenko%26aufirst%3DR.%2BV.%26aulast%3DAdunyah%26aufirst%3DS.%2BE.%26aulast%3DShanker%26aufirst%3DA.%26atitle%3DCommon%2520gamma%2520chain%2520cytokines%2520in%2520combinatorial%2520immune%2520strategies%2520against%2520cancer%26jtitle%3DImmunol.%2520Lett.%26date%3D2016%26volume%3D169%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.imlet.2015.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Chirifu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemizu, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1038/ni1492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2Fni1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=17643103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlSkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1001-1007&author=M.+Chirifuauthor=C.+Hayashiauthor=T.+Nakamuraauthor=S.+Tomaauthor=T.+Shutoauthor=H.+Kaiauthor=Y.+Yamagataauthor=S.+J.+Davisauthor=S.+Ikemizu&title=Crystal+structure+of+the+IL-15-IL-15R%CE%B1+complex%2C+a+cytokine-receptor+unit+presented+in+trans&doi=10.1038%2Fni1492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans</span></div><div class="casAuthors">Chirifu, Mami; Hayashi, Chiharu; Nakamura, Teruya; Toma, Sachiko; Shuto, Tsuyoshi; Kai, Hirofumi; Yamagata, Yuriko; Davis, Simon J.; Ikemizu, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1001-1007</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 15 (IL-15) and IL-2, which promote the survival of memory CD8+ T cells and regulatory T cells, resp., bind receptor complexes that share β- and γ-signaling subunits.  Receptor specificity is provided by unique, nonsignaling α-subunits.  Whereas IL-2 receptor-α (IL-2Rα) is expressed together in cis with the β- and γ-subunits on T cells and B cells, IL-15Rα is expressed in trans on antigen-presenting cells.  Here we present a 1.85-Å crystal structure of the human IL-15-IL-15Rα complex.  The structure provides insight into the mol. basis of the specificity of cytokine recognition and emphasizes the importance of water in generating this very high-affinity complex.  Despite very low IL-15-IL-2 sequence homol. and distinct receptor architecture, the topologies of the IL-15-IL-15Rα and IL-2-IL-2Rα complexes are very similar.  Our data raise the possibility that IL-2, like IL-15, might be capable of being presented in trans in the context of its unique receptor α-chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVSxvqs0CsLVg90H21EOLACvtfcHk0ljKyQ525sDgoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlSkurs%253D&md5=4bd905b164f7ef9a136d9c0e65b9cb5f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fni1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1492%26sid%3Dliteratum%253Aachs%26aulast%3DChirifu%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DShuto%26aufirst%3DT.%26aulast%3DKai%26aufirst%3DH.%26aulast%3DYamagata%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DS.%2BJ.%26aulast%3DIkemizu%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520IL-15-IL-15R%25CE%25B1%2520complex%252C%2520a%2520cytokine-receptor%2520unit%2520presented%2520in%2520trans%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1001%26epage%3D1007%26doi%3D10.1038%2Fni1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shanafelt, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanafelt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Stringfellow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaria, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greve, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plym, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roczniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serban, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiyama, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolotorev, A.</span><span> </span><span class="NLM_article-title">A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span><span class="refDoi"> DOI: 10.1038/81199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2F81199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1197-1202&author=A.+B.+Shanafeltauthor=Y.+Linauthor=M.+C.+Shanafeltauthor=C.+P.+Forteauthor=N.+Dubois-Stringfellowauthor=C.+Carterauthor=J.+A.+Gibbonsauthor=S.+L.+Chengauthor=K.+A.+Delariaauthor=R.+Fleischerauthor=J.+M.+Greveauthor=R.+Gundelauthor=K.+Harrisauthor=R.+Kellyauthor=B.+Kohauthor=Y.+Liauthor=L.+Lantzauthor=P.+Makauthor=L.+Neyerauthor=M.+J.+Plymauthor=S.+Roczniakauthor=D.+Serbanauthor=J.+Thriftauthor=L.+Tsuchiyamaauthor=M.+Wetzelauthor=M.+Wongauthor=A.+Zolotorev&title=A+T-cell-selective+interleukin+2+mutein+exhibits+potent+antitumor+activity+and+is+well+tolerated+in+vivo&doi=10.1038%2F81199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F81199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F81199%26sid%3Dliteratum%253Aachs%26aulast%3DShanafelt%26aufirst%3DA.%2BB.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DShanafelt%26aufirst%3DM.%2BC.%26aulast%3DForte%26aufirst%3DC.%2BP.%26aulast%3DDubois-Stringfellow%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DGibbons%26aufirst%3DJ.%2BA.%26aulast%3DCheng%26aufirst%3DS.%2BL.%26aulast%3DDelaria%26aufirst%3DK.%2BA.%26aulast%3DFleischer%26aufirst%3DR.%26aulast%3DGreve%26aufirst%3DJ.%2BM.%26aulast%3DGundel%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DR.%26aulast%3DKoh%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLantz%26aufirst%3DL.%26aulast%3DMak%26aufirst%3DP.%26aulast%3DNeyer%26aufirst%3DL.%26aulast%3DPlym%26aufirst%3DM.%2BJ.%26aulast%3DRoczniak%26aufirst%3DS.%26aulast%3DSerban%26aufirst%3DD.%26aulast%3DThrift%26aufirst%3DJ.%26aulast%3DTsuchiyama%26aufirst%3DL.%26aulast%3DWetzel%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DZolotorev%26aufirst%3DA.%26atitle%3DA%2520T-cell-selective%2520interleukin%25202%2520mutein%2520exhibits%2520potent%2520antitumor%2520activity%2520and%2520is%2520well%2520tolerated%2520in%2520vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2000%26volume%3D18%26spage%3D1197%26epage%3D1202%26doi%3D10.1038%2F81199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Collins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seals, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoskings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toome, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, G.</span><span> </span><span class="NLM_article-title">Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit(p70) of the interleukin 2 receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">7709</span><span class="NLM_x">–</span> <span class="NLM_lpage">7713</span><span class="refDoi"> DOI: 10.1073/pnas.85.20.7709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.85.20.7709" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=7709-7713&author=L.+Collinsauthor=W.+H.+Tsienauthor=C.+Sealsauthor=J.+Hakimiauthor=D.+Weberauthor=P.+Bailonauthor=J.+Hoskingsauthor=W.+C.+Greeneauthor=V.+Toomeauthor=G.+Ju&title=Identification+of+specific+residues+of+human+interleukin+2+that+affect+binding+to+the+70-kDa+subunit%28p70%29+of+the+interleukin+2+receptor&doi=10.1073%2Fpnas.85.20.7709"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.20.7709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.20.7709%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DL.%26aulast%3DTsien%26aufirst%3DW.%2BH.%26aulast%3DSeals%26aufirst%3DC.%26aulast%3DHakimi%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DD.%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DHoskings%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26aulast%3DToome%26aufirst%3DV.%26aulast%3DJu%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520specific%2520residues%2520of%2520human%2520interleukin%25202%2520that%2520affect%2520binding%2520to%2520the%252070-kDa%2520subunit%2528p70%2529%2520of%2520the%2520interleukin%25202%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D7709%26epage%3D7713%26doi%3D10.1073%2Fpnas.85.20.7709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Structure of the quaternary complex of interleukin-2 with its α, β, and γc receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span><span class="refDoi"> DOI: 10.1126/science.1117893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1126%2Fscience.1117893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1159-1163&author=X.+Wangauthor=M.+Rickertauthor=K.+C.+Garcia&title=Structure+of+the+quaternary+complex+of+interleukin-2+with+its+%CE%B1%2C+%CE%B2%2C+and+%CE%B3c+receptors&doi=10.1126%2Fscience.1117893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1117893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1117893%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructure%2520of%2520the%2520quaternary%2520complex%2520of%2520interleukin-2%2520with%2520its%2520%25CE%25B1%252C%2520%25CE%25B2%252C%2520and%2520%25CE%25B3c%2520receptors%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1159%26epage%3D1163%26doi%3D10.1126%2Fscience.1117893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pande, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraga, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spolski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozkan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1038/ni.2449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2Fni.2449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=23104097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOmtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1187-1195&author=A.+M.+Ringauthor=J.+X.+Linauthor=D.+Fengauthor=S.+Mitraauthor=M.+Rickertauthor=G.+R.+Bowmanauthor=V.+S.+Pandeauthor=P.+Liauthor=I.+Moragaauthor=R.+Spolskiauthor=E.+Ozkanauthor=W.+J.+Leonardauthor=K.+C.+Garcia&title=Mechanistic+and+structural+insight+into+the+functional+dichotomy+between+IL-2+and+IL-15&doi=10.1038%2Fni.2449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15</span></div><div class="casAuthors">Ring, Aaron M.; Lin, Jian-Xin; Feng, Dan; Mitra, Suman; Rickert, Mathias; Bowman, Gregory R.; Pande, Vijay S.; Li, Peng; Moraga, Ignacio; Spolski, Rosanne; Uezkan, Engin; Leonard, Warren J.; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1187-1195</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 15 (IL-15) and IL-2 have distinct immunol. functions even though both signal through the receptor subunit IL-2Rβ and the common γ-chain (γc).  Here we found that in the structure of the IL-15-IL-15Rα-IL-2Rβ-γc quaternary complex, IL-15 binds to IL-2Rβ and γc in a heterodimer nearly indistinguishable from that of the IL-2-IL-2Rα-IL-2Rβ-γc complex, despite their different receptor-binding chemistries.  IL-15Rα substantially increased the affinity of IL-15 for IL-2Rβ, and this allostery was required for IL-15 trans signaling.  Consistent with their identical IL-2Rβ-γc dimer geometries, IL-2 and IL-15 showed similar signaling properties in lymphocytes, with any differences resulting from disparate receptor affinities.  Thus, IL-15 and IL-2 induced similar signals, and the cytokine specificity of IL-2Rα vs. IL-15Rα detd. cellular responsiveness.  Our results provide new insights for the development of specific immunotherapeutics based on IL-15 or IL-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mi_MfxbISLVg90H21EOLACvtfcHk0liLyFxqs4glHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOmtLbP&md5=2f64d0f8222104408df56ca27f22523a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fni.2449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2449%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DLin%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DG.%2BR.%26aulast%3DPande%26aufirst%3DV.%2BS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMoraga%26aufirst%3DI.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DOzkan%26aufirst%3DE.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DMechanistic%2520and%2520structural%2520insight%2520into%2520the%2520functional%2520dichotomy%2520between%2520IL-2%2520and%2520IL-15%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D1187%26epage%3D1195%26doi%3D10.1038%2Fni.2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mortier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vusio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boublik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Soluble interleukin-15 receptor α(IL-15Rα)-sushi as a selective and potent agonist of IL-15 action through IL-15Rβ/γ. Hyperagonist IL-15 x IL-15Rα fusion proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1619</span><span class="refDoi"> DOI: 10.1074/jbc.M508624200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M508624200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1612-1619&author=E.+Mortierauthor=A.+Quemenerauthor=P.+Vusioauthor=I.+Lorenzenauthor=Y.+Boublikauthor=J.+Grotzingerauthor=A.+Pletauthor=Y.+Jacques&title=Soluble+interleukin-15+receptor+%CE%B1%28IL-15R%CE%B1%29-sushi+as+a+selective+and+potent+agonist+of+IL-15+action+through+IL-15R%CE%B2%2F%CE%B3.+Hyperagonist+IL-15+x+IL-15R%CE%B1+fusion+proteins&doi=10.1074%2Fjbc.M508624200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508624200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508624200%26sid%3Dliteratum%253Aachs%26aulast%3DMortier%26aufirst%3DE.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DVusio%26aufirst%3DP.%26aulast%3DLorenzen%26aufirst%3DI.%26aulast%3DBoublik%26aufirst%3DY.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DSoluble%2520interleukin-15%2520receptor%2520%25CE%25B1%2528IL-15R%25CE%25B1%2529-sushi%2520as%2520a%2520selective%2520and%2520potent%2520agonist%2520of%2520IL-15%2520action%2520through%2520IL-15R%25CE%25B2%252F%25CE%25B3.%2520Hyperagonist%2520IL-15%2520x%2520IL-15R%25CE%25B1%2520fusion%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1612%26epage%3D1619%26doi%3D10.1074%2Fjbc.M508624200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0liLyFxqs4glHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Polucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauteruccio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malgesini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirtori, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riceputi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucchi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span> </span><span class="NLM_article-title">Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1021/jm3013213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=437-450&author=P.+Polucciauthor=P.+Magnaghiauthor=M.+Angioliniauthor=D.+Asaauthor=N.+Avanziauthor=A.+Badariauthor=J.+Bertrandauthor=E.+Casaleauthor=S.+Cauteruccioauthor=A.+Cirlaauthor=L.+Cozziauthor=A.+Galvaniauthor=P.+K.+Jacksonauthor=Y.+Liuauthor=S.+Magnusonauthor=B.+Malgesiniauthor=S.+Nuvoloniauthor=C.+Orreniusauthor=F.+R.+Sirtoriauthor=L.+Riceputiauthor=S.+Rizziauthor=B.+Trucchiauthor=T.+O%E2%80%99Brienauthor=A.+Isacchiauthor=D.+Donatiauthor=R.+D%E2%80%99Alessio&title=Alkylsulfanyl-1%2C2%2C4-triazoles%2C+a+new+class+of+allosteric+valosine+containing+protein+inhibitors.+Synthesis+and+structure-activity+relationships&doi=10.1021%2Fjm3013213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure-Activity Relationships</span></div><div class="casAuthors">Polucci, Paolo; Magnaghi, Paola; Angiolini, Mauro; Asa, Daniela; Avanzi, Nilla; Badari, Alessandra; Bertrand, Jay; Casale, Elena; Cauteruccio, Silvia; Cirla, Alessandra; Cozzi, Liviana; Galvani, Arturo; Jackson, Peter K.; Liu, Yichin; Magnuson, Steven; Malgesini, Beatrice; Nuvoloni, Stefano; Orrenius, Christian; Sirtori, Federico Riccardi; Riceputi, Laura; Rizzi, Simona; Trucchi, Beatrice; O'Brien, Tom; Isacchi, Antonella; Donati, Daniele; D'Alessio, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Valosine contg. protein (VCP), also known as p97, is a member of AAA ATPase family that is involved in several biol. processes and plays a central role in the ubiquitin-mediated degrdn. of misfolded proteins.  VCP is an ubiquitously expressed, highly abundant protein and has been found overexpressed in many tumor types, sometimes assocd. with poor prognosis.  In this respect, VCP has recently received a great deal of attention as a potential new target for cancer therapy.  In this paper, the discovery and structure-activity relationships of alkylsulfanyl-1,2,4-triazoles, a new class of potent, allosteric VCP inhibitors, are described.  Medicinal chem. manipulation of 3-(isopropylthio)-5-(phenoxymethyl)-4-phenyl-1,2,4-triazole, identified via HTS, led to the discovery of potent and selective inhibitors with submicromolar activity in cells and clear mechanism of action at consistent doses.  This represents a first step toward a new class of potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcvefolxe1ZrVg90H21EOLACvtfcHk0liJhBOlGcNKUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL7E&md5=23eab31badb2321c77945100f4f1001f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3013213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013213%26sid%3Dliteratum%253Aachs%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DAsa%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBadari%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DJ.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCauteruccio%26aufirst%3DS.%26aulast%3DCirla%26aufirst%3DA.%26aulast%3DCozzi%26aufirst%3DL.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DMalgesini%26aufirst%3DB.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DSirtori%26aufirst%3DF.%2BR.%26aulast%3DRiceputi%26aufirst%3DL.%26aulast%3DRizzi%26aufirst%3DS.%26aulast%3DTrucchi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26atitle%3DAlkylsulfanyl-1%252C2%252C4-triazoles%252C%2520a%2520new%2520class%2520of%2520allosteric%2520valosine%2520containing%2520protein%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D437%26epage%3D450%26doi%3D10.1021%2Fjm3013213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Faham, A.</span><span> </span><span class="NLM_article-title">The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6330</span><span class="refDoi"> DOI: 10.1016/S0040-4020(99)00344-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0040-4020%2899%2900344-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1MXjs12mt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=6813-6330&author=L.+A.+Carpinoauthor=A.+El-Faham&title=The+diisopropylcarbodiimide%2F1-hydroxy-7-azabenzotriazole+system%3A+segment+coupling+and+stepwise+peptide+assembly&doi=10.1016%2FS0040-4020%2899%2900344-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly</span></div><div class="casAuthors">Carpino, Louis A.; El-Faham, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6813-6830</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">For a group of model peptide segments, coupling reactions carried out using soln.- or solid-phase techniques have demonstrated the advantages of DIC/HOAt system over DIC/HOBt, and also, for systems involving other selected carbodiimides and substituted HOBt derivs. bearing electron-withdrawing substituents.  Very little, if any, loss of configuration occurred in DCM (dichloromethane) regardless of the additive used, although the relative order of efficiency was similar in solvents such as DMF in which more extensive epimerization resulted.  Using DIC/HOAt system for stepwise peptide assembly by solid-phase techniques, it was found that the hindered pyridine base 2,4,6-collidine enhanced the step involving preactivation of the carboxylic acid residue in contrast to the normal situation in which bases such as DIEA, NMM, or non-hindered pyridine bases inhibit this step.  These results led to the development of a stepwise procedure for peptide assembly in which 2,4,6-collidine is added to enhance activation and subsequently DIEA is added to enhance coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS9-3K0QIkurVg90H21EOLACvtfcHk0liJhBOlGcNKUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs12mt7c%253D&md5=ee9e96944c58f1f5432798ddf15db50b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900344-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900344-0%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26aulast%3DEl-Faham%26aufirst%3DA.%26atitle%3DThe%2520diisopropylcarbodiimide%252F1-hydroxy-7-azabenzotriazole%2520system%253A%2520segment%2520coupling%2520and%2520stepwise%2520peptide%2520assembly%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D6813%26epage%3D6330%26doi%3D10.1016%2FS0040-4020%2899%2900344-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Montalbetti, C. A. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falque, V.</span><span> </span><span class="NLM_article-title">Amide bond formation and peptide coupling</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">10827</span><span class="NLM_x">–</span> <span class="NLM_lpage">10852</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.tet.2005.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCnsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=10827-10852&author=C.+A.+G.+N.+Montalbettiauthor=V.+Falque&title=Amide+bond+formation+and+peptide+coupling&doi=10.1016%2Fj.tet.2005.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Amide bond formation and peptide coupling</span></div><div class="casAuthors">Montalbetti, Christian A. G. N.; Falque, Virginie</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10827-10852</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Methods and strategies for the amide bond formation and peptide coupling in solns. and on solid phase are discussed and summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRl3ythUyGCrVg90H21EOLACvtfcHk0liJhBOlGcNKUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCnsbfN&md5=04346ec39e739fcd7b1570b5f547afc4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%2BG.%2BN.%26aulast%3DFalque%26aufirst%3DV.%26atitle%3DAmide%2520bond%2520formation%2520and%2520peptide%2520coupling%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D10827%26epage%3D10852%26doi%3D10.1016%2Fj.tet.2005.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorla, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavitha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striepen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span> </span><span class="NLM_article-title">Phthalazinone inhibitors of inosine-5′-monophosphate dehydrogenase from Cryptosporidium parvum</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.bmcl.2012.12.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1004-1007&author=C.+R.+Johnsonauthor=S.+K.+Gorlaauthor=M.+Kavithaauthor=M.+Zhangauthor=X.+Liuauthor=B.+Striepenauthor=J.+R.+Meadauthor=G.+D.+Cunyauthor=L.+Hedstrom&title=Phthalazinone+inhibitors+of+inosine-5%E2%80%B2-monophosphate+dehydrogenase+from+Cryptosporidium+parvum&doi=10.1016%2Fj.bmcl.2012.12.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DGorla%26aufirst%3DS.%2BK.%26aulast%3DKavitha%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStriepen%26aufirst%3DB.%26aulast%3DMead%26aufirst%3DJ.%2BR.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DHedstrom%26aufirst%3DL.%26atitle%3DPhthalazinone%2520inhibitors%2520of%2520inosine-5%25E2%2580%25B2-monophosphate%2520dehydrogenase%2520from%2520Cryptosporidium%2520parvum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1004%26epage%3D1007%26doi%3D10.1016%2Fj.bmcl.2012.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Sridhara, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopala Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavayya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Goud, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somashekar, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peethambar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaddam, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4983</span><span class="NLM_x">–</span> <span class="NLM_lpage">4989</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.ejmech.2010.08.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4983-4989&author=A.+M.+Sridharaauthor=K.+R.+Venugopala+Reddyauthor=J.+Keshavayyaauthor=P.+S.+Kumar+Goudauthor=B.+C.+Somashekarauthor=P.+Boseauthor=S.+K.+Peethambarauthor=S.+K.+Gaddam&title=Synthesis+and+antimicrobial+activity+of+2-substituted+%5B4-%281%2C3%2C4-oxadiazol-2-yl+methyl%29%5D+phthalazin-1%282H%29-one+derivatives&doi=10.1016%2Fj.ejmech.2010.08.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DSridhara%26aufirst%3DA.%2BM.%26aulast%3DVenugopala%2BReddy%26aufirst%3DK.%2BR.%26aulast%3DKeshavayya%26aufirst%3DJ.%26aulast%3DKumar%2BGoud%26aufirst%3DP.%2BS.%26aulast%3DSomashekar%26aufirst%3DB.%2BC.%26aulast%3DBose%26aufirst%3DP.%26aulast%3DPeethambar%26aufirst%3DS.%2BK.%26aulast%3DGaddam%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520activity%2520of%25202-substituted%2520%255B4-%25281%252C3%252C4-oxadiazol-2-yl%2520methyl%2529%255D%2520phthalazin-1%25282H%2529-one%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4983%26epage%3D4989%26doi%3D10.1016%2Fj.ejmech.2010.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Plech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luszczki, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wujec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizon, M.</span><span> </span><span class="NLM_article-title">Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.ejmech.2012.11.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=208-215&author=T.+Plechauthor=J.+J.+Luszczkiauthor=M.+Wujecauthor=J.+Fliegerauthor=M.+Pizon&title=Synthesis%2C+characterization+and+preliminary+anticonvulsant+evaluation+of+some+4-alkyl-1%2C2%2C4-triazoles&doi=10.1016%2Fj.ejmech.2012.11.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DPlech%26aufirst%3DT.%26aulast%3DLuszczki%26aufirst%3DJ.%2BJ.%26aulast%3DWujec%26aufirst%3DM.%26aulast%3DFlieger%26aufirst%3DJ.%26aulast%3DPizon%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520preliminary%2520anticonvulsant%2520evaluation%2520of%2520some%25204-alkyl-1%252C2%252C4-triazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D208%26epage%3D215%26doi%3D10.1016%2Fj.ejmech.2012.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sridhara, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopala Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavayya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambika, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peethambar, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and antimicrobial studies of some new 3-isoxazoline substituted phthalazine methylsulfonyl oxadiazoles</span> <span class="citation_source-journal">E-J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1155/2011/356437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1155%2F2011%2F356437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFyhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1022-1029&author=A.+M.+Sridharaauthor=K.+R.+Venugopala+Reddyauthor=J.+Keshavayyaauthor=D.+S.+Ambikaauthor=S.+Goudauthor=S.+K.+Peethambar&title=Synthesis+and+antimicrobial+studies+of+some+new+3-isoxazoline+substituted+phthalazine+methylsulfonyl+oxadiazoles&doi=10.1155%2F2011%2F356437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimicrobial studies of some new 3-isoxazoline substituted phthalazine methylsulfonyl oxadiazoles</span></div><div class="casAuthors">Sridhara, A. M.; Venugopala Reddy, K. R.; Keshavayya, J.; Ambika, D. S.; Goud, Sanathkumar; Peethambar, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">E-Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1022-1029</span>CODEN:
                <span class="NLM_cas:coden">ECJHAO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">WWW Publications</span>)
        </div><div class="casAbstract">3-Isoxazoline substituted phthalazine methylthio oxadiazoles were prepd. from 2-(4-oxo-3,4-dihydro-1-phthalazinyl)acetate Me ester and the synthesis of the target compds. was subsequently achieved by a dipolar cyclization of aldoxime-derived nitrile oxides with 4-[[5-(methylthio)-1,3,4-oxadiazol-2-yl]methyl]-2-(2-propenyl)-1(2H)-phthalazinone.  The product structures were confirmed by spectral data and the title compds. were screened for their antimicrobial activities against bacterial strains and fungal strains and it was discovered that these compds. displayed activity as antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUp_I963gv5LVg90H21EOLACvtfcHk0ljIgkUDV8r-1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFyhs78%253D&md5=eee69b010a14321571a4aa8b77cb87b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1155%2F2011%2F356437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F356437%26sid%3Dliteratum%253Aachs%26aulast%3DSridhara%26aufirst%3DA.%2BM.%26aulast%3DVenugopala%2BReddy%26aufirst%3DK.%2BR.%26aulast%3DKeshavayya%26aufirst%3DJ.%26aulast%3DAmbika%26aufirst%3DD.%2BS.%26aulast%3DGoud%26aufirst%3DS.%26aulast%3DPeethambar%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520studies%2520of%2520some%2520new%25203-isoxazoline%2520substituted%2520phthalazine%2520methylsulfonyl%2520oxadiazoles%26jtitle%3DE-J.%2520Chem.%26date%3D2011%26volume%3D8%26spage%3D1022%26epage%3D1029%26doi%3D10.1155%2F2011%2F356437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Shaker, M. R.</span><span> </span><span class="NLM_article-title">The chemistry of mercapto- and thione- substituted 1,2,4-triazoles and their utility in heterocyclic synthesis</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">ix</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=ix&publication_year=2006&pages=59-112&author=M.+R.+Shaker&title=The+chemistry+of+mercapto-+and+thione-+substituted+1%2C2%2C4-triazoles+and+their+utility+in+heterocyclic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DM.%2BR.%26atitle%3DThe%2520chemistry%2520of%2520mercapto-%2520and%2520thione-%2520substituted%25201%252C2%252C4-triazoles%2520and%2520their%2520utility%2520in%2520heterocyclic%2520synthesis%26jtitle%3DARKIVOC%26date%3D2006%26volume%3Dix%26spage%3D59%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">The growing impact of click chemistry on drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02933-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS1359-6446%2803%2902933-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=14678739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1128-1137&author=H.+C.+Kolbauthor=K.+B.+Sharpless&title=The+growing+impact+of+click+chemistry+on+drug+discovery&doi=10.1016%2FS1359-6446%2803%2902933-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The growing impact of click chemistry on drug discovery</span></div><div class="casAuthors">Kolb, Hartmuth C.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1128-1137</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Click chem. is a modular approach that uses only the most practical and reliable chem. transformations.  Its applications are increasingly found in all aspects of drug discovery, ranging from lead finding through combinatorial chem. and target-templated in situ chem., to proteomics and DNA research, using bioconjugation reactions.  The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal acetylenes is a particularly powerful linking reaction, due to its high degree of dependability, complete specificity, and the bio-compatibility of the reactants.  The triazole products are more than just passive linkers; they readily assoc. with biol. targets, through hydrogen bonding and dipole interactions.  Click chem., a modular approach based on highly reliable chem. transformations, is being applied in all aspects of drug discovery, ranging from lead finding to proteomics and DNA research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEB1hjIBNhbVg90H21EOLACvtfcHk0liT_2JPNAtxEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D&md5=f0042f3a8f153d1c1192533d90699d19</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902933-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902933-7%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DThe%2520growing%2520impact%2520of%2520click%2520chemistry%2520on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D1128%26epage%3D1137%26doi%3D10.1016%2FS1359-6446%2803%2902933-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ″ligation″ of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span><span class="refDoi"> DOI: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=12203546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+huisgen+cycloaddition+process%3A+copper%28I%29-catalyzed+regioselective+%E2%80%B3ligation%E2%80%B3+of+azides+and+terminal+alkynes&doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes</span></div><div class="casAuthors">Rostovtsev, Vsevolod V.; Green, Luke G.; Fokin, Valery V.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2596-2599</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">1,4-Disubstituted 1,2,3-triazoles I (R1 = PhCH2, PhCH2OCH2, 1-adamantyl, etc.; R2 = HO2C, Ph, PhOCH2, Et2NCH2, etc.) were readily and cleanly prepd. via highly efficient and regioselective copper(I)-catalyzed cycloaddn. of azides R1N3 with terminal alkynes R2C≡CH in 82-93% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcW2JUNM1r7Vg90H21EOLACvtfcHk0liT_2JPNAtxEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D&md5=4603664be6639353b5e70f19b9f8d59f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020715%252941%253A14%253C2596%253A%253AAID-ANIE2596%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520huisgen%2520cycloaddition%2520process%253A%2520copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%25B3ligation%25E2%2580%25B3%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D2596%26epage%3D2599%26doi%3D10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Vincent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochonneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillasson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigue-Antar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span><span class="refDoi"> DOI: 10.1002/ijc.28059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fijc.28059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=23354868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=757-765&author=M.+Vincentauthor=A.+Bessardauthor=D.+Cochonneauauthor=G.+Teppazauthor=V.+Soleauthor=M.+Maillassonauthor=S.+Birkleauthor=L.+Garrigue-Antarauthor=A.+Quemenerauthor=Y.+Jacques&title=Tumor+targeting+of+the+IL-15+superagonist+RLI+by+an+anti-GD2+antibody+strongly+enhances+its+antitumor+potency&doi=10.1002%2Fijc.28059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency</span></div><div class="casAuthors">Vincent, Marie; Bessard, Anne; Cochonneau, Denis; Teppaz, Geraldine; Sole, Veronique; Maillasson, Mike; Birkle, Stephane; Garrigue-Antar, Laure; Quemener, Agnes; Jacques, Yannick</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">757-765</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Immunocytokines (ICKs) targeting cytokines to the tumor environment using antibodies directed against a tumor-assocd. antigen often have a higher therapeutic index than the corresponding unconjugated cytokines.  Various ICKs displaying significant antitumoral effects in several murine tumor models have already been developed, and some of them, in particular interleukin (IL)-2-based ICKs, are in Phase II clin. trials.  Although sharing common biol. activities with IL-2 in vitro, IL-15 is now considered as having a better potential in antitumor immunotherapeutical strategies and has been shown to be less toxic than IL-2 in preclin. studies.  We previously developed the fusion protein RLI, linking a sol. form of human IL-15Rα-sushi+ domain to human IL-15.  RLI showed better biol. activities than IL-15 in vitro as well as higher antitumoral effects in vivo in murine and human cancer models.  Here, we investigated, in the context of an ICK, the effect of assocg. RLI with an antibody targeting the GD2 ganglioside, a validated tumoral target expressed on many neurectodermal tumors.  Anti-GD2-RLI fully retained the cytokine potential of RLI and the antibody effector functions (antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity).  It displayed strong antitumor activities in two syngeneic cancer models in immunocompetent mice (s.c. EL4 and metastatic NXS2).  Its therapeutic potency was higher than those of RLI and anti-GD2 alone or in combination.  We suggest that this is related to its bifunctional (cytokine and antibody) nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptQrWVU8Sz57Vg90H21EOLACvtfcHk0lh1TACt3CVyag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFemsbs%253D&md5=449f590ea5a8023ede2e85ffd56e33d7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fijc.28059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28059%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DM.%26aulast%3DBessard%26aufirst%3DA.%26aulast%3DCochonneau%26aufirst%3DD.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DSole%26aufirst%3DV.%26aulast%3DMaillasson%26aufirst%3DM.%26aulast%3DBirkle%26aufirst%3DS.%26aulast%3DGarrigue-Antar%26aufirst%3DL.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DTumor%2520targeting%2520of%2520the%2520IL-15%2520superagonist%2520RLI%2520by%2520an%2520anti-GD2%2520antibody%2520strongly%2520enhances%2520its%2520antitumor%2520potency%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D133%26spage%3D757%26epage%3D765%26doi%3D10.1002%2Fijc.28059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Vincent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lajoie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillasson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loisel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemenceau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigue-Antar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span> </span><span class="NLM_article-title">Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse</span> <span class="citation_source-journal">MAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.4161/mabs.28699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4161%2Fmabs.28699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1026-1037&author=M.+Vincentauthor=G.+Teppazauthor=L.+Lajoieauthor=V.+Soleauthor=A.+Bessardauthor=M.+Maillassonauthor=S.+Loiselauthor=D.+Bechardauthor=B.+Clemenceauauthor=G.+Thibaultauthor=L.+Garrigue-Antarauthor=Y.+Jacquesauthor=A.+Quemener&title=Highly+potent+anti-CD20-RLI+immunocytokine+targeting+established+human+B+lymphoma+in+SCID+mouse&doi=10.4161%2Fmabs.28699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.4161%2Fmabs.28699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.28699%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DM.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DLajoie%26aufirst%3DL.%26aulast%3DSole%26aufirst%3DV.%26aulast%3DBessard%26aufirst%3DA.%26aulast%3DMaillasson%26aufirst%3DM.%26aulast%3DLoisel%26aufirst%3DS.%26aulast%3DBechard%26aufirst%3DD.%26aulast%3DClemenceau%26aufirst%3DB.%26aulast%3DThibault%26aufirst%3DG.%26aulast%3DGarrigue-Antar%26aufirst%3DL.%26aulast%3DJacques%26aufirst%3DY.%26aulast%3DQuemener%26aufirst%3DA.%26atitle%3DHighly%2520potent%2520anti-CD20-RLI%2520immunocytokine%2520targeting%2520established%2520human%2520B%2520lymphoma%2520in%2520SCID%2520mouse%26jtitle%3DMAbs%26date%3D2014%26volume%3D6%26spage%3D1026%26epage%3D1037%26doi%3D10.4161%2Fmabs.28699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trilles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMahieu, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, R.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, G.</span><span> </span><span class="NLM_article-title">Identification of a small molecule inhibitor of the IL-2/IL-2Rα receptor interaction which binds to IL-2</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">7589</span><span class="NLM_x">–</span> <span class="NLM_lpage">7590</span><span class="refDoi"> DOI: 10.1021/ja970702x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja970702x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7589-7590&author=J.+W.+Tilleyauthor=L.+Chenauthor=D.+C.+Fryauthor=S.+D.+Emersonauthor=G.+D.+Powersauthor=D.+Biondiauthor=T.+Varnellauthor=R.+Trillesauthor=R.+Guthrieauthor=F.+Mennonaauthor=G.+Kaplanauthor=R.+A.+LeMahieuauthor=M.+Carsonauthor=R.-J.+Hanauthor=C.-M.+Liuauthor=R.+Palermoauthor=G.+Ju&title=Identification+of+a+small+molecule+inhibitor+of+the+IL-2%2FIL-2R%CE%B1+receptor+interaction+which+binds+to+IL-2&doi=10.1021%2Fja970702x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja970702x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja970702x%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFry%26aufirst%3DD.%2BC.%26aulast%3DEmerson%26aufirst%3DS.%2BD.%26aulast%3DPowers%26aufirst%3DG.%2BD.%26aulast%3DBiondi%26aufirst%3DD.%26aulast%3DVarnell%26aufirst%3DT.%26aulast%3DTrilles%26aufirst%3DR.%26aulast%3DGuthrie%26aufirst%3DR.%26aulast%3DMennona%26aufirst%3DF.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DLeMahieu%26aufirst%3DR.%2BA.%26aulast%3DCarson%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DR.-J.%26aulast%3DLiu%26aufirst%3DC.-M.%26aulast%3DPalermo%26aufirst%3DR.%26aulast%3DJu%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520the%2520IL-2%252FIL-2R%25CE%25B1%2520receptor%2520interaction%2520which%2520binds%2520to%2520IL-2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7589%26epage%3D7590%26doi%3D10.1021%2Fja970702x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Geng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umlauf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallai, P. V.</span><span> </span><span class="NLM_article-title">The synthesis and selective IL-2 inhibitory activity of bis piperazine-phenol Mannich adducts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00011-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0960-894X%2802%2900011-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=775-778&author=B.+Gengauthor=P.+R.+Flemingauthor=S.+Umlaufauthor=A.+Linauthor=P.+V.+Pallai&title=The+synthesis+and+selective+IL-2+inhibitory+activity+of+bis+piperazine-phenol+Mannich+adducts&doi=10.1016%2FS0960-894X%2802%2900011-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900011-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900011-2%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DP.%2BR.%26aulast%3DUmlauf%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DPallai%26aufirst%3DP.%2BV.%26atitle%3DThe%2520synthesis%2520and%2520selective%2520IL-2%2520inhibitory%2520activity%2520of%2520bis%2520piperazine-phenol%2520Mannich%2520adducts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D775%26epage%3D778%26doi%3D10.1016%2FS0960-894X%2802%2900011-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1186/ar1202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1186%2Far1202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=15225362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=174-177&author=T.+A.+Waldmann&title=Targeting+the+interleukin-15%2Finterleukin-15+receptor+system+in+inflammatory+autoimmune+diseases&doi=10.1186%2Far1202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases</span></div><div class="casAuthors">Waldmann, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-177</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Interleukin (IL)-15 is a dangerous inflammatory cytokine that induces tumor necrosis factor-α, IL-1β, and inflammatory chemokines.  It inhibits self-tolerance mediated by IL-2 mediated activation-induced cell death (apoptosis) and facilitates maintenance of CD8+ memory T-cell survival including that of self-directed memory cells.  Disordered IL-15 expression has been reported in patients with an array of inflammatory autoimmune diseases.  A series of therapeutic agents that inhibit IL-15 action have been introduced, including the sol. IL-15 receptor (IL-15R) α chain, mutant IL-15, and antibodies directed against the IL-15 cytokine and against the IL-2R/IL-15R β subunit used by IL-2 and IL-15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokhrK56JpqV7Vg90H21EOLACvtfcHk0lj1sNCu9m7SrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFanu7s%253D&md5=190cc54760f6eacdab96a160f8f8c608</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Far1202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1202%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DTargeting%2520the%2520interleukin-15%252Finterleukin-15%2520receptor%2520system%2520in%2520inflammatory%2520autoimmune%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2004%26volume%3D6%26spage%3D174%26epage%3D177%26doi%3D10.1186%2Far1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">Targeting the interleukin-15 system in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1002/art.21363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fart.21363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=16142738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A280%3ADC%252BD2MrksVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2585-2588&author=T.+A.+Waldmann&title=Targeting+the+interleukin-15+system+in+rheumatoid+arthritis&doi=10.1002%2Fart.21363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interleukin-15 system in rheumatoid arthritis</span></div><div class="casAuthors">Waldmann Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2585-8</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOCOHM3rv-fkPI-fCgwosgfW6udTcc2eZemhYtkijIzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrksVeltQ%253D%253D&md5=ab01c6af630c5332bf1c87b4fd7da101</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fart.21363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21363%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DTargeting%2520the%2520interleukin-15%2520system%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2585%26epage%3D2588%26doi%3D10.1002%2Fart.21363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Tinubu, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Familletti, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crittenden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenteau, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirbas, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsudo, M.</span><span> </span><span class="NLM_article-title">Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">4330</span><span class="NLM_x">–</span> <span class="NLM_lpage">4338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=4330-4338&author=S.+A.+Tinubuauthor=J.+Hakimiauthor=J.+A.+Kondasauthor=P.+Bailonauthor=P.+C.+Famillettiauthor=C.+Spenceauthor=M.+D.+Crittendenauthor=G.+L.+Parenteauauthor=F.+M.+Dirbasauthor=M.+Tsudo&title=Humanized+antibody+directed+to+the+IL-2+receptor+beta-chain+prolongs+primate+cardiac+allograft+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTinubu%26aufirst%3DS.%2BA.%26aulast%3DHakimi%26aufirst%3DJ.%26aulast%3DKondas%26aufirst%3DJ.%2BA.%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DFamilletti%26aufirst%3DP.%2BC.%26aulast%3DSpence%26aufirst%3DC.%26aulast%3DCrittenden%26aufirst%3DM.%2BD.%26aulast%3DParenteau%26aufirst%3DG.%2BL.%26aulast%3DDirbas%26aufirst%3DF.%2BM.%26aulast%3DTsudo%26aufirst%3DM.%26atitle%3DHumanized%2520antibody%2520directed%2520to%2520the%2520IL-2%2520receptor%2520beta-chain%2520prolongs%2520primate%2520cardiac%2520allograft%2520survival%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D4330%26epage%3D4338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Nata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Besien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massoud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagaya, Y.</span><span> </span><span class="NLM_article-title">Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">22338</span><span class="NLM_x">–</span> <span class="NLM_lpage">22351</span><span class="refDoi"> DOI: 10.1074/jbc.M115.661074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M115.661074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=22338-22351&author=T.+Nataauthor=A.+Basheerauthor=F.+Cocchiauthor=R.+van+Besienauthor=R.+Massoudauthor=S.+Jacobsonauthor=N.+Azimiauthor=Y.+Tagaya&title=Targeting+the+binding+interface+on+a+shared+receptor+subunit+of+a+cytokine+family+enables+the+inhibition+of+multiple+member+cytokines+with+selectable+target+spectrum&doi=10.1074%2Fjbc.M115.661074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.661074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.661074%26sid%3Dliteratum%253Aachs%26aulast%3DNata%26aufirst%3DT.%26aulast%3DBasheer%26aufirst%3DA.%26aulast%3DCocchi%26aufirst%3DF.%26aulast%3Dvan%2BBesien%26aufirst%3DR.%26aulast%3DMassoud%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DS.%26aulast%3DAzimi%26aufirst%3DN.%26aulast%3DTagaya%26aufirst%3DY.%26atitle%3DTargeting%2520the%2520binding%2520interface%2520on%2520a%2520shared%2520receptor%2520subunit%2520of%2520a%2520cytokine%2520family%2520enables%2520the%2520inhibition%2520of%2520multiple%2520member%2520cytokines%2520with%2520selectable%2520target%2520spectrum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D22338%26epage%3D22351%26doi%3D10.1074%2Fjbc.M115.661074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Krammer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatachalam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span> </span><span class="NLM_article-title">LigScore: a novel scoring function for predicting binding affinities</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.jmgm.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=15781182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlChtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=395-407&author=A.+Krammerauthor=P.+D.+Kirchhoffauthor=X.+Jiangauthor=C.+M.+Venkatachalamauthor=M.+Waldman&title=LigScore%3A+a+novel+scoring+function+for+predicting+binding+affinities&doi=10.1016%2Fj.jmgm.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">LigScore: a novel scoring function for predicting binding affinities</span></div><div class="casAuthors">Krammer, Andre; Kirchhoff, Paul D.; Jiang, X.; Venkatachalam, C. M.; Waldman, Marvin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-407</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We present two new empirical scoring functions, LigScore1 and LigScore2, that attempt to accurately predict the binding affinity between ligand mols. and their protein receptors.  The LigScore functions consist of three distinct terms that describe the van der Waals interaction, the polar attraction between the ligand and protein, and the desolvation penalty attributed to the binding of the polar ligand atoms to the protein and vice versa.  Utilizing a regression approach on a data set of 118 protein-ligand complexes we have obtained a linear equation, LigScore2, using these three descriptors.  LigScore2 has good predictability with regard to exptl. pKi values yielding a correlation coeff., r2, of 0.75 and a std. deviation of 1.04 over the training data set, which consists of a diverse set of proteins that span more than seven protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ92LlTK_aQrVg90H21EOLACvtfcHk0lg6p7SvjsKNmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlChtrY%253D&md5=2158de5b2413ee6fa79fda1a72eca96f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DKrammer%26aufirst%3DA.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DVenkatachalam%26aufirst%3DC.%2BM.%26aulast%3DWaldman%26aufirst%3DM.%26atitle%3DLigScore%253A%2520a%2520novel%2520scoring%2520function%2520for%2520predicting%2520binding%2520affinities%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2005%26volume%3D23%26spage%3D395%26epage%3D407%26doi%3D10.1016%2Fj.jmgm.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/1074-5521(95)90050-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming&doi=10.1016%2F1074-5521%2895%2990050-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lhcDsVr0bKKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324%26doi%3D10.1016%2F1074-5521%2895%2990050-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Muegge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, Y. C.</span><span> </span><span class="NLM_article-title">A general and fast scoring function for protein-ligand interactions: a simplified potential approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span><span class="refDoi"> DOI: 10.1021/jm980536j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980536j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1MXht1aksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=791-804&author=I.+Mueggeauthor=Y.+C.+Martin&title=A+general+and+fast+scoring+function+for+protein-ligand+interactions%3A+a+simplified+potential+approach&doi=10.1021%2Fjm980536j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A General and Fast Scoring Function for Protein-Ligand Interactions: A Simplified Potential Approach</span></div><div class="casAuthors">Muegge, Ingo; Martin, Yvonne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fast, simplified potential-based approach is presented that ests. the protein-ligand binding affinity based on the given 3D structure of a protein-ligand complex.  This general, knowledge-based approach exploits structural information of known protein-ligand complexes extd. from the Brookhaven Protein Data Bank and converts it into distance-dependent Helmholtz free interaction energies of protein-ligand atom pairs (potentials of mean force, PMF).  The definition of an appropriate ref. state and the introduction of a correction term accounting for the vol. taken by the ligand were found to be crucial for deriving the relevant interaction potentials that treat solvation and entropic contributions implicitly.  A significant correlation between exptl. binding affinities and computed score was found for sets of diverse protein-ligand complexes and for sets of different ligands bound to the same target.  For 77 protein-ligand complexes taken from the Brookhaven Protein Data Bank, the calcd. score showed a std. deviation from obsd. binding affinities of 1.8 log Ki units and an R2 value of 0.61.  The best results were obtained for the subset of 16 serine protease complexes with a std. deviation of 1.0 log Ki unit and an R2 value of 0.86.  A set of 33 inhibitors modeled into a crystal structure of HIV-1 protease yielded a std. deviation of 0.8 log Ki units from measured inhibition consts. and an R2 value of 0.74.  In contrast to empirical scoring functions that show similar or sometimes better correlation with obsd. binding affinities, our method does not involve deriving specific parameters that fit the obsd. binding affinities of protein-ligand complexes of a given training set.  We compared the performance of the PMF score, B.ovrddot.ohm's score (LUDI), and the SMOG score for eight different test sets of protein-ligand complexes.  It was found that for the majority of test sets the PMF score performs best.  The strength of the new approach presented here lies in its generality as no knowledge about measured binding affinities is needed to derive at. interaction potentials.  The use of the new scoring function in docking studies is outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1fvneEthHV7Vg90H21EOLACvtfcHk0lhcDsVr0bKKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1aksrk%253D&md5=92e0d327fa62b15e9d8033aaea5b9091</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm980536j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980536j%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DY.%2BC.%26atitle%3DA%2520general%2520and%2520fast%2520scoring%2520function%2520for%2520protein-ligand%2520interactions%253A%2520a%2520simplified%2520potential%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D791%26epage%3D804%26doi%3D10.1021%2Fjm980536j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Venkatachalam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span> </span><span class="NLM_article-title">LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/S1093-3263(02)00164-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS1093-3263%2802%2900164-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=12479928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlWmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=289-307&author=C.+M.+Venkatachalamauthor=X.+Jiangauthor=T.+Oldfieldauthor=M.+Waldman&title=LigandFit%3A+a+novel+method+for+the+shape-directed+rapid+docking+of+ligands+to+protein+active+sites&doi=10.1016%2FS1093-3263%2802%2900164-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites</span></div><div class="casAuthors">Venkatachalam, C. M.; Jiang, X.; Oldfield, T.; Waldman, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-307</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We present a new shape-based method, LigandFit, for accurately docking ligands into protein active sites.  The method employs a cavity detection algorithm for detecting invaginations in the protein as candidate active site regions.  A shape comparison filter is combined with a Monte Carlo conformational search for generating ligand poses consistent with the active site shape.  Candidate poses are minimized in the context of the active site using a grid-based method for evaluating protein-ligand interaction energies.  Errors arising from grid interpolation are dramatically reduced using a new non-linear interpolation scheme.  Results are presented for 19 diverse protein-ligand complexes.  The method appears quite promising, reproducing the x-ray structure ligand pose within an RMS of 2 Å in 14 out of the 19 complexes.  A high-throughput screening study applied to the thymidine kinase receptor is also presented in which LigandFit, when combined with LigScore, an internally developed scoring function, yields very good hit rates for a ligand pool seeded with known actives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMpMvQ1uY5bVg90H21EOLACvtfcHk0lhcDsVr0bKKLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlWmuro%253D&md5=0908c3b84f9eec3ffd05d30e938b9690</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900164-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900164-X%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatachalam%26aufirst%3DC.%2BM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DOldfield%26aufirst%3DT.%26aulast%3DWaldman%26aufirst%3DM.%26atitle%3DLigandFit%253A%2520a%2520novel%2520method%2520for%2520the%2520shape-directed%2520rapid%2520docking%2520of%2520ligands%2520to%2520protein%2520active%2520sites%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2003%26volume%3D21%26spage%3D289%26epage%3D307%26doi%3D10.1016%2FS1093-3263%2802%2900164-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds(PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Lagorce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span> </span><span class="NLM_article-title">FAF-Drugs3: a web server for compound property calculation and chemical library design</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">W200</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1093/nar/gkv353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1093%2Fnar%2Fgkv353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=25883137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVymtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=W200-207&author=D.+Lagorceauthor=O.+Sperandioauthor=J.+B.+Baellauthor=M.+A.+Mitevaauthor=B.+O.+Villoutreix&title=FAF-Drugs3%3A+a+web+server+for+compound+property+calculation+and+chemical+library+design&doi=10.1093%2Fnar%2Fgkv353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">FAF-Drugs3: a web server for compound property calculation and chemical library design</span></div><div class="casAuthors">Lagorce, David; Sperandio, Olivier; Baell, Jonathan B.; Miteva, Maria A.; Villoutreix, Bruno O.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W200-W207</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Drug attrition late in preclin. or clin. development is a serious economic problem in the field of drug discovery.  These problems can be linked, in part, to the quality of the compd. collections used during the hit generation stage and to the selection of compds. undergoing optimization.  Here, we present FAF-Drugs3, a web server that can be used for drug discovery and chem. biol. projects to help in prepg. compd. libraries and to assist decision-making during the hit selection/lead optimization phase.  Since it was first described in 2006, FAF-Drugs has been significantly modified.  The tool now applies an enhanced structure curation procedure, can filter or analyze mols. with user-defined or eight predefined physicochem. filters as well as with several simple ADMET (absorption, distribution, metab., excretion and toxicity) rules.  In addn., compds. can be filtered using an updated list of 154 hand-curated structural alerts while Pan Assay Interference compds. (PAINS) and other, generally unwanted groups are also investigated.  FAF-Drugs3 offers access to user-friendly html result pages and the possibility to download all computed data.  The server requires as input an SDF file of the compds.; it is open to all users and can be accessed without registration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYZ-hCUhlmrVg90H21EOLACvtfcHk0lg8G7PFMnm1pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVymtLfM&md5=5cf8888c489b90f392117ab065986214</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv353%26sid%3Dliteratum%253Aachs%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26atitle%3DFAF-Drugs3%253A%2520a%2520web%2520server%2520for%2520compound%2520property%2520calculation%2520and%2520chemical%2520library%2520design%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2015%26volume%3D43%26spage%3DW200%26epage%3D207%26doi%3D10.1093%2Fnar%2Fgkv353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Tamzalit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieux, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedellec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisseau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, E.</span><span> </span><span class="NLM_article-title">IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">8565</span><span class="NLM_x">–</span> <span class="NLM_lpage">8570</span><span class="refDoi"> DOI: 10.1073/pnas.1405514111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.1405514111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=8565-8570&author=F.+Tamzalitauthor=I.+Barbieuxauthor=A.+Pletauthor=J.+Heimauthor=S.+Nedellecauthor=S.+Morisseauauthor=Y.+Jacquesauthor=E.+Mortier&title=IL-15.IL-15R%CE%B1+complex+shedding+following+trans-presentation+is+essential+for+the+survival+of+IL-15+responding+NK+and+T+cells&doi=10.1073%2Fpnas.1405514111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1405514111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1405514111%26sid%3Dliteratum%253Aachs%26aulast%3DTamzalit%26aufirst%3DF.%26aulast%3DBarbieux%26aufirst%3DI.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DHeim%26aufirst%3DJ.%26aulast%3DNedellec%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DS.%26aulast%3DJacques%26aufirst%3DY.%26aulast%3DMortier%26aufirst%3DE.%26atitle%3DIL-15.IL-15R%25CE%25B1%2520complex%2520shedding%2520following%2520trans-presentation%2520is%2520essential%2520for%2520the%2520survival%2520of%2520IL-15%2520responding%2520NK%2520and%2520T%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D8565%26epage%3D8570%26doi%3D10.1073%2Fpnas.1405514111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dongdong  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Yao  Wu</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Xuefei  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part III): Targeting cytokines and cytokine receptor complexes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128229. <a href="https://doi.org/10.1016/j.bmcl.2021.128229" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128229%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BIII%252529%25253A%252BTargeting%252Bcytokines%252Band%252Bcytokine%252Breceptor%252Bcomplexes%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D48%26spage%3D128229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jimmy  Smadja</span>, <span class="hlFld-ContribAuthor ">Agnès  Quéméner</span>, <span class="hlFld-ContribAuthor ">Mike  Maillasson</span>, <span class="hlFld-ContribAuthor ">Benoit  Sicard</span>, <span class="hlFld-ContribAuthor ">Aurélien  Leray</span>, <span class="hlFld-ContribAuthor ">Laurence  Arzel</span>, <span class="hlFld-ContribAuthor ">Jacques  Lebreton</span>, <span class="hlFld-ContribAuthor ">Erwan  Mortier</span>, <span class="hlFld-ContribAuthor ">Didier  Dubreuil</span>, <span class="hlFld-ContribAuthor ">Monique  Mathé-Allainmat</span>. </span><span class="cited-content_cbyCitation_article-title">Rational modification, synthesis and biological evaluation of N-substituted phthalazinone derivatives designed to target interleukine-15 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>39 </em>, 116161. <a href="https://doi.org/10.1016/j.bmc.2021.116161" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116161%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bmodification%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-substituted%252Bphthalazinone%252Bderivatives%252Bdesigned%252Bto%252Btarget%252Binterleukine-15%252Bprotein%26aulast%3DSmadja%26aufirst%3DJimmy%26date%3D2021%26volume%3D39%26spage%3D116161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Żyżyńska-Granica</span>, <span class="hlFld-ContribAuthor ">Bartosz  Trzaskowski</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Dutkiewicz</span>, <span class="hlFld-ContribAuthor ">Oliwia  Zegrocka-Stendel</span>, <span class="hlFld-ContribAuthor ">Maja  Machcińska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Bocian</span>, <span class="hlFld-ContribAuthor ">Magdalena  Kowalewska</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Koziak</span>. </span><span class="cited-content_cbyCitation_article-title">The anti-inflammatory potential of cefazolin as common gamma chain cytokine inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-59798-3" title="DOI URL">https://doi.org/10.1038/s41598-020-59798-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-59798-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-59798-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DThe%252Banti-inflammatory%252Bpotential%252Bof%252Bcefazolin%252Bas%252Bcommon%252Bgamma%252Bchain%252Bcytokine%252Binhibitor%26aulast%3D%25C5%25BBy%25C5%25BCy%25C5%2584ska-Granica%26aufirst%3DBarbara%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xujie  Wang</span>, <span class="hlFld-ContribAuthor ">Gangsheng  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Ziming  Feng</span>, <span class="hlFld-ContribAuthor ">Jianshuang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yanan  Yang</span>, <span class="hlFld-ContribAuthor ">Peicheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis of (Z)-3-ylidenephthalides via AlCl3-mediated cyclization with 2-acylbenzoic acids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (14)
                                     , 151734. <a href="https://doi.org/10.1016/j.tetlet.2020.151734" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151734%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DStereoselective%252Bsynthesis%252Bof%252B%252528Z%252529-3-ylidenephthalides%252Bvia%252BAlCl3-mediated%252Bcyclization%252Bwith%252B2-acylbenzoic%252Bacids%26aulast%3DWang%26aufirst%3DXujie%26date%3D2020%26volume%3D61%26issue%3D14%26spage%3D151734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Opsomer</span>, <span class="hlFld-ContribAuthor ">Wim  Dehaen</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Triazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14854-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14854-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14854-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14854-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Triazoles%26aulast%3DOpsomer%26aufirst%3DTomas%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%25205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Qi  Feng</span>, <span class="hlFld-ContribAuthor ">Shuang-Xi  Gu</span>, <span class="hlFld-ContribAuthor ">Yong-Shou  Chen</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Gao</span>, <span class="hlFld-ContribAuthor ">Yi-Xin  Ren</span>, <span class="hlFld-ContribAuthor ">Jian-Chao  Chen</span>, <span class="hlFld-ContribAuthor ">Yin-Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuang  Cao</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Virtual Screening and Optimization of Novel mTOR Inhibitors for Radiosensitization of Hepatocellular Carcinoma</p>. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2020,</strong> <em>Volume 14 </em>, 1779-1798. <a href="https://doi.org/10.2147/DDDT.S249156" title="DOI URL">https://doi.org/10.2147/DDDT.S249156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S249156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S249156%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3D%25253Cp%25253EVirtual%252BScreening%252Band%252BOptimization%252Bof%252BNovel%252BmTOR%252BInhibitors%252Bfor%252BRadiosensitization%252Bof%252BHepatocellular%252BCarcinoma%25253C%25252Fp%25253E%26aulast%3DFeng%26aufirst%3DYing-Qi%26date%3D2020%26date%3D2020%26volume%3DVolume%252014%26spage%3D1779%26epage%3D1798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepyan  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Gurkirat  Kaur</span>, <span class="hlFld-ContribAuthor ">Shilpa  Muradia</span>, <span class="hlFld-ContribAuthor ">Balvinder  Singh</span>, <span class="hlFld-ContribAuthor ">Javed N.  Agrewala</span>. </span><span class="cited-content_cbyCitation_article-title">ImmtorLig_DB: repertoire of virtually screened small molecules against immune receptors to bolster host immunity. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-36179-5" title="DOI URL">https://doi.org/10.1038/s41598-018-36179-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-36179-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-36179-5%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DImmtorLig_DB%25253A%252Brepertoire%252Bof%252Bvirtually%252Bscreened%252Bsmall%252Bmolecules%252Bagainst%252Bimmune%252Breceptors%252Bto%252Bbolster%252Bhost%252Bimmunity%26aulast%3DChatterjee%26aufirst%3DDeepyan%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">İnci Selin  Doğan</span>, <span class="hlFld-ContribAuthor ">Hasan Erdinç  Sellitepe</span>, <span class="hlFld-ContribAuthor ">Bahittin  Kahveci</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Reaction of Some Ester Ethoxycarbonyl Hydrazones with 1-Adamantyl Amine. </span><span class="cited-content_cbyCitation_journal-name">Hacettepe Journal of Biology and Chemistry</span><span> <strong>2019,</strong> <em>47 </em>
                                    (2)
                                     , 203-208. <a href="https://doi.org/10.15671/hjbc.623792" title="DOI URL">https://doi.org/10.15671/hjbc.623792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15671/hjbc.623792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15671%2Fhjbc.623792%26sid%3Dliteratum%253Aachs%26jtitle%3DHacettepe%2520Journal%2520of%2520Biology%2520and%2520Chemistry%26atitle%3DInvestigation%252Bof%252BReaction%252Bof%252BSome%252BEster%252BEthoxycarbonyl%252BHydrazones%252Bwith%252B1-Adamantyl%252BAmine%26aulast%3DDo%25C4%259Fan%26aufirst%3D%25C4%25B0nci%2BSelin%26date%3D2019%26date%3D2019%26volume%3D47%26issue%3D2%26spage%3D203%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sousa</span>, <span class="hlFld-ContribAuthor ">Laurent</span>, <span class="hlFld-ContribAuthor ">Quéméner</span>, <span class="hlFld-ContribAuthor ">Mortier</span>, <span class="hlFld-ContribAuthor ">Questel</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic and Structural Insights on the IL-15 System through Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (18)
                                     , 3261. <a href="https://doi.org/10.3390/molecules24183261" title="DOI URL">https://doi.org/10.3390/molecules24183261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24183261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24183261%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMechanistic%252Band%252BStructural%252BInsights%252Bon%252Bthe%252BIL-15%252BSystem%252Bthrough%252BMolecular%252BDynamics%252BSimulations%26aulast%3DSousa%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D18%26spage%3D3261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazunori  Hirayama</span>, <span class="hlFld-ContribAuthor ">Yuuki  Fujiwara</span>, <span class="hlFld-ContribAuthor ">Tohru  Terada</span>, <span class="hlFld-ContribAuthor ">Kentaro  Shimizu</span>, <span class="hlFld-ContribAuthor ">Keiji  Wada</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kabuta</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual screening identification of novel chemical inhibitors for aberrant interactions between pathogenic mutant SOD1 and tubulin. </span><span class="cited-content_cbyCitation_journal-name">Neurochemistry International</span><span> <strong>2019,</strong> <em>126 </em>, 19-26. <a href="https://doi.org/10.1016/j.neuint.2019.02.020" title="DOI URL">https://doi.org/10.1016/j.neuint.2019.02.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuint.2019.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuint.2019.02.020%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurochemistry%2520International%26atitle%3DVirtual%252Bscreening%252Bidentification%252Bof%252Bnovel%252Bchemical%252Binhibitors%252Bfor%252Baberrant%252Binteractions%252Bbetween%252Bpathogenic%252Bmutant%252BSOD1%252Band%252Btubulin%26aulast%3DHirayama%26aufirst%3DKazunori%26date%3D2019%26volume%3D126%26spage%3D19%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun-Hee  Ahn</span>, <span class="hlFld-ContribAuthor ">Jin-Kyung  Lee</span>, <span class="hlFld-ContribAuthor ">Nam  Kim</span>, <span class="hlFld-ContribAuthor ">Seok-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Sunwoo  Lee</span>, <span class="hlFld-ContribAuthor ">Seunggon  Jung</span>, <span class="hlFld-ContribAuthor ">Kee-Oh  Chay</span>, <span class="hlFld-ContribAuthor ">Tae-Hoon  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">DPIE [2-(1,2-diphenyl-1H-indol-3-yl)ethanamine] Augments Pro-Inflammatory Cytokine Production in IL-1β-Stimulated Primary Human Oral Cells. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (7)
                                     , 1835. <a href="https://doi.org/10.3390/ijms19071835" title="DOI URL">https://doi.org/10.3390/ijms19071835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19071835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19071835%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDPIE%252B%25255B2-%2525281%25252C2-diphenyl-1H-indol-3-yl%252529ethanamine%25255D%252BAugments%252BPro-Inflammatory%252BCytokine%252BProduction%252Bin%252BIL-1%2525CE%2525B2-Stimulated%252BPrimary%252BHuman%252BOral%252BCells%26aulast%3DAhn%26aufirst%3DSun-Hee%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D7%26spage%3D1835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. IL-2– and IL-15–IL-2Rβ interfaces and pharmacophore model. (A) Ribbon diagram of IL-2 in complex with IL-2Rβ (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I">2B5I</a>) and (B) of IL-15 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q">2Z3Q</a>) showing the side chains of Asp20 (D20), Asn88 (N88) and Ile92 (I92) of IL-2 involved in the hydrogen bonding networks to 2 water molecules and Gln70 (Q70) and Tyr134 (Y134) of IL-2Rβ, and the homologous residues Asp8 (D8), Asn65 (N65) and Leu69 (L69) of IL-15. (C) Pharmacophore model used for database searches. HB donor projection (HBD) indicated as pink spheres, HB donor or acceptor (HBDA) projection as a purple sphere, hydrophobic feature (HY) as a cyan sphere, and exclusion spheres in gray.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR analysis and HTRF assays. SPR sensorgrams of binding to immobilized IL-15 with (A) one concentration of 100 μM or (B) increasing concentrations (3.125, 6.25, 12.5, 25, 50, and 100 μM) of one positive compound. (C) HTRF principle with Lumi4-Tb-NHS cryptate (Tb) and D2 as donor and acceptor, respectively. If the labeled soluble IL-2Rβ binds to biotinylated IL-15, the two fluorophores will be in close proximity to allow FRET to occur, which results in a specific long-lived fluorescence emission of D2 at 665 nm. A chemical inhibitor binding to IL-15 will modify the intensity of the fluorescence emission. (D) An example of HTRF screening of a hundred small molecular compounds against IL-15/IL-2Rβ interaction. Data are normalized based on negative (○) and positive (□) controls.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of the selected hit <b>1</b> with three modulable fragments and both chemical disconnections considered (route 1 and route 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of compound <b>1</b>. (A) Binding mode of compound <b>1</b> as predicted by LigandFit and C-Docker docking simulation. Compound <b>1</b> made π–alkyl hydrophobic interactions with residues Ile68 (I68) and Leu69 (L69), an amide−π stacked interaction with Asp8 (D8) and Ser7 (S7) peptidic bond, a HB with Asp8 (D8), and a carbon HB with Asn65 (N65, the distance between the hydrogen and acceptor atoms is 2.690 Å). (B) Two views of the Connolly surface of IL-15 colored according to the hydrophobicity index of the exposed residues (hydrophobic in brown; hydrophilic in blue) showing the environment of compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Phathalazinone Main Cores <b>4</b> and <b>5</b> of the Targeted Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P═CHCOOEt (1 equiv), toluene, 3 h, then reflux 30 min, 90% yield; (b) MeNHNH<sub>2</sub> (1 equiv), EtOH, rt, 30 min, then NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O (4 equiv), reflux, 2 h, 97% yield; (c) MeNCS (5 equiv), Et<sub>3</sub>N (5 equiv), EtOH, reflux, 5 h, 99% yield; (d) CS<sub>2</sub>, KOH (2.5 equiv), reflux, 3 h, 65% yield.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Halogenoalkylamide Reagents <b>6–39</b> and the Azide Reagent <b>40</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (COCl)<sub>2</sub> (1.2 equiv), DMF cat, DCM, rt, 18 h; (b) RNH<sub>2</sub>, Et<sub>3</sub>N (5 equiv), THF, rt, 3–24 h, 20–93%; (c) MeI (5 equiv), K<sub>2</sub>CO<sub>3</sub> (1.2 equiv), DMF, 40 °C, 4 h, 8%; (d) NaN<sub>3</sub> (5 equiv), DMF, 80 °C, 1 h, 72%.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Demethylation of Amide <b>24</b> with BBr<sub>3</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <i>S</i>-Alkylation Step of Thiol <b>4</b>, with the Bromoalkylamides <b>6</b>–<b>38</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. <i>S</i>-Alkylation Step of Thiols <b>4</b> and <b>5</b> with Alkyl Halides</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Demethylation Step of Compounds <b>51</b> and <b>74</b>, To Access the Targeted Final Hydroxy Analogs <b>57</b> and <b>79</b> and Alkoxy Analogs <b>58–60</b> and <b>80–82</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0012.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Hydrolysis of Benzoate Derivatives <b>52</b>, <b>53</b>, and <b>75</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0013.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of the 1,2,3-Triazole Derivatives <b>56</b> and <b>84</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuSO<sub>4</sub>·5H<sub>2</sub>O (0.01 equiv), sodium ascorbate (0.1 equiv), <i>t</i>BuOH/H<sub>2</sub>O (1:1), 60 °C, 20 h, <b>56</b> (61%) and <b>84</b> (60%).</p></p></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/medium/jm-2017-00485r_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Inhibition of IL-15-dependent cell proliferation and Stat5 phosphorylation. (A–F) 32Dβ cell proliferation induced by a fixed concentration of RLI (100 pM) and increasing concentrations of indicated compounds was assessed by the Alamar Blue reduction assay. Data show the inhibitory effect of indicated compounds calculated as the percentage of reduction of the proliferative effect of RLI (100 pM). (G, H) Phosphorylation of Stat5 was evaluated in NK-92 cells stimulated for 1 h by a fixed concentration of IL-15 (50 pM) after a 30 min incubation with increasing concentrations of indicated compounds. Data show the inhibitory effect of indicated compounds calculated as the percentage of reduction of the p-Stat5 response induced by 50 pM of IL-15. All data are the mean ± SEM of at least 3 independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-14/acs.jmedchem.7b00485/20170721/images/large/jm-2017-00485r_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00485&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i98">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 52 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Grabstein, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanebeck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoenborn, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahdieh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giri, J. G.</span><span> </span><span class="NLM_article-title">Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">965</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1126/science.8178155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1126%2Fscience.8178155" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=965-968&author=K.+H.+Grabsteinauthor=J.+Eisenmanauthor=K.+Shanebeckauthor=C.+Rauchauthor=S.+Srinivasanauthor=V.+Fungauthor=C.+Beersauthor=J.+Richardsonauthor=M.+A.+Schoenbornauthor=M.+Ahdiehauthor=L.+Johnsonauthor=M.+R.+Aldersonauthor=J.+D.+Watsonauthor=D.+M.+Andersonauthor=J.+G.+Giri&title=Cloning+of+a+T+cell+growth+factor+that+interacts+with+the+beta+chain+of+the+interleukin-2+receptor&doi=10.1126%2Fscience.8178155"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.8178155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.8178155%26sid%3Dliteratum%253Aachs%26aulast%3DGrabstein%26aufirst%3DK.%2BH.%26aulast%3DEisenman%26aufirst%3DJ.%26aulast%3DShanebeck%26aufirst%3DK.%26aulast%3DRauch%26aufirst%3DC.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DFung%26aufirst%3DV.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DRichardson%26aufirst%3DJ.%26aulast%3DSchoenborn%26aufirst%3DM.%2BA.%26aulast%3DAhdieh%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DAlderson%26aufirst%3DM.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BD.%26aulast%3DAnderson%26aufirst%3DD.%2BM.%26aulast%3DGiri%26aufirst%3DJ.%2BG.%26atitle%3DCloning%2520of%2520a%2520T%2520cell%2520growth%2520factor%2520that%2520interacts%2520with%2520the%2520beta%2520chain%2520of%2520the%2520interleukin-2%2520receptor%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D965%26epage%3D968%26doi%3D10.1126%2Fscience.8178155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Burton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roessler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">4935</span><span class="NLM_x">–</span> <span class="NLM_lpage">4939</span><span class="refDoi"> DOI: 10.1073/pnas.91.11.4935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.91.11.4935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=4935-4939&author=J.+D.+Burtonauthor=R.+N.+Bamfordauthor=C.+Petersauthor=A.+J.+Grantauthor=G.+Kurysauthor=C.+K.+Goldmanauthor=J.+Brennanauthor=E.+Roesslerauthor=T.+A.+Waldmann&title=A+lymphokine%2C+provisionally+designated+interleukin+T+and+produced+by+a+human+adult+T-cell+leukemia+line%2C+stimulates+T-cell+proliferation+and+the+induction+of+lymphokine-activated+killer+cells&doi=10.1073%2Fpnas.91.11.4935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.11.4935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.11.4935%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DJ.%2BD.%26aulast%3DBamford%26aufirst%3DR.%2BN.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DGrant%26aufirst%3DA.%2BJ.%26aulast%3DKurys%26aufirst%3DG.%26aulast%3DGoldman%26aufirst%3DC.%2BK.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DRoessler%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DA%2520lymphokine%252C%2520provisionally%2520designated%2520interleukin%2520T%2520and%2520produced%2520by%2520a%2520human%2520adult%2520T-cell%2520leukemia%2520line%252C%2520stimulates%2520T-cell%2520proliferation%2520and%2520the%2520induction%2520of%2520lymphokine-activated%2520killer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D4935%26epage%3D4939%26doi%3D10.1073%2Fpnas.91.11.4935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kirman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, O. H.</span><span> </span><span class="NLM_article-title">Increased numbers of interleukin-15-expressing cells in active ulcerative colitis</span> <span class="citation_source-journal">Am. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">1789</span><span class="NLM_x">–</span> <span class="NLM_lpage">1794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=8792700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A280%3ADyaK28zosVynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1996&pages=1789-1794&author=I.+Kirmanauthor=O.+H.+Nielsen&title=Increased+numbers+of+interleukin-15-expressing+cells+in+active+ulcerative+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Increased numbers of interleukin-15-expressing cells in active ulcerative colitis</span></div><div class="casAuthors">Kirman I; Nielsen O H</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of gastroenterology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1789-94</span>
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    </div><div class="casAbstract">OBJECTIVES:  Interleukin-15 (IL-15) is a novel cytokine sharing many of the activities of IL-2.  The goal of this study was to evaluate intracellular and serum IL-15 in ulcerative colitis (UC) and Crohn's disease (CD).  METHODS:  Intracellular expression of IL-15 in peripheral blood mononuclear cells (PBMC) from UC patients, CD patients, and controls was studied using cell permeabilization and staining with monoclonal antibodies.  Serum levels of IL-15 were detected using ELISA.  RESULTS:  Percentage of IL-15 expressing PBMC was increased in UC patients and in five of six of CD patients with moderate and severe disease activity compared with controls.  The number of IL-15 expressing cells in patients with active inflammatory bowel disease (IBD) declined within 2 wk of treatment.  Serum IL-15 reached detectable levels in 62.5% of UC patients with moderate and severe disease activity but not in UC patients with slight disease activity or in remission, neither in CD patients nor in controls.  In vitro lipopolysaccharide (LPS)-induced activation of PBMC from controls was associated with up-regulation of intracellular IL-15 expression (p < 0.01) and release of IL-15.  CONCLUSIONS:  UC patients with moderate and severe disease activity have increased percentage of IL-15 expressing PBMC, which might be induced by in vivo cell activation and can lead to elevation of released IL-15 in serum.  Increased IL-15 expression after in vitro LPS stimulation of control PBMC suggests a nonspecific production of this cytokine during the immunoinflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlQEHGUcd1P_6xYuD7tu2XfW6udTcc2ebQTIWNe7U5MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zosVynsg%253D%253D&md5=a7eb0037a53c79b627bdd0f859528c77</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKirman%26aufirst%3DI.%26aulast%3DNielsen%26aufirst%3DO.%2BH.%26atitle%3DIncreased%2520numbers%2520of%2520interleukin-15-expressing%2520cells%2520in%2520active%2520ulcerative%2520colitis%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D1996%26volume%3D91%26spage%3D1789%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ruckert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asadullah, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seifert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budagian, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trombotto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulfone-Paus, S.</span><span> </span><span class="NLM_article-title">Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasis?</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">2240</span><span class="NLM_x">–</span> <span class="NLM_lpage">2250</span><span class="refDoi"> DOI: 10.4049/jimmunol.165.4.2240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4049%2Fjimmunol.165.4.2240" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2000&pages=2240-2250&author=R.+Ruckertauthor=K.+Asadullahauthor=M.+Seifertauthor=V.+M.+Budagianauthor=R.+Arnoldauthor=C.+Trombottoauthor=R.+Pausauthor=S.+Bulfone-Paus&title=Inhibition+of+keratinocyte+apoptosis+by+IL-15%3A+a+new+parameter+in+the+pathogenesis+of+psoriasis%3F&doi=10.4049%2Fjimmunol.165.4.2240"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.165.4.2240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.165.4.2240%26sid%3Dliteratum%253Aachs%26aulast%3DRuckert%26aufirst%3DR.%26aulast%3DAsadullah%26aufirst%3DK.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DBudagian%26aufirst%3DV.%2BM.%26aulast%3DArnold%26aufirst%3DR.%26aulast%3DTrombotto%26aufirst%3DC.%26aulast%3DPaus%26aufirst%3DR.%26aulast%3DBulfone-Paus%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520keratinocyte%2520apoptosis%2520by%2520IL-15%253A%2520a%2520new%2520parameter%2520in%2520the%2520pathogenesis%2520of%2520psoriasis%253F%26jtitle%3DJ.%2520Immunol.%26date%3D2000%26volume%3D165%26spage%3D2240%26epage%3D2250%26doi%3D10.4049%2Fjimmunol.165.4.2240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamihira, S.</span><span> </span><span class="NLM_article-title">Pathological roles of interleukin-15 in adult T-cell leukemia</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.3109/10428199909145703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.3109%2F10428199909145703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10512161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvFal" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=37-45&author=Y.+Yamadaauthor=S.+Kamihira&title=Pathological+roles+of+interleukin-15+in+adult+T-cell+leukemia&doi=10.3109%2F10428199909145703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Pathological roles of interleukin-15 in adult T-cell leukemia</span></div><div class="casAuthors">Yamada, Yasuaki; Kamihira, Shimeru</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 63 refs.  Interleukin-15 (IL-15) is a 14-kDa glycoprotein belonging to the same 4 helix bundle-cytokine family as IL-2.  Although the biol. activity of IL-15 in vitro has been studied extensively, its physiol. role is still obscure.  The receptors for IL-15 and IL-2 consist of 3 subunits, an unique α chain and shared β and γ chains.  Since β and γ chains transduce the signals from the receptors, both cytokines share similar biol. functions, although IL-15 and IL-2 do not have sequence homol.  The α chains function to increase binding affinity for each cytokines.  Adult T-cell leukemia (ATL) cells constitutively express the IL-2 receptor (IL-2R) α and expression is believed to be essential in the early stages of disease development.  We have recently shown that ATL cells also express the complete form of IL-15R including the α chain, and that ATL cells proliferate in response to exogenous IL-15.  Since the mRNA of IL-15 is ubiquitous and is detected in many tissues and cells, it is possible that IL-15R stimulation is involved in the development and progression of ATL.  Here, we review recent studies on IL-15 and IL-15R and their assocn. with ATL and other lymphoproliferative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOIWYHWXxkw7Vg90H21EOLACvtfcHk0ljcFzhoIBR_Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvFal&md5=81f029fcd2b05e33dba25b3ce1449648</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3109%2F10428199909145703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428199909145703%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DKamihira%26aufirst%3DS.%26atitle%3DPathological%2520roles%2520of%2520interleukin-15%2520in%2520adult%2520T-cell%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1999%26volume%3D35%26spage%3D37%26epage%3D45%26doi%3D10.3109%2F10428199909145703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span> </span><span class="NLM_article-title">Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1016/S0167-5699(97)01205-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0167-5699%2897%2901205-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9509762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1cXhtlWlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=75-79&author=I.+B.+McInnesauthor=F.+Y.+Liew&title=Interleukin+15%3A+a+proinflammatory+role+in+rheumatoid+arthritis+synovitis&doi=10.1016%2FS0167-5699%2897%2901205-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis</span></div><div class="casAuthors">McInnes, Iain B.; Liew, Foo Y.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">75-79</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 32 refs.  In rheumatoid arthritis (RA), locally produced interleukin 15 (IL-15) can recruit and activate synovial T cells, which then amplify and perpetuate inflammation through induction of monocyte-derived tumor necrosis factor α (TNF-α) via a cell-contact-dependent mechanism.  Thus, IL-15 could play a pivotal role in disease pathogenesis, acting upstream of TNF-α in orchestrating the induction of a cascade of inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1_p7D8AlaibVg90H21EOLACvtfcHk0ljcFzhoIBR_Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtlWlsL0%253D&md5=1b4b3ff0ee5d2ed41ff8dfcdab73f9a2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2897%2901205-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252897%252901205-X%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26atitle%3DInterleukin%252015%253A%2520a%2520proinflammatory%2520role%2520in%2520rheumatoid%2520arthritis%2520synovitis%26jtitle%3DImmunol.%2520Today%26date%3D1998%26volume%3D19%26spage%3D75%26epage%3D79%26doi%3D10.1016%2FS0167-5699%2897%2901205-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Pavlakis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strehlau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span> </span><span class="NLM_article-title">Intragraft IL-15 transcripts are increased in human renal allograft rejection</span> <span class="citation_source-journal">Transplantation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.1097/00007890-199608270-00020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1097%2F00007890-199608270-00020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1996&pages=543-545&author=M.+Pavlakisauthor=J.+Strehlauauthor=M.+Lipmanauthor=M.+Shapiroauthor=W.+Maslinskiauthor=T.+B.+Strom&title=Intragraft+IL-15+transcripts+are+increased+in+human+renal+allograft+rejection&doi=10.1097%2F00007890-199608270-00020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00007890-199608270-00020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007890-199608270-00020%26sid%3Dliteratum%253Aachs%26aulast%3DPavlakis%26aufirst%3DM.%26aulast%3DStrehlau%26aufirst%3DJ.%26aulast%3DLipman%26aufirst%3DM.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26atitle%3DIntragraft%2520IL-15%2520transcripts%2520are%2520increased%2520in%2520human%2520renal%2520allograft%2520rejection%26jtitle%3DTransplantation%26date%3D1996%26volume%3D62%26spage%3D543%26epage%3D545%26doi%3D10.1097%2F00007890-199608270-00020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Manfro, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy-Chaudhury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span> </span><span class="NLM_article-title">Interleukin-15 gene transcripts are present in rejecting islet allografts</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1077</span><span class="NLM_x">–</span> <span class="NLM_lpage">1078</span><span class="refDoi"> DOI: 10.1016/S0041-1345(96)00410-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0041-1345%2896%2900410-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9123207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK2sXit12gurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=1077-1078&author=R.+C.+Manfroauthor=P.+Roy-Chaudhuryauthor=X.+X.+Zhengauthor=J.+Steigerauthor=P.+W.+Nickersonauthor=Y.+Liauthor=W.+Maslinskiauthor=T.+B.+Strom&title=Interleukin-15+gene+transcripts+are+present+in+rejecting+islet+allografts&doi=10.1016%2FS0041-1345%2896%2900410-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-15 gene transcripts are present in rejecting islet allografts</span></div><div class="casAuthors">Manfro, R. C.; Roy-Chaudhury, P.; Zheng, X. X.; Steiger, J.; Nickerson, P. W.; Li, Y.; Maslinski, W.; Strom, T. B.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">1077-1078</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Greater interleukin-15 gene expression was present in murine pancreatic islet allografts than in murine syngeneic islet grafts.  Furthermore, interleukin-15 gene expression was greater in allografts in interleukin-2-deficient (knockout) mice than in allografts in interleukin-2 wild type mice.  Apparently, factors other than interleukin-2 are able to mediate allograft rejection in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxr4zLqC_UvLVg90H21EOLACvtfcHk0ljcFzhoIBR_Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit12gurY%253D&md5=48e38f6eef507be17b8407068c8c6f30</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2896%2900410-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252896%252900410-1%26sid%3Dliteratum%253Aachs%26aulast%3DManfro%26aufirst%3DR.%2BC.%26aulast%3DRoy-Chaudhury%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DSteiger%26aufirst%3DJ.%26aulast%3DNickerson%26aufirst%3DP.%2BW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26atitle%3DInterleukin-15%2520gene%2520transcripts%2520are%2520present%2520in%2520rejecting%2520islet%2520allografts%26jtitle%3DTransplant.%2520Proc.%26date%3D1997%26volume%3D29%26spage%3D1077%26epage%3D1078%26doi%3D10.1016%2FS0041-1345%2896%2900410-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ruchatz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liew, F. Y.</span><span> </span><span class="NLM_article-title">Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5654</span><span class="NLM_x">–</span> <span class="NLM_lpage">5660</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5654-5660&author=H.+Ruchatzauthor=B.+P.+Leungauthor=X.+Q.+Weiauthor=I.+B.+McInnesauthor=F.+Y.+Liew&title=Soluble+IL-15+receptor+%CE%B1-chain+administration+prevents+murine+collagen-induced+arthritis%3A+a+role+for+IL-15+in+development+of+antigen-induced+immunopathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuchatz%26aufirst%3DH.%26aulast%3DLeung%26aufirst%3DB.%2BP.%26aulast%3DWei%26aufirst%3DX.%2BQ.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DLiew%26aufirst%3DF.%2BY.%26atitle%3DSoluble%2520IL-15%2520receptor%2520%25CE%25B1-chain%2520administration%2520prevents%2520murine%2520collagen-induced%2520arthritis%253A%2520a%2520role%2520for%2520IL-15%2520in%2520development%2520of%2520antigen-induced%2520immunopathology%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5654%26epage%3D5660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ferrari-Lacraz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donskoy, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maslinski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strom, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, T.</span><span> </span><span class="NLM_article-title">Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">5818</span><span class="NLM_x">–</span> <span class="NLM_lpage">5826</span><span class="refDoi"> DOI: 10.4049/jimmunol.173.9.5818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4049%2Fjimmunol.173.9.5818" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=5818-5826&author=S.+Ferrari-Lacrazauthor=E.+Zanelliauthor=M.+Neubergauthor=E.+Donskoyauthor=Y.+S.+Kimauthor=X.+X.+Zhengauthor=W.+W.+Hancockauthor=W.+Maslinskiauthor=X.+C.+Liauthor=T.+B.+Stromauthor=T.+Moll&title=Targeting+IL-15+receptor-bearing+cells+with+an+antagonist+mutant+IL-15%2FFc+protein+prevents+disease+development+and+progression+in+murine+collagen-induced+arthritis&doi=10.4049%2Fjimmunol.173.9.5818"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.173.9.5818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.173.9.5818%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari-Lacraz%26aufirst%3DS.%26aulast%3DZanelli%26aufirst%3DE.%26aulast%3DNeuberg%26aufirst%3DM.%26aulast%3DDonskoy%26aufirst%3DE.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DZheng%26aufirst%3DX.%2BX.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DMaslinski%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DX.%2BC.%26aulast%3DStrom%26aufirst%3DT.%2BB.%26aulast%3DMoll%26aufirst%3DT.%26atitle%3DTargeting%2520IL-15%2520receptor-bearing%2520cells%2520with%2520an%2520antagonist%2520mutant%2520IL-15%252FFc%2520protein%2520prevents%2520disease%2520development%2520and%2520progression%2520in%2520murine%2520collagen-induced%2520arthritis%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D5818%26epage%3D5826%26doi%3D10.4049%2Fjimmunol.173.9.5818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span> </span><span class="NLM_article-title">Interleukin-15 receptor-directed immunotoxins atteunuate disease severity in rat adjuvant arthritis</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1535</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span><span class="refDoi"> DOI: 10.1016/j.molimm.2010.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.molimm.2010.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=20188418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Kgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=1535-1543&author=D.+Wangauthor=X.+Dengauthor=X.+Lengauthor=X.+Mao&title=Interleukin-15+receptor-directed+immunotoxins+atteunuate+disease+severity+in+rat+adjuvant+arthritis&doi=10.1016%2Fj.molimm.2010.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-15 receptor-directed immunotoxins attenuate disease severity in rat adjuvant arthritis</span></div><div class="casAuthors">Wang, Deling; Deng, Xianglei; Leng, Xiaoyan; Mao, Xiaohua</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">1535-1543</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors previously constructed two Pseudomonas exotoxin (PE)-based immunotoxins, IL15-PEΔ293 (IT1) and IL15M-PEΔ293 (IT2), for eliminating interleukin-15 receptor (IL-15R)-overexpressing cells.  These two immunotoxins were generated by fusing either wild-type human IL-15 or an antagonist mutant IL-15 (IL-15M) to a modified form of PE.  In this study the anti-arthritic effect of IT1 and IT2 was investigated using the rat model of adjuvant arthritis (AA).  The authors found that both IT1 and IT2 could specifically target IL-15R-pos. cells and induce apoptosis.  After AA induction, treatment with either IT1 or IT2 resulted in profound improvement of the disease, with redns. in levels of synovial mononuclear leukocytes and certain inflammatory factors.  Clin. and histol. comparisons, together with the analyses of mRNA expression and the signal transducer and activator of transcription-3 (STAT-3) phosphorylation, revealed that the two immunotoxins decreased joint inflammation in AA rats to a similar extent.  These data suggest that eliminating IL-15R-bearing cells via immunotoxins may be a promising approach for RA treatment.  In addn., wild-type IL-15-based immunotoxins can be as effective as antagonist mutant IL-15-based immunotoxins in preventing joint inflammation assocd. with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWucqvyNO9JrVg90H21EOLACvtfcHk0likDFz_J-I1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Kgsr8%253D&md5=b95a72cf23d905a84fae7016c5ff993c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2010.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2010.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DLeng%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DInterleukin-15%2520receptor-directed%2520immunotoxins%2520atteunuate%2520disease%2520severity%2520in%2520rat%2520adjuvant%2520arthritis%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D47%26spage%3D1535%26epage%3D1543%26doi%3D10.1016%2Fj.molimm.2010.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yang, X. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leng, R. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, D. Q.</span><span> </span><span class="NLM_article-title">Therapeutic potential of IL-15 in rheumatoid arthritis</span> <span class="citation_source-journal">Hum. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">812</span><span class="NLM_x">–</span> <span class="NLM_lpage">818</span><span class="refDoi"> DOI: 10.1016/j.humimm.2015.09.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.humimm.2015.09.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=26429323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsF2htLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2015&pages=812-818&author=X.+K.+Yangauthor=W.+D.+Xuauthor=R.+X.+Lengauthor=Y.+Liangauthor=Y.+Y.+Liuauthor=X.+Y.+Fangauthor=C.+C.+Fengauthor=R.+Liauthor=H.+Cenauthor=H.+F.+Panauthor=D.+Q.+Ye&title=Therapeutic+potential+of+IL-15+in+rheumatoid+arthritis&doi=10.1016%2Fj.humimm.2015.09.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of IL-15 in rheumatoid arthritis</span></div><div class="casAuthors">Yang, Xiao-Ke; Xu, Wang-Dong; Leng, Rui-Xue; Liang, Yan; Liu, Yan-Yan; Fang, Xin-Yu; Feng, Chen-Chen; Li, Rui; Cen, Han; Pan, Hai-Feng; Ye, Dong-Qing</div><div class="citationInfo"><span class="NLM_cas:title">Human Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">812-818</span>CODEN:
                <span class="NLM_cas:coden">HUIMDQ</span>;
        ISSN:<span class="NLM_cas:issn">0198-8859</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Rheumatoid arthritis (RA) is a chronic, destructive inflammatory autoimmune disease.  Cytokine-mediated immunity has been found to play an important role in the pathogenesis of autoimmune diseases including RA.  Recently, much attention has been paid on the role of IL-15, which is a member of the 4 α-helix bundle cytokine family.  IL-15 was detected in serum and synovial fluid from RA patients and arthritis mice models.  Moreover, administration of IL-15 leads to the development of severe inflammatory arthritis, suggesting that IL-15 may be therapeutically relevant in RA.  Therefore, targeting IL-15 may be significantly important and valuable.  In this article, we discuss the biol. features and effects of IL-15 and summarize recent advances on the pathol. roles of IL-15 in RA and treatment for RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWgvwmK6HqmbVg90H21EOLACvtfcHk0likDFz_J-I1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsF2htLzI&md5=4307d67f06360dd3c3e03e9b0a4853f0</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.humimm.2015.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.humimm.2015.09.041%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BK.%26aulast%3DXu%26aufirst%3DW.%2BD.%26aulast%3DLeng%26aufirst%3DR.%2BX.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%2BY.%26aulast%3DFang%26aufirst%3DX.%2BY.%26aulast%3DFeng%26aufirst%3DC.%2BC.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DCen%26aufirst%3DH.%26aulast%3DPan%26aufirst%3DH.%2BF.%26aulast%3DYe%26aufirst%3DD.%2BQ.%26atitle%3DTherapeutic%2520potential%2520of%2520IL-15%2520in%2520rheumatoid%2520arthritis%26jtitle%3DHum.%2520Immunol.%26date%3D2015%26volume%3D76%26spage%3D812%26epage%3D818%26doi%3D10.1016%2Fj.humimm.2015.09.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sheng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span> </span><span class="NLM_article-title">State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">8238</span><span class="NLM_x">–</span> <span class="NLM_lpage">8259</span><span class="refDoi"> DOI: 10.1039/C5CS00252D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1039%2FC5CS00252D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=26248294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12mtb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=8238-8259&author=C.+Shengauthor=G.+Dongauthor=Z.+Miaoauthor=W.+Zhangauthor=W.+Wang&title=State-of-the-art+strategies+for+targeting+protein-protein+interactions+by+small-molecule+inhibitors&doi=10.1039%2FC5CS00252D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors</span></div><div class="casAuthors">Sheng, Chunquan; Dong, Guoqiang; Miao, Zhenyuan; Zhang, Wannian; Wang, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8238-8259</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Targeting protein-protein interactions (PPIs) has emerged as a viable approach in modern drug discovery.  However, the identification of small mols. enabling us to effectively interrupt their interactions presents significant challenges.  In the recent past, significant advances have been made in the development of new biol. and chem. strategies to facilitate the discovery process of small-mol. PPI inhibitors.  This review aims to highlight the state-of-the-art technologies and the achievements made recently in this field.  The "hot spots" of PPIs have been proved to be crit. for small mols. to bind.  Three strategies including screening, designing, and synthetic approaches have been explored for discovering PPI inhibitors by targeting the "hot spots".  Although the classic high throughput screening approach can be used, fragment screening, fragment-based drug design and newly improved virtual screening are demonstrated to be more effective in the discovery of PPI inhibitors.  In addn. to screening approaches, design strategies including anchor-based and small mol. mimetics of secondary structures involved in PPIs have become powerful tools as well.  Finally, constructing new chem. spaced libraries with high diversity and complexity is becoming an important area of interest for PPI inhibitors.  The successful cases from the recent five year studies are used to illustrate how these approaches are implemented to uncover and optimize small mol. PPI inhibitors and notably some of them have become promising therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGresOJEXOV1r7Vg90H21EOLACvtfcHk0likDFz_J-I1GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12mtb3J&md5=770274ca159e2a9e01e4c1a42b4c2c28</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC5CS00252D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CS00252D%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DState-of-the-art%2520strategies%2520for%2520targeting%2520protein-protein%2520interactions%2520by%2520small-molecule%2520inhibitors%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2015%26volume%3D44%26spage%3D8238%26epage%3D8259%26doi%3D10.1039%2FC5CS00252D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuenemann, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyet, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzoni-Giovanelli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagorce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, M. A.</span><span> </span><span class="NLM_article-title">Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology</span> <span class="citation_source-journal">Mol. Inf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span><span class="refDoi"> DOI: 10.1002/minf.201400040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fminf.201400040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=25254076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFCmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=414-437&author=B.+O.+Villoutreixauthor=M.+A.+Kuenemannauthor=J.+L.+Poyetauthor=H.+Bruzzoni-Giovanelliauthor=C.+Labbeauthor=D.+Lagorceauthor=O.+Sperandioauthor=M.+A.+Miteva&title=Drug-Like+Protein-Protein+Interaction+Modulators%3A+Challenges+and+Opportunities+for+Drug+Discovery+and+Chemical+Biology&doi=10.1002%2Fminf.201400040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology</span></div><div class="casAuthors">Villoutreix, Bruno O.; Kuenemann, Melaine A.; Poyet, Jean-Luc; Bruzzoni-Giovanelli, Heriberto; Labbe, Celine; Lagorce, David; Sperandio, Olivier; Miteva, Maria A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Informatics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6-7</span>),
    <span class="NLM_cas:pages">414-437</span>CODEN:
                <span class="NLM_cas:coden">MIONBS</span>;
        ISSN:<span class="NLM_cas:issn">1868-1743</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Fundamental processes in living cells are largely controlled by macromol. interactions and among them, protein-protein interactions (PPIs) have a crit. role while their dysregulations can contribute to the pathogenesis of numerous diseases.  Although PPIs were considered as attractive pharmaceutical targets already some years ago, they have been thus far largely unexploited for therapeutic interventions with low mol. wt. compds.  Several limiting factors, from technol. hurdles to conceptual barriers, are known, which, taken together, explain why research in this area has been relatively slow.  However, this last decade, the scientific community has challenged the dogma and became more enthusiastic about the modulation of PPIs with small drug-like mols.  In fact, several success stories were reported both, at the preclin. and clin. stages.  In this review article, written for the 2014 International Summer School in Chemoinformatics (Strasbourg, France), we discuss in silico tools (essentially post 2012) and databases that can assist the design of low mol. wt. PPI modulators (these tools can be found at www.vls3d.com).  We first introduce the field of protein-protein interaction research, discuss key challenges and comment recently reported in silico packages, protocols and databases dedicated to PPIs.  Then, we illustrate how in silico methods can be used and combined with exptl. work to identify PPI modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppampn_mwHg7Vg90H21EOLACvtfcHk0li5QF1oEz2xJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFCmur4%253D&md5=768a72c4cbebea40e9451b4f6048f41c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fminf.201400040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201400040%26sid%3Dliteratum%253Aachs%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26aulast%3DKuenemann%26aufirst%3DM.%2BA.%26aulast%3DPoyet%26aufirst%3DJ.%2BL.%26aulast%3DBruzzoni-Giovanelli%26aufirst%3DH.%26aulast%3DLabbe%26aufirst%3DC.%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26atitle%3DDrug-Like%2520Protein-Protein%2520Interaction%2520Modulators%253A%2520Challenges%2520and%2520Opportunities%2520for%2520Drug%2520Discovery%2520and%2520Chemical%2520Biology%26jtitle%3DMol.%2520Inf.%26date%3D2014%26volume%3D33%26spage%3D414%26epage%3D437%26doi%3D10.1002%2Fminf.201400040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Raimundo, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oslob, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braisted, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waal, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arkin, M. R.</span><span> </span><span class="NLM_article-title">Integrating fragment assembly and biophysical methods in the chemical advancement of small-molecule antagonists of IL-2: an approach for inhibiting protein-protein interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3111</span><span class="NLM_x">–</span> <span class="NLM_lpage">3130</span><span class="refDoi"> DOI: 10.1021/jm049967u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm049967u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3111-3130&author=B.+C.+Raimundoauthor=J.+D.+Oslobauthor=A.+C.+Braistedauthor=J.+Hydeauthor=R.+S.+McDowellauthor=M.+Randalauthor=N.+D.+Waalauthor=J.+Wilkinsonauthor=C.+H.+Yuauthor=M.+R.+Arkin&title=Integrating+fragment+assembly+and+biophysical+methods+in+the+chemical+advancement+of+small-molecule+antagonists+of+IL-2%3A+an+approach+for+inhibiting+protein-protein+interactions&doi=10.1021%2Fjm049967u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm049967u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049967u%26sid%3Dliteratum%253Aachs%26aulast%3DRaimundo%26aufirst%3DB.%2BC.%26aulast%3DOslob%26aufirst%3DJ.%2BD.%26aulast%3DBraisted%26aufirst%3DA.%2BC.%26aulast%3DHyde%26aufirst%3DJ.%26aulast%3DMcDowell%26aufirst%3DR.%2BS.%26aulast%3DRandal%26aufirst%3DM.%26aulast%3DWaal%26aufirst%3DN.%2BD.%26aulast%3DWilkinson%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DC.%2BH.%26aulast%3DArkin%26aufirst%3DM.%2BR.%26atitle%3DIntegrating%2520fragment%2520assembly%2520and%2520biophysical%2520methods%2520in%2520the%2520chemical%2520advancement%2520of%2520small-molecule%2520antagonists%2520of%2520IL-2%253A%2520an%2520approach%2520for%2520inhibiting%2520protein-protein%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3111%26epage%3D3130%26doi%3D10.1021%2Fjm049967u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kalsoom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rashid, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaukat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdalla, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesaik, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaheer-ul-Haq</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansari, F. L.</span><span> </span><span class="NLM_article-title">In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5739</span><span class="NLM_x">–</span> <span class="NLM_lpage">5751</span><span class="refDoi"> DOI: 10.1007/s00044-013-0564-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1007%2Fs00044-013-0564-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjvVegtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=5739-5751&author=S.+Kalsoomauthor=U.+Rashidauthor=A.+Shaukatauthor=O.+M.+Abdallaauthor=K.+Hussainauthor=W.+Khanauthor=S.+Nazirauthor=M.+A.+Mesaikauthor=+Zaheer-ul-Haqauthor=F.+L.+Ansari&title=In+vitro+and+in+silico+exploration+of+IL-2+inhibition+by+small+drug-like+molecules&doi=10.1007%2Fs00044-013-0564-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules</span></div><div class="casAuthors">Kalsoom, Saima; Rashid, Umer; Shaukat, Awais; Abdalla, Omer Mohamed; Hussain, Khalida; Khan, Waqasuddin; Nazir, Samina; Mesaik, Mohammad Ahmad; Zaheer-ul-Haq; Ansari, Farzana Latif</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5739-5751</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">Interleukin-2 (IL-2) is an immunoregulatory cytokine produced by T lymphocytes in response to antigen.  It is a potent growth and differentiation factor for several cell-types and is structurally related to the four-helix bundle family of cytokines.  Here, we report IL-2 inhibitory potential and computational studies on different series of chalcones, benzothiazepines, semicarbazones, and dihydropyrimidines.  These compds. were synthesized in wet lab and were then tested for their potency as IL-2 inhibitors through in vitro T cell proliferation, IL-2 cytokine prodn. as well as their effect on oxidative burst.  Compds. that showed significant suppressive activity were further evaluated for their cytotoxicity on normal two cell lines.  Most of the chalcones were found to have a powerful inhibitory effect on T-lymphocytes proliferation and cytokine prodn.  Among the aza heterocycles benzothiazepines, benzoxazepines, and benzodiazepinones were found to be the strongest IL-2 inhibitors.  Mol. docking and MD simulation studies were carried out to correlate exptl. and theor. results whereby a good correlation was obsd. which indicated that computational studies could provide an alternate tool for the identification and designing of more potent IL-2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGor7PYLP79sU7Vg90H21EOLACvtfcHk0li5QF1oEz2xJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjvVegtbw%253D&md5=97c062e0ab3537daf5c9fee7af2c6fa0</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00044-013-0564-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-013-0564-x%26sid%3Dliteratum%253Aachs%26aulast%3DKalsoom%26aufirst%3DS.%26aulast%3DRashid%26aufirst%3DU.%26aulast%3DShaukat%26aufirst%3DA.%26aulast%3DAbdalla%26aufirst%3DO.%2BM.%26aulast%3DHussain%26aufirst%3DK.%26aulast%3DKhan%26aufirst%3DW.%26aulast%3DNazir%26aufirst%3DS.%26aulast%3DMesaik%26aufirst%3DM.%2BA.%26aulast%3DZaheer-ul-Haq%26aulast%3DAnsari%26aufirst%3DF.%2BL.%26atitle%3DIn%2520vitro%2520and%2520in%2520silico%2520exploration%2520of%2520IL-2%2520inhibition%2520by%2520small%2520drug-like%2520molecules%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26spage%3D5739%26epage%3D5751%26doi%3D10.1007%2Fs00044-013-0564-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span> </span><span class="NLM_article-title">Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e78619</span><span class="refDoi"> DOI: 10.1371/journal.pone.0078619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1371%2Fjournal.pone.0078619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e78619&author=T.+Zhangauthor=X.+Baiauthor=X.+Mao&title=Systemic+delivery+of+small+interfering+RNA+targeting+the+interleukin-2%2F15+receptor+%CE%B2+chain+prevents+disease+progression+in+experimental+arthritis&doi=10.1371%2Fjournal.pone.0078619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078619%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DX.%26atitle%3DSystemic%2520delivery%2520of%2520small%2520interfering%2520RNA%2520targeting%2520the%2520interleukin-2%252F15%2520receptor%2520%25CE%25B2%2520chain%2520prevents%2520disease%2520progression%2520in%2520experimental%2520arthritis%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De78619%26doi%3D10.1371%2Fjournal.pone.0078619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Pettit, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnert, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabstein, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gombotz, W. R.</span><span> </span><span class="NLM_article-title">Structure-function studies of interleukin 15 using site-specific mutagenesis, polyethylene glycol conjugation, and homology modeling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">2312</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span><span class="refDoi"> DOI: 10.1074/jbc.272.4.2312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.272.4.2312" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=2312-2318&author=D.+K.+Pettitauthor=T.+P.+Bonnertauthor=J.+Eisenmanauthor=S.+Srinivasanauthor=R.+Paxtonauthor=C.+Beersauthor=D.+Lynchauthor=B.+Millerauthor=J.+Yostauthor=K.+H.+Grabsteinauthor=W.+R.+Gombotz&title=Structure-function+studies+of+interleukin+15+using+site-specific+mutagenesis%2C+polyethylene+glycol+conjugation%2C+and+homology+modeling&doi=10.1074%2Fjbc.272.4.2312"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.4.2312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.4.2312%26sid%3Dliteratum%253Aachs%26aulast%3DPettit%26aufirst%3DD.%2BK.%26aulast%3DBonnert%26aufirst%3DT.%2BP.%26aulast%3DEisenman%26aufirst%3DJ.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DPaxton%26aufirst%3DR.%26aulast%3DBeers%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DB.%26aulast%3DYost%26aufirst%3DJ.%26aulast%3DGrabstein%26aufirst%3DK.%2BH.%26aulast%3DGombotz%26aufirst%3DW.%2BR.%26atitle%3DStructure-function%2520studies%2520of%2520interleukin%252015%2520using%2520site-specific%2520mutagenesis%252C%2520polyethylene%2520glycol%2520conjugation%252C%2520and%2520homology%2520modeling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D2312%26epage%3D2318%26doi%3D10.1074%2Fjbc.272.4.2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bernard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermot-Desroches, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijdeness, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Dijken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slootstra, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Identification of an interleukin-15α receptor-binding site on human interleukin-15</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">24313</span><span class="NLM_x">–</span> <span class="NLM_lpage">24322</span><span class="refDoi"> DOI: 10.1074/jbc.M312458200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M312458200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=24313-24322&author=J.+Bernardauthor=C.+Harbauthor=E.+Mortierauthor=A.+Quemenerauthor=R.+H.+Meloenauthor=C.+Vermot-Desrochesauthor=J.+Wijdenessauthor=P.+van+Dijkenauthor=J.+Grotzingerauthor=J.+W.+Slootstraauthor=A.+Pletauthor=Y.+Jacques&title=Identification+of+an+interleukin-15%CE%B1+receptor-binding+site+on+human+interleukin-15&doi=10.1074%2Fjbc.M312458200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312458200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312458200%26sid%3Dliteratum%253Aachs%26aulast%3DBernard%26aufirst%3DJ.%26aulast%3DHarb%26aufirst%3DC.%26aulast%3DMortier%26aufirst%3DE.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DMeloen%26aufirst%3DR.%2BH.%26aulast%3DVermot-Desroches%26aufirst%3DC.%26aulast%3DWijdeness%26aufirst%3DJ.%26aulast%3Dvan%2BDijken%26aufirst%3DP.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DSlootstra%26aufirst%3DJ.%2BW.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520an%2520interleukin-15%25CE%25B1%2520receptor-binding%2520site%2520on%2520human%2520interleukin-15%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D24313%26epage%3D24322%26doi%3D10.1074%2Fjbc.M312458200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Pulliam, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzhachenko, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adunyah, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanker, A.</span><span> </span><span class="NLM_article-title">Common gamma chain cytokines in combinatorial immune strategies against cancer</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.imlet.2015.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.imlet.2015.11.007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2016&pages=61-72&author=S.+R.+Pulliamauthor=R.+V.+Uzhachenkoauthor=S.+E.+Adunyahauthor=A.+Shanker&title=Common+gamma+chain+cytokines+in+combinatorial+immune+strategies+against+cancer&doi=10.1016%2Fj.imlet.2015.11.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2015.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2015.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DPulliam%26aufirst%3DS.%2BR.%26aulast%3DUzhachenko%26aufirst%3DR.%2BV.%26aulast%3DAdunyah%26aufirst%3DS.%2BE.%26aulast%3DShanker%26aufirst%3DA.%26atitle%3DCommon%2520gamma%2520chain%2520cytokines%2520in%2520combinatorial%2520immune%2520strategies%2520against%2520cancer%26jtitle%3DImmunol.%2520Lett.%26date%3D2016%26volume%3D169%26spage%3D61%26epage%3D72%26doi%3D10.1016%2Fj.imlet.2015.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Chirifu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemizu, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1038/ni1492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2Fni1492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=17643103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptlSkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=1001-1007&author=M.+Chirifuauthor=C.+Hayashiauthor=T.+Nakamuraauthor=S.+Tomaauthor=T.+Shutoauthor=H.+Kaiauthor=Y.+Yamagataauthor=S.+J.+Davisauthor=S.+Ikemizu&title=Crystal+structure+of+the+IL-15-IL-15R%CE%B1+complex%2C+a+cytokine-receptor+unit+presented+in+trans&doi=10.1038%2Fni1492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the IL-15-IL-15Rα complex, a cytokine-receptor unit presented in trans</span></div><div class="casAuthors">Chirifu, Mami; Hayashi, Chiharu; Nakamura, Teruya; Toma, Sachiko; Shuto, Tsuyoshi; Kai, Hirofumi; Yamagata, Yuriko; Davis, Simon J.; Ikemizu, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1001-1007</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 15 (IL-15) and IL-2, which promote the survival of memory CD8+ T cells and regulatory T cells, resp., bind receptor complexes that share β- and γ-signaling subunits.  Receptor specificity is provided by unique, nonsignaling α-subunits.  Whereas IL-2 receptor-α (IL-2Rα) is expressed together in cis with the β- and γ-subunits on T cells and B cells, IL-15Rα is expressed in trans on antigen-presenting cells.  Here we present a 1.85-Å crystal structure of the human IL-15-IL-15Rα complex.  The structure provides insight into the mol. basis of the specificity of cytokine recognition and emphasizes the importance of water in generating this very high-affinity complex.  Despite very low IL-15-IL-2 sequence homol. and distinct receptor architecture, the topologies of the IL-15-IL-15Rα and IL-2-IL-2Rα complexes are very similar.  Our data raise the possibility that IL-2, like IL-15, might be capable of being presented in trans in the context of its unique receptor α-chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVSxvqs0CsLVg90H21EOLACvtfcHk0lh7v5I9b38p0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptlSkurs%253D&md5=4bd905b164f7ef9a136d9c0e65b9cb5f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fni1492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1492%26sid%3Dliteratum%253Aachs%26aulast%3DChirifu%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DC.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DToma%26aufirst%3DS.%26aulast%3DShuto%26aufirst%3DT.%26aulast%3DKai%26aufirst%3DH.%26aulast%3DYamagata%26aufirst%3DY.%26aulast%3DDavis%26aufirst%3DS.%2BJ.%26aulast%3DIkemizu%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520IL-15-IL-15R%25CE%25B1%2520complex%252C%2520a%2520cytokine-receptor%2520unit%2520presented%2520in%2520trans%26jtitle%3DNat.%2520Immunol.%26date%3D2007%26volume%3D8%26spage%3D1001%26epage%3D1007%26doi%3D10.1038%2Fni1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shanafelt, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanafelt, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forte, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois-Stringfellow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaria, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greve, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gundel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plym, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roczniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serban, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrift, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiyama, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetzel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zolotorev, A.</span><span> </span><span class="NLM_article-title">A T-cell-selective interleukin 2 mutein exhibits potent antitumor activity and is well tolerated in vivo</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1197</span><span class="NLM_x">–</span> <span class="NLM_lpage">1202</span><span class="refDoi"> DOI: 10.1038/81199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2F81199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2000&pages=1197-1202&author=A.+B.+Shanafeltauthor=Y.+Linauthor=M.+C.+Shanafeltauthor=C.+P.+Forteauthor=N.+Dubois-Stringfellowauthor=C.+Carterauthor=J.+A.+Gibbonsauthor=S.+L.+Chengauthor=K.+A.+Delariaauthor=R.+Fleischerauthor=J.+M.+Greveauthor=R.+Gundelauthor=K.+Harrisauthor=R.+Kellyauthor=B.+Kohauthor=Y.+Liauthor=L.+Lantzauthor=P.+Makauthor=L.+Neyerauthor=M.+J.+Plymauthor=S.+Roczniakauthor=D.+Serbanauthor=J.+Thriftauthor=L.+Tsuchiyamaauthor=M.+Wetzelauthor=M.+Wongauthor=A.+Zolotorev&title=A+T-cell-selective+interleukin+2+mutein+exhibits+potent+antitumor+activity+and+is+well+tolerated+in+vivo&doi=10.1038%2F81199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2F81199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F81199%26sid%3Dliteratum%253Aachs%26aulast%3DShanafelt%26aufirst%3DA.%2BB.%26aulast%3DLin%26aufirst%3DY.%26aulast%3DShanafelt%26aufirst%3DM.%2BC.%26aulast%3DForte%26aufirst%3DC.%2BP.%26aulast%3DDubois-Stringfellow%26aufirst%3DN.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DGibbons%26aufirst%3DJ.%2BA.%26aulast%3DCheng%26aufirst%3DS.%2BL.%26aulast%3DDelaria%26aufirst%3DK.%2BA.%26aulast%3DFleischer%26aufirst%3DR.%26aulast%3DGreve%26aufirst%3DJ.%2BM.%26aulast%3DGundel%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DK.%26aulast%3DKelly%26aufirst%3DR.%26aulast%3DKoh%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLantz%26aufirst%3DL.%26aulast%3DMak%26aufirst%3DP.%26aulast%3DNeyer%26aufirst%3DL.%26aulast%3DPlym%26aufirst%3DM.%2BJ.%26aulast%3DRoczniak%26aufirst%3DS.%26aulast%3DSerban%26aufirst%3DD.%26aulast%3DThrift%26aufirst%3DJ.%26aulast%3DTsuchiyama%26aufirst%3DL.%26aulast%3DWetzel%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DZolotorev%26aufirst%3DA.%26atitle%3DA%2520T-cell-selective%2520interleukin%25202%2520mutein%2520exhibits%2520potent%2520antitumor%2520activity%2520and%2520is%2520well%2520tolerated%2520in%2520vivo%26jtitle%3DNat.%2520Biotechnol.%26date%3D2000%26volume%3D18%26spage%3D1197%26epage%3D1202%26doi%3D10.1038%2F81199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Collins, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsien, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seals, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoskings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toome, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, G.</span><span> </span><span class="NLM_article-title">Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit(p70) of the interleukin 2 receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">7709</span><span class="NLM_x">–</span> <span class="NLM_lpage">7713</span><span class="refDoi"> DOI: 10.1073/pnas.85.20.7709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.85.20.7709" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=7709-7713&author=L.+Collinsauthor=W.+H.+Tsienauthor=C.+Sealsauthor=J.+Hakimiauthor=D.+Weberauthor=P.+Bailonauthor=J.+Hoskingsauthor=W.+C.+Greeneauthor=V.+Toomeauthor=G.+Ju&title=Identification+of+specific+residues+of+human+interleukin+2+that+affect+binding+to+the+70-kDa+subunit%28p70%29+of+the+interleukin+2+receptor&doi=10.1073%2Fpnas.85.20.7709"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.20.7709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.20.7709%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DL.%26aulast%3DTsien%26aufirst%3DW.%2BH.%26aulast%3DSeals%26aufirst%3DC.%26aulast%3DHakimi%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DD.%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DHoskings%26aufirst%3DJ.%26aulast%3DGreene%26aufirst%3DW.%2BC.%26aulast%3DToome%26aufirst%3DV.%26aulast%3DJu%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520specific%2520residues%2520of%2520human%2520interleukin%25202%2520that%2520affect%2520binding%2520to%2520the%252070-kDa%2520subunit%2528p70%2529%2520of%2520the%2520interleukin%25202%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D7709%26epage%3D7713%26doi%3D10.1073%2Fpnas.85.20.7709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Structure of the quaternary complex of interleukin-2 with its α, β, and γc receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x">, </span> <span class="NLM_fpage">1159</span><span class="NLM_x">–</span> <span class="NLM_lpage">1163</span><span class="refDoi"> DOI: 10.1126/science.1117893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1126%2Fscience.1117893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1159-1163&author=X.+Wangauthor=M.+Rickertauthor=K.+C.+Garcia&title=Structure+of+the+quaternary+complex+of+interleukin-2+with+its+%CE%B1%2C+%CE%B2%2C+and+%CE%B3c+receptors&doi=10.1126%2Fscience.1117893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1117893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1117893%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DStructure%2520of%2520the%2520quaternary%2520complex%2520of%2520interleukin-2%2520with%2520its%2520%25CE%25B1%252C%2520%25CE%25B2%252C%2520and%2520%25CE%25B3c%2520receptors%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1159%26epage%3D1163%26doi%3D10.1126%2Fscience.1117893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ring, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pande, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraga, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spolski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozkan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K. C.</span><span> </span><span class="NLM_article-title">Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1187</span><span class="NLM_x">–</span> <span class="NLM_lpage">1195</span><span class="refDoi"> DOI: 10.1038/ni.2449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1038%2Fni.2449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=23104097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOmtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=1187-1195&author=A.+M.+Ringauthor=J.+X.+Linauthor=D.+Fengauthor=S.+Mitraauthor=M.+Rickertauthor=G.+R.+Bowmanauthor=V.+S.+Pandeauthor=P.+Liauthor=I.+Moragaauthor=R.+Spolskiauthor=E.+Ozkanauthor=W.+J.+Leonardauthor=K.+C.+Garcia&title=Mechanistic+and+structural+insight+into+the+functional+dichotomy+between+IL-2+and+IL-15&doi=10.1038%2Fni.2449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15</span></div><div class="casAuthors">Ring, Aaron M.; Lin, Jian-Xin; Feng, Dan; Mitra, Suman; Rickert, Mathias; Bowman, Gregory R.; Pande, Vijay S.; Li, Peng; Moraga, Ignacio; Spolski, Rosanne; Uezkan, Engin; Leonard, Warren J.; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1187-1195</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interleukin 15 (IL-15) and IL-2 have distinct immunol. functions even though both signal through the receptor subunit IL-2Rβ and the common γ-chain (γc).  Here we found that in the structure of the IL-15-IL-15Rα-IL-2Rβ-γc quaternary complex, IL-15 binds to IL-2Rβ and γc in a heterodimer nearly indistinguishable from that of the IL-2-IL-2Rα-IL-2Rβ-γc complex, despite their different receptor-binding chemistries.  IL-15Rα substantially increased the affinity of IL-15 for IL-2Rβ, and this allostery was required for IL-15 trans signaling.  Consistent with their identical IL-2Rβ-γc dimer geometries, IL-2 and IL-15 showed similar signaling properties in lymphocytes, with any differences resulting from disparate receptor affinities.  Thus, IL-15 and IL-2 induced similar signals, and the cytokine specificity of IL-2Rα vs. IL-15Rα detd. cellular responsiveness.  Our results provide new insights for the development of specific immunotherapeutics based on IL-15 or IL-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6mi_MfxbISLVg90H21EOLACvtfcHk0likgttkBrp4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOmtLbP&md5=2f64d0f8222104408df56ca27f22523a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fni.2449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2449%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DA.%2BM.%26aulast%3DLin%26aufirst%3DJ.%2BX.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DRickert%26aufirst%3DM.%26aulast%3DBowman%26aufirst%3DG.%2BR.%26aulast%3DPande%26aufirst%3DV.%2BS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMoraga%26aufirst%3DI.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DOzkan%26aufirst%3DE.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DMechanistic%2520and%2520structural%2520insight%2520into%2520the%2520functional%2520dichotomy%2520between%2520IL-2%2520and%2520IL-15%26jtitle%3DNat.%2520Immunol.%26date%3D2012%26volume%3D13%26spage%3D1187%26epage%3D1195%26doi%3D10.1038%2Fni.2449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mortier, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vusio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boublik, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Soluble interleukin-15 receptor α(IL-15Rα)-sushi as a selective and potent agonist of IL-15 action through IL-15Rβ/γ. Hyperagonist IL-15 x IL-15Rα fusion proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1612</span><span class="NLM_x">–</span> <span class="NLM_lpage">1619</span><span class="refDoi"> DOI: 10.1074/jbc.M508624200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M508624200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=1612-1619&author=E.+Mortierauthor=A.+Quemenerauthor=P.+Vusioauthor=I.+Lorenzenauthor=Y.+Boublikauthor=J.+Grotzingerauthor=A.+Pletauthor=Y.+Jacques&title=Soluble+interleukin-15+receptor+%CE%B1%28IL-15R%CE%B1%29-sushi+as+a+selective+and+potent+agonist+of+IL-15+action+through+IL-15R%CE%B2%2F%CE%B3.+Hyperagonist+IL-15+x+IL-15R%CE%B1+fusion+proteins&doi=10.1074%2Fjbc.M508624200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M508624200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M508624200%26sid%3Dliteratum%253Aachs%26aulast%3DMortier%26aufirst%3DE.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DVusio%26aufirst%3DP.%26aulast%3DLorenzen%26aufirst%3DI.%26aulast%3DBoublik%26aufirst%3DY.%26aulast%3DGrotzinger%26aufirst%3DJ.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DSoluble%2520interleukin-15%2520receptor%2520%25CE%25B1%2528IL-15R%25CE%25B1%2529-sushi%2520as%2520a%2520selective%2520and%2520potent%2520agonist%2520of%2520IL-15%2520action%2520through%2520IL-15R%25CE%25B2%252F%25CE%25B3.%2520Hyperagonist%2520IL-15%2520x%2520IL-15R%25CE%25B1%2520fusion%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D1612%26epage%3D1619%26doi%3D10.1074%2Fjbc.M508624200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bissantz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span> </span><span class="NLM_article-title">A medicinal chemist’s guide to molecular interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5061</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1021/jm100112j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100112j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5061-5084&author=C.+Bissantzauthor=B.+Kuhnauthor=M.+Stahl&title=A+medicinal+chemist%E2%80%99s+guide+to+molecular+interactions&doi=10.1021%2Fjm100112j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A Medicinal Chemist's Guide to Molecular Interactions</span></div><div class="casAuthors">Bissantz, Caterina; Kuhn, Bernd; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5061-5084</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraV8HPbwsihbVg90H21EOLACvtfcHk0likgttkBrp4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFKjtbs%253D&md5=f39cf8700267cdc311c73de4d433bab0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm100112j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100112j%26sid%3Dliteratum%253Aachs%26aulast%3DBissantz%26aufirst%3DC.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DA%2520medicinal%2520chemist%25E2%2580%2599s%2520guide%2520to%2520molecular%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5061%26epage%3D5084%26doi%3D10.1021%2Fjm100112j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Polucci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asa, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badari, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauteruccio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malgesini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirtori, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riceputi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trucchi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alessio, R.</span><span> </span><span class="NLM_article-title">Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1021/jm3013213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3013213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=437-450&author=P.+Polucciauthor=P.+Magnaghiauthor=M.+Angioliniauthor=D.+Asaauthor=N.+Avanziauthor=A.+Badariauthor=J.+Bertrandauthor=E.+Casaleauthor=S.+Cauteruccioauthor=A.+Cirlaauthor=L.+Cozziauthor=A.+Galvaniauthor=P.+K.+Jacksonauthor=Y.+Liuauthor=S.+Magnusonauthor=B.+Malgesiniauthor=S.+Nuvoloniauthor=C.+Orreniusauthor=F.+R.+Sirtoriauthor=L.+Riceputiauthor=S.+Rizziauthor=B.+Trucchiauthor=T.+O%E2%80%99Brienauthor=A.+Isacchiauthor=D.+Donatiauthor=R.+D%E2%80%99Alessio&title=Alkylsulfanyl-1%2C2%2C4-triazoles%2C+a+new+class+of+allosteric+valosine+containing+protein+inhibitors.+Synthesis+and+structure-activity+relationships&doi=10.1021%2Fjm3013213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylsulfanyl-1,2,4-triazoles, a New Class of Allosteric Valosine Containing Protein Inhibitors. Synthesis and Structure-Activity Relationships</span></div><div class="casAuthors">Polucci, Paolo; Magnaghi, Paola; Angiolini, Mauro; Asa, Daniela; Avanzi, Nilla; Badari, Alessandra; Bertrand, Jay; Casale, Elena; Cauteruccio, Silvia; Cirla, Alessandra; Cozzi, Liviana; Galvani, Arturo; Jackson, Peter K.; Liu, Yichin; Magnuson, Steven; Malgesini, Beatrice; Nuvoloni, Stefano; Orrenius, Christian; Sirtori, Federico Riccardi; Riceputi, Laura; Rizzi, Simona; Trucchi, Beatrice; O'Brien, Tom; Isacchi, Antonella; Donati, Daniele; D'Alessio, Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">437-450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Valosine contg. protein (VCP), also known as p97, is a member of AAA ATPase family that is involved in several biol. processes and plays a central role in the ubiquitin-mediated degrdn. of misfolded proteins.  VCP is an ubiquitously expressed, highly abundant protein and has been found overexpressed in many tumor types, sometimes assocd. with poor prognosis.  In this respect, VCP has recently received a great deal of attention as a potential new target for cancer therapy.  In this paper, the discovery and structure-activity relationships of alkylsulfanyl-1,2,4-triazoles, a new class of potent, allosteric VCP inhibitors, are described.  Medicinal chem. manipulation of 3-(isopropylthio)-5-(phenoxymethyl)-4-phenyl-1,2,4-triazole, identified via HTS, led to the discovery of potent and selective inhibitors with submicromolar activity in cells and clear mechanism of action at consistent doses.  This represents a first step toward a new class of potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcvefolxe1ZrVg90H21EOLACvtfcHk0ljuZYfnWvfoyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCqsL7E&md5=23eab31badb2321c77945100f4f1001f</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm3013213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3013213%26sid%3Dliteratum%253Aachs%26aulast%3DPolucci%26aufirst%3DP.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DAsa%26aufirst%3DD.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBadari%26aufirst%3DA.%26aulast%3DBertrand%26aufirst%3DJ.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DCauteruccio%26aufirst%3DS.%26aulast%3DCirla%26aufirst%3DA.%26aulast%3DCozzi%26aufirst%3DL.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DJackson%26aufirst%3DP.%2BK.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DMalgesini%26aufirst%3DB.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DSirtori%26aufirst%3DF.%2BR.%26aulast%3DRiceputi%26aufirst%3DL.%26aulast%3DRizzi%26aufirst%3DS.%26aulast%3DTrucchi%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DT.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Alessio%26aufirst%3DR.%26atitle%3DAlkylsulfanyl-1%252C2%252C4-triazoles%252C%2520a%2520new%2520class%2520of%2520allosteric%2520valosine%2520containing%2520protein%2520inhibitors.%2520Synthesis%2520and%2520structure-activity%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D437%26epage%3D450%26doi%3D10.1021%2Fjm3013213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Carpino, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Faham, A.</span><span> </span><span class="NLM_article-title">The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6330</span><span class="refDoi"> DOI: 10.1016/S0040-4020(99)00344-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0040-4020%2899%2900344-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1MXjs12mt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=6813-6330&author=L.+A.+Carpinoauthor=A.+El-Faham&title=The+diisopropylcarbodiimide%2F1-hydroxy-7-azabenzotriazole+system%3A+segment+coupling+and+stepwise+peptide+assembly&doi=10.1016%2FS0040-4020%2899%2900344-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The diisopropylcarbodiimide/1-hydroxy-7-azabenzotriazole system: segment coupling and stepwise peptide assembly</span></div><div class="casAuthors">Carpino, Louis A.; El-Faham, Ayman</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6813-6830</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">For a group of model peptide segments, coupling reactions carried out using soln.- or solid-phase techniques have demonstrated the advantages of DIC/HOAt system over DIC/HOBt, and also, for systems involving other selected carbodiimides and substituted HOBt derivs. bearing electron-withdrawing substituents.  Very little, if any, loss of configuration occurred in DCM (dichloromethane) regardless of the additive used, although the relative order of efficiency was similar in solvents such as DMF in which more extensive epimerization resulted.  Using DIC/HOAt system for stepwise peptide assembly by solid-phase techniques, it was found that the hindered pyridine base 2,4,6-collidine enhanced the step involving preactivation of the carboxylic acid residue in contrast to the normal situation in which bases such as DIEA, NMM, or non-hindered pyridine bases inhibit this step.  These results led to the development of a stepwise procedure for peptide assembly in which 2,4,6-collidine is added to enhance activation and subsequently DIEA is added to enhance coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS9-3K0QIkurVg90H21EOLACvtfcHk0ljuZYfnWvfoyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs12mt7c%253D&md5=ee9e96944c58f1f5432798ddf15db50b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900344-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900344-0%26sid%3Dliteratum%253Aachs%26aulast%3DCarpino%26aufirst%3DL.%2BA.%26aulast%3DEl-Faham%26aufirst%3DA.%26atitle%3DThe%2520diisopropylcarbodiimide%252F1-hydroxy-7-azabenzotriazole%2520system%253A%2520segment%2520coupling%2520and%2520stepwise%2520peptide%2520assembly%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D6813%26epage%3D6330%26doi%3D10.1016%2FS0040-4020%2899%2900344-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Montalbetti, C. A. G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falque, V.</span><span> </span><span class="NLM_article-title">Amide bond formation and peptide coupling</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">10827</span><span class="NLM_x">–</span> <span class="NLM_lpage">10852</span><span class="refDoi"> DOI: 10.1016/j.tet.2005.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.tet.2005.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCnsbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=10827-10852&author=C.+A.+G.+N.+Montalbettiauthor=V.+Falque&title=Amide+bond+formation+and+peptide+coupling&doi=10.1016%2Fj.tet.2005.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Amide bond formation and peptide coupling</span></div><div class="casAuthors">Montalbetti, Christian A. G. N.; Falque, Virginie</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10827-10852</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Methods and strategies for the amide bond formation and peptide coupling in solns. and on solid phase are discussed and summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRl3ythUyGCrVg90H21EOLACvtfcHk0lgH2IERYgACoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCnsbfN&md5=04346ec39e739fcd7b1570b5f547afc4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2005.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2005.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DMontalbetti%26aufirst%3DC.%2BA.%2BG.%2BN.%26aulast%3DFalque%26aufirst%3DV.%26atitle%3DAmide%2520bond%2520formation%2520and%2520peptide%2520coupling%26jtitle%3DTetrahedron%26date%3D2005%26volume%3D61%26spage%3D10827%26epage%3D10852%26doi%3D10.1016%2Fj.tet.2005.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Johnson, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorla, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavitha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Striepen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mead, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuny, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span> </span><span class="NLM_article-title">Phthalazinone inhibitors of inosine-5′-monophosphate dehydrogenase from Cryptosporidium parvum</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.bmcl.2012.12.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1004-1007&author=C.+R.+Johnsonauthor=S.+K.+Gorlaauthor=M.+Kavithaauthor=M.+Zhangauthor=X.+Liuauthor=B.+Striepenauthor=J.+R.+Meadauthor=G.+D.+Cunyauthor=L.+Hedstrom&title=Phthalazinone+inhibitors+of+inosine-5%E2%80%B2-monophosphate+dehydrogenase+from+Cryptosporidium+parvum&doi=10.1016%2Fj.bmcl.2012.12.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BR.%26aulast%3DGorla%26aufirst%3DS.%2BK.%26aulast%3DKavitha%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStriepen%26aufirst%3DB.%26aulast%3DMead%26aufirst%3DJ.%2BR.%26aulast%3DCuny%26aufirst%3DG.%2BD.%26aulast%3DHedstrom%26aufirst%3DL.%26atitle%3DPhthalazinone%2520inhibitors%2520of%2520inosine-5%25E2%2580%25B2-monophosphate%2520dehydrogenase%2520from%2520Cryptosporidium%2520parvum%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1004%26epage%3D1007%26doi%3D10.1016%2Fj.bmcl.2012.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Sridhara, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopala Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavayya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar Goud, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somashekar, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peethambar, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaddam, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4983</span><span class="NLM_x">–</span> <span class="NLM_lpage">4989</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2010.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.ejmech.2010.08.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4983-4989&author=A.+M.+Sridharaauthor=K.+R.+Venugopala+Reddyauthor=J.+Keshavayyaauthor=P.+S.+Kumar+Goudauthor=B.+C.+Somashekarauthor=P.+Boseauthor=S.+K.+Peethambarauthor=S.+K.+Gaddam&title=Synthesis+and+antimicrobial+activity+of+2-substituted+%5B4-%281%2C3%2C4-oxadiazol-2-yl+methyl%29%5D+phthalazin-1%282H%29-one+derivatives&doi=10.1016%2Fj.ejmech.2010.08.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DSridhara%26aufirst%3DA.%2BM.%26aulast%3DVenugopala%2BReddy%26aufirst%3DK.%2BR.%26aulast%3DKeshavayya%26aufirst%3DJ.%26aulast%3DKumar%2BGoud%26aufirst%3DP.%2BS.%26aulast%3DSomashekar%26aufirst%3DB.%2BC.%26aulast%3DBose%26aufirst%3DP.%26aulast%3DPeethambar%26aufirst%3DS.%2BK.%26aulast%3DGaddam%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520activity%2520of%25202-substituted%2520%255B4-%25281%252C3%252C4-oxadiazol-2-yl%2520methyl%2529%255D%2520phthalazin-1%25282H%2529-one%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4983%26epage%3D4989%26doi%3D10.1016%2Fj.ejmech.2010.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Plech, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luszczki, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wujec, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizon, M.</span><span> </span><span class="NLM_article-title">Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.ejmech.2012.11.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=208-215&author=T.+Plechauthor=J.+J.+Luszczkiauthor=M.+Wujecauthor=J.+Fliegerauthor=M.+Pizon&title=Synthesis%2C+characterization+and+preliminary+anticonvulsant+evaluation+of+some+4-alkyl-1%2C2%2C4-triazoles&doi=10.1016%2Fj.ejmech.2012.11.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DPlech%26aufirst%3DT.%26aulast%3DLuszczki%26aufirst%3DJ.%2BJ.%26aulast%3DWujec%26aufirst%3DM.%26aulast%3DFlieger%26aufirst%3DJ.%26aulast%3DPizon%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520preliminary%2520anticonvulsant%2520evaluation%2520of%2520some%25204-alkyl-1%252C2%252C4-triazoles%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D208%26epage%3D215%26doi%3D10.1016%2Fj.ejmech.2012.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sridhara, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venugopala Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshavayya, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambika, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peethambar, S. K.</span><span> </span><span class="NLM_article-title">Synthesis and antimicrobial studies of some new 3-isoxazoline substituted phthalazine methylsulfonyl oxadiazoles</span> <span class="citation_source-journal">E-J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1022</span><span class="NLM_x">–</span> <span class="NLM_lpage">1029</span><span class="refDoi"> DOI: 10.1155/2011/356437</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1155%2F2011%2F356437" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFyhs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1022-1029&author=A.+M.+Sridharaauthor=K.+R.+Venugopala+Reddyauthor=J.+Keshavayyaauthor=D.+S.+Ambikaauthor=S.+Goudauthor=S.+K.+Peethambar&title=Synthesis+and+antimicrobial+studies+of+some+new+3-isoxazoline+substituted+phthalazine+methylsulfonyl+oxadiazoles&doi=10.1155%2F2011%2F356437"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimicrobial studies of some new 3-isoxazoline substituted phthalazine methylsulfonyl oxadiazoles</span></div><div class="casAuthors">Sridhara, A. M.; Venugopala Reddy, K. R.; Keshavayya, J.; Ambika, D. S.; Goud, Sanathkumar; Peethambar, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">E-Journal of Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1022-1029</span>CODEN:
                <span class="NLM_cas:coden">ECJHAO</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">WWW Publications</span>)
        </div><div class="casAbstract">3-Isoxazoline substituted phthalazine methylthio oxadiazoles were prepd. from 2-(4-oxo-3,4-dihydro-1-phthalazinyl)acetate Me ester and the synthesis of the target compds. was subsequently achieved by a dipolar cyclization of aldoxime-derived nitrile oxides with 4-[[5-(methylthio)-1,3,4-oxadiazol-2-yl]methyl]-2-(2-propenyl)-1(2H)-phthalazinone.  The product structures were confirmed by spectral data and the title compds. were screened for their antimicrobial activities against bacterial strains and fungal strains and it was discovered that these compds. displayed activity as antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUp_I963gv5LVg90H21EOLACvtfcHk0lgH2IERYgACoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFyhs78%253D&md5=eee69b010a14321571a4aa8b77cb87b9</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1155%2F2011%2F356437&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F356437%26sid%3Dliteratum%253Aachs%26aulast%3DSridhara%26aufirst%3DA.%2BM.%26aulast%3DVenugopala%2BReddy%26aufirst%3DK.%2BR.%26aulast%3DKeshavayya%26aufirst%3DJ.%26aulast%3DAmbika%26aufirst%3DD.%2BS.%26aulast%3DGoud%26aufirst%3DS.%26aulast%3DPeethambar%26aufirst%3DS.%2BK.%26atitle%3DSynthesis%2520and%2520antimicrobial%2520studies%2520of%2520some%2520new%25203-isoxazoline%2520substituted%2520phthalazine%2520methylsulfonyl%2520oxadiazoles%26jtitle%3DE-J.%2520Chem.%26date%3D2011%26volume%3D8%26spage%3D1022%26epage%3D1029%26doi%3D10.1155%2F2011%2F356437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Shaker, M. R.</span><span> </span><span class="NLM_article-title">The chemistry of mercapto- and thione- substituted 1,2,4-triazoles and their utility in heterocyclic synthesis</span> <span class="citation_source-journal">ARKIVOC</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">ix</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=ix&publication_year=2006&pages=59-112&author=M.+R.+Shaker&title=The+chemistry+of+mercapto-+and+thione-+substituted+1%2C2%2C4-triazoles+and+their+utility+in+heterocyclic+synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DM.%2BR.%26atitle%3DThe%2520chemistry%2520of%2520mercapto-%2520and%2520thione-%2520substituted%25201%252C2%252C4-triazoles%2520and%2520their%2520utility%2520in%2520heterocyclic%2520synthesis%26jtitle%3DARKIVOC%26date%3D2006%26volume%3Dix%26spage%3D59%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">The growing impact of click chemistry on drug discovery</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1128</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span><span class="refDoi"> DOI: 10.1016/S1359-6446(03)02933-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS1359-6446%2803%2902933-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=14678739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=1128-1137&author=H.+C.+Kolbauthor=K.+B.+Sharpless&title=The+growing+impact+of+click+chemistry+on+drug+discovery&doi=10.1016%2FS1359-6446%2803%2902933-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The growing impact of click chemistry on drug discovery</span></div><div class="casAuthors">Kolb, Hartmuth C.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">1128-1137</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Click chem. is a modular approach that uses only the most practical and reliable chem. transformations.  Its applications are increasingly found in all aspects of drug discovery, ranging from lead finding through combinatorial chem. and target-templated in situ chem., to proteomics and DNA research, using bioconjugation reactions.  The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal acetylenes is a particularly powerful linking reaction, due to its high degree of dependability, complete specificity, and the bio-compatibility of the reactants.  The triazole products are more than just passive linkers; they readily assoc. with biol. targets, through hydrogen bonding and dipole interactions.  Click chem., a modular approach based on highly reliable chem. transformations, is being applied in all aspects of drug discovery, ranging from lead finding to proteomics and DNA research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqEB1hjIBNhbVg90H21EOLACvtfcHk0lhSgOhyHWLIsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWkuro%253D&md5=f0042f3a8f153d1c1192533d90699d19</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2803%2902933-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252803%252902933-7%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DThe%2520growing%2520impact%2520of%2520click%2520chemistry%2520on%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D1128%26epage%3D1137%26doi%3D10.1016%2FS1359-6446%2803%2902933-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rostovtsev, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fokin, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective ″ligation″ of azides and terminal alkynes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2596</span><span class="NLM_x">–</span> <span class="NLM_lpage">2599</span><span class="refDoi"> DOI: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=12203546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2596-2599&author=V.+V.+Rostovtsevauthor=L.+G.+Greenauthor=V.+V.+Fokinauthor=K.+B.+Sharpless&title=A+stepwise+huisgen+cycloaddition+process%3A+copper%28I%29-catalyzed+regioselective+%E2%80%B3ligation%E2%80%B3+of+azides+and+terminal+alkynes&doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes</span></div><div class="casAuthors">Rostovtsev, Vsevolod V.; Green, Luke G.; Fokin, Valery V.; Sharpless, K. Barry</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2596-2599</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH</span>)
        </div><div class="casAbstract">1,4-Disubstituted 1,2,3-triazoles I (R1 = PhCH2, PhCH2OCH2, 1-adamantyl, etc.; R2 = HO2C, Ph, PhOCH2, Et2NCH2, etc.) were readily and cleanly prepd. via highly efficient and regioselective copper(I)-catalyzed cycloaddn. of azides R1N3 with terminal alkynes R2C≡CH in 82-93% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcW2JUNM1r7Vg90H21EOLACvtfcHk0lhSgOhyHWLIsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Ohsr4%253D&md5=4603664be6639353b5e70f19b9f8d59f</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1521-3773%252820020715%252941%253A14%253C2596%253A%253AAID-ANIE2596%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostovtsev%26aufirst%3DV.%2BV.%26aulast%3DGreen%26aufirst%3DL.%2BG.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DA%2520stepwise%2520huisgen%2520cycloaddition%2520process%253A%2520copper%2528I%2529-catalyzed%2520regioselective%2520%25E2%2580%25B3ligation%25E2%2580%25B3%2520of%2520azides%2520and%2520terminal%2520alkynes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2002%26volume%3D41%26spage%3D2596%26epage%3D2599%26doi%3D10.1002%2F1521-3773%2820020715%2941%3A14%3C2596%3A%3AAID-ANIE2596%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Vincent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochonneau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillasson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birkle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigue-Antar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span> </span><span class="NLM_article-title">Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">133</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span><span class="refDoi"> DOI: 10.1002/ijc.28059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fijc.28059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=23354868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFemsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=757-765&author=M.+Vincentauthor=A.+Bessardauthor=D.+Cochonneauauthor=G.+Teppazauthor=V.+Soleauthor=M.+Maillassonauthor=S.+Birkleauthor=L.+Garrigue-Antarauthor=A.+Quemenerauthor=Y.+Jacques&title=Tumor+targeting+of+the+IL-15+superagonist+RLI+by+an+anti-GD2+antibody+strongly+enhances+its+antitumor+potency&doi=10.1002%2Fijc.28059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency</span></div><div class="casAuthors">Vincent, Marie; Bessard, Anne; Cochonneau, Denis; Teppaz, Geraldine; Sole, Veronique; Maillasson, Mike; Birkle, Stephane; Garrigue-Antar, Laure; Quemener, Agnes; Jacques, Yannick</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">757-765</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Immunocytokines (ICKs) targeting cytokines to the tumor environment using antibodies directed against a tumor-assocd. antigen often have a higher therapeutic index than the corresponding unconjugated cytokines.  Various ICKs displaying significant antitumoral effects in several murine tumor models have already been developed, and some of them, in particular interleukin (IL)-2-based ICKs, are in Phase II clin. trials.  Although sharing common biol. activities with IL-2 in vitro, IL-15 is now considered as having a better potential in antitumor immunotherapeutical strategies and has been shown to be less toxic than IL-2 in preclin. studies.  We previously developed the fusion protein RLI, linking a sol. form of human IL-15Rα-sushi+ domain to human IL-15.  RLI showed better biol. activities than IL-15 in vitro as well as higher antitumoral effects in vivo in murine and human cancer models.  Here, we investigated, in the context of an ICK, the effect of assocg. RLI with an antibody targeting the GD2 ganglioside, a validated tumoral target expressed on many neurectodermal tumors.  Anti-GD2-RLI fully retained the cytokine potential of RLI and the antibody effector functions (antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity).  It displayed strong antitumor activities in two syngeneic cancer models in immunocompetent mice (s.c. EL4 and metastatic NXS2).  Its therapeutic potency was higher than those of RLI and anti-GD2 alone or in combination.  We suggest that this is related to its bifunctional (cytokine and antibody) nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptQrWVU8Sz57Vg90H21EOLACvtfcHk0lhSgOhyHWLIsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFemsbs%253D&md5=449f590ea5a8023ede2e85ffd56e33d7</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fijc.28059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28059%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DM.%26aulast%3DBessard%26aufirst%3DA.%26aulast%3DCochonneau%26aufirst%3DD.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DSole%26aufirst%3DV.%26aulast%3DMaillasson%26aufirst%3DM.%26aulast%3DBirkle%26aufirst%3DS.%26aulast%3DGarrigue-Antar%26aufirst%3DL.%26aulast%3DQuemener%26aufirst%3DA.%26aulast%3DJacques%26aufirst%3DY.%26atitle%3DTumor%2520targeting%2520of%2520the%2520IL-15%2520superagonist%2520RLI%2520by%2520an%2520anti-GD2%2520antibody%2520strongly%2520enhances%2520its%2520antitumor%2520potency%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2013%26volume%3D133%26spage%3D757%26epage%3D765%26doi%3D10.1002%2Fijc.28059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Vincent, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teppaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lajoie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sole, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillasson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loisel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemenceau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibault, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrigue-Antar, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quemener, A.</span><span> </span><span class="NLM_article-title">Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse</span> <span class="citation_source-journal">MAbs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1026</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span><span class="refDoi"> DOI: 10.4161/mabs.28699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.4161%2Fmabs.28699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1026-1037&author=M.+Vincentauthor=G.+Teppazauthor=L.+Lajoieauthor=V.+Soleauthor=A.+Bessardauthor=M.+Maillassonauthor=S.+Loiselauthor=D.+Bechardauthor=B.+Clemenceauauthor=G.+Thibaultauthor=L.+Garrigue-Antarauthor=Y.+Jacquesauthor=A.+Quemener&title=Highly+potent+anti-CD20-RLI+immunocytokine+targeting+established+human+B+lymphoma+in+SCID+mouse&doi=10.4161%2Fmabs.28699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.4161%2Fmabs.28699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fmabs.28699%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DM.%26aulast%3DTeppaz%26aufirst%3DG.%26aulast%3DLajoie%26aufirst%3DL.%26aulast%3DSole%26aufirst%3DV.%26aulast%3DBessard%26aufirst%3DA.%26aulast%3DMaillasson%26aufirst%3DM.%26aulast%3DLoisel%26aufirst%3DS.%26aulast%3DBechard%26aufirst%3DD.%26aulast%3DClemenceau%26aufirst%3DB.%26aulast%3DThibault%26aufirst%3DG.%26aulast%3DGarrigue-Antar%26aufirst%3DL.%26aulast%3DJacques%26aufirst%3DY.%26aulast%3DQuemener%26aufirst%3DA.%26atitle%3DHighly%2520potent%2520anti-CD20-RLI%2520immunocytokine%2520targeting%2520established%2520human%2520B%2520lymphoma%2520in%2520SCID%2520mouse%26jtitle%3DMAbs%26date%3D2014%26volume%3D6%26spage%3D1026%26epage%3D1037%26doi%3D10.4161%2Fmabs.28699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tilley, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fry, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varnell, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trilles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guthrie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennona, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeMahieu, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, R.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, G.</span><span> </span><span class="NLM_article-title">Identification of a small molecule inhibitor of the IL-2/IL-2Rα receptor interaction which binds to IL-2</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">7589</span><span class="NLM_x">–</span> <span class="NLM_lpage">7590</span><span class="refDoi"> DOI: 10.1021/ja970702x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja970702x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=7589-7590&author=J.+W.+Tilleyauthor=L.+Chenauthor=D.+C.+Fryauthor=S.+D.+Emersonauthor=G.+D.+Powersauthor=D.+Biondiauthor=T.+Varnellauthor=R.+Trillesauthor=R.+Guthrieauthor=F.+Mennonaauthor=G.+Kaplanauthor=R.+A.+LeMahieuauthor=M.+Carsonauthor=R.-J.+Hanauthor=C.-M.+Liuauthor=R.+Palermoauthor=G.+Ju&title=Identification+of+a+small+molecule+inhibitor+of+the+IL-2%2FIL-2R%CE%B1+receptor+interaction+which+binds+to+IL-2&doi=10.1021%2Fja970702x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fja970702x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja970702x%26sid%3Dliteratum%253Aachs%26aulast%3DTilley%26aufirst%3DJ.%2BW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DFry%26aufirst%3DD.%2BC.%26aulast%3DEmerson%26aufirst%3DS.%2BD.%26aulast%3DPowers%26aufirst%3DG.%2BD.%26aulast%3DBiondi%26aufirst%3DD.%26aulast%3DVarnell%26aufirst%3DT.%26aulast%3DTrilles%26aufirst%3DR.%26aulast%3DGuthrie%26aufirst%3DR.%26aulast%3DMennona%26aufirst%3DF.%26aulast%3DKaplan%26aufirst%3DG.%26aulast%3DLeMahieu%26aufirst%3DR.%2BA.%26aulast%3DCarson%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DR.-J.%26aulast%3DLiu%26aufirst%3DC.-M.%26aulast%3DPalermo%26aufirst%3DR.%26aulast%3DJu%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520small%2520molecule%2520inhibitor%2520of%2520the%2520IL-2%252FIL-2R%25CE%25B1%2520receptor%2520interaction%2520which%2520binds%2520to%2520IL-2%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D7589%26epage%3D7590%26doi%3D10.1021%2Fja970702x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Geng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umlauf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallai, P. V.</span><span> </span><span class="NLM_article-title">The synthesis and selective IL-2 inhibitory activity of bis piperazine-phenol Mannich adducts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">775</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span><span class="refDoi"> DOI: 10.1016/S0960-894X(02)00011-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS0960-894X%2802%2900011-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=775-778&author=B.+Gengauthor=P.+R.+Flemingauthor=S.+Umlaufauthor=A.+Linauthor=P.+V.+Pallai&title=The+synthesis+and+selective+IL-2+inhibitory+activity+of+bis+piperazine-phenol+Mannich+adducts&doi=10.1016%2FS0960-894X%2802%2900011-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900011-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900011-2%26sid%3Dliteratum%253Aachs%26aulast%3DGeng%26aufirst%3DB.%26aulast%3DFleming%26aufirst%3DP.%2BR.%26aulast%3DUmlauf%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DA.%26aulast%3DPallai%26aufirst%3DP.%2BV.%26atitle%3DThe%2520synthesis%2520and%2520selective%2520IL-2%2520inhibitory%2520activity%2520of%2520bis%2520piperazine-phenol%2520Mannich%2520adducts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D775%26epage%3D778%26doi%3D10.1016%2FS0960-894X%2802%2900011-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">174</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1186/ar1202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1186%2Far1202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=15225362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=174-177&author=T.+A.+Waldmann&title=Targeting+the+interleukin-15%2Finterleukin-15+receptor+system+in+inflammatory+autoimmune+diseases&doi=10.1186%2Far1202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interleukin-15/interleukin-15 receptor system in inflammatory autoimmune diseases</span></div><div class="casAuthors">Waldmann, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">174-177</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Interleukin (IL)-15 is a dangerous inflammatory cytokine that induces tumor necrosis factor-α, IL-1β, and inflammatory chemokines.  It inhibits self-tolerance mediated by IL-2 mediated activation-induced cell death (apoptosis) and facilitates maintenance of CD8+ memory T-cell survival including that of self-directed memory cells.  Disordered IL-15 expression has been reported in patients with an array of inflammatory autoimmune diseases.  A series of therapeutic agents that inhibit IL-15 action have been introduced, including the sol. IL-15 receptor (IL-15R) α chain, mutant IL-15, and antibodies directed against the IL-15 cytokine and against the IL-2R/IL-15R β subunit used by IL-2 and IL-15.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokhrK56JpqV7Vg90H21EOLACvtfcHk0lhG6Ovb176B7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFanu7s%253D&md5=190cc54760f6eacdab96a160f8f8c608</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1186%2Far1202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far1202%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DTargeting%2520the%2520interleukin-15%252Finterleukin-15%2520receptor%2520system%2520in%2520inflammatory%2520autoimmune%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2004%26volume%3D6%26spage%3D174%26epage%3D177%26doi%3D10.1186%2Far1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Waldmann, T. A.</span><span> </span><span class="NLM_article-title">Targeting the interleukin-15 system in rheumatoid arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">2585</span><span class="NLM_x">–</span> <span class="NLM_lpage">2588</span><span class="refDoi"> DOI: 10.1002/art.21363</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1002%2Fart.21363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=16142738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A280%3ADC%252BD2MrksVeltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2005&pages=2585-2588&author=T.+A.+Waldmann&title=Targeting+the+interleukin-15+system+in+rheumatoid+arthritis&doi=10.1002%2Fart.21363"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the interleukin-15 system in rheumatoid arthritis</span></div><div class="casAuthors">Waldmann Thomas A</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis and rheumatism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2585-8</span>
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOCOHM3rv-fkPI-fCgwosgfW6udTcc2ea7Jzay729curntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrksVeltQ%253D%253D&md5=ab01c6af630c5332bf1c87b4fd7da101</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fart.21363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.21363%26sid%3Dliteratum%253Aachs%26aulast%3DWaldmann%26aufirst%3DT.%2BA.%26atitle%3DTargeting%2520the%2520interleukin-15%2520system%2520in%2520rheumatoid%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2005%26volume%3D52%26spage%3D2585%26epage%3D2588%26doi%3D10.1002%2Fart.21363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Tinubu, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakimi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Familletti, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spence, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crittenden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenteau, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirbas, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsudo, M.</span><span> </span><span class="NLM_article-title">Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">4330</span><span class="NLM_x">–</span> <span class="NLM_lpage">4338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=1994&pages=4330-4338&author=S.+A.+Tinubuauthor=J.+Hakimiauthor=J.+A.+Kondasauthor=P.+Bailonauthor=P.+C.+Famillettiauthor=C.+Spenceauthor=M.+D.+Crittendenauthor=G.+L.+Parenteauauthor=F.+M.+Dirbasauthor=M.+Tsudo&title=Humanized+antibody+directed+to+the+IL-2+receptor+beta-chain+prolongs+primate+cardiac+allograft+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTinubu%26aufirst%3DS.%2BA.%26aulast%3DHakimi%26aufirst%3DJ.%26aulast%3DKondas%26aufirst%3DJ.%2BA.%26aulast%3DBailon%26aufirst%3DP.%26aulast%3DFamilletti%26aufirst%3DP.%2BC.%26aulast%3DSpence%26aufirst%3DC.%26aulast%3DCrittenden%26aufirst%3DM.%2BD.%26aulast%3DParenteau%26aufirst%3DG.%2BL.%26aulast%3DDirbas%26aufirst%3DF.%2BM.%26aulast%3DTsudo%26aufirst%3DM.%26atitle%3DHumanized%2520antibody%2520directed%2520to%2520the%2520IL-2%2520receptor%2520beta-chain%2520prolongs%2520primate%2520cardiac%2520allograft%2520survival%26jtitle%3DJ.%2520Immunol.%26date%3D1994%26volume%3D153%26spage%3D4330%26epage%3D4338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Nata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basheer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Besien, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massoud, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagaya, Y.</span><span> </span><span class="NLM_article-title">Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">22338</span><span class="NLM_x">–</span> <span class="NLM_lpage">22351</span><span class="refDoi"> DOI: 10.1074/jbc.M115.661074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1074%2Fjbc.M115.661074" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=22338-22351&author=T.+Nataauthor=A.+Basheerauthor=F.+Cocchiauthor=R.+van+Besienauthor=R.+Massoudauthor=S.+Jacobsonauthor=N.+Azimiauthor=Y.+Tagaya&title=Targeting+the+binding+interface+on+a+shared+receptor+subunit+of+a+cytokine+family+enables+the+inhibition+of+multiple+member+cytokines+with+selectable+target+spectrum&doi=10.1074%2Fjbc.M115.661074"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.661074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.661074%26sid%3Dliteratum%253Aachs%26aulast%3DNata%26aufirst%3DT.%26aulast%3DBasheer%26aufirst%3DA.%26aulast%3DCocchi%26aufirst%3DF.%26aulast%3Dvan%2BBesien%26aufirst%3DR.%26aulast%3DMassoud%26aufirst%3DR.%26aulast%3DJacobson%26aufirst%3DS.%26aulast%3DAzimi%26aufirst%3DN.%26aulast%3DTagaya%26aufirst%3DY.%26atitle%3DTargeting%2520the%2520binding%2520interface%2520on%2520a%2520shared%2520receptor%2520subunit%2520of%2520a%2520cytokine%2520family%2520enables%2520the%2520inhibition%2520of%2520multiple%2520member%2520cytokines%2520with%2520selectable%2520target%2520spectrum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D22338%26epage%3D22351%26doi%3D10.1074%2Fjbc.M115.661074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Krammer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhoff, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatachalam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span> </span><span class="NLM_article-title">LigScore: a novel scoring function for predicting binding affinities</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">395</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2Fj.jmgm.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=15781182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitlChtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=395-407&author=A.+Krammerauthor=P.+D.+Kirchhoffauthor=X.+Jiangauthor=C.+M.+Venkatachalamauthor=M.+Waldman&title=LigScore%3A+a+novel+scoring+function+for+predicting+binding+affinities&doi=10.1016%2Fj.jmgm.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">LigScore: a novel scoring function for predicting binding affinities</span></div><div class="casAuthors">Krammer, Andre; Kirchhoff, Paul D.; Jiang, X.; Venkatachalam, C. M.; Waldman, Marvin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">395-407</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We present two new empirical scoring functions, LigScore1 and LigScore2, that attempt to accurately predict the binding affinity between ligand mols. and their protein receptors.  The LigScore functions consist of three distinct terms that describe the van der Waals interaction, the polar attraction between the ligand and protein, and the desolvation penalty attributed to the binding of the polar ligand atoms to the protein and vice versa.  Utilizing a regression approach on a data set of 118 protein-ligand complexes we have obtained a linear equation, LigScore2, using these three descriptors.  LigScore2 has good predictability with regard to exptl. pKi values yielding a correlation coeff., r2, of 0.75 and a std. deviation of 1.04 over the training data set, which consists of a diverse set of proteins that span more than seven protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ92LlTK_aQrVg90H21EOLACvtfcHk0likPUyFL0n0jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitlChtrY%253D&md5=2158de5b2413ee6fa79fda1a72eca96f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DKrammer%26aufirst%3DA.%26aulast%3DKirchhoff%26aufirst%3DP.%2BD.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DVenkatachalam%26aufirst%3DC.%2BM.%26aulast%3DWaldman%26aufirst%3DM.%26atitle%3DLigScore%253A%2520a%2520novel%2520scoring%2520function%2520for%2520predicting%2520binding%2520affinities%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2005%26volume%3D23%26spage%3D395%26epage%3D407%26doi%3D10.1016%2Fj.jmgm.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span><span class="refDoi"> DOI: 10.1016/1074-5521(95)90050-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming&doi=10.1016%2F1074-5521%2895%2990050-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0likPUyFL0n0jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324%26doi%3D10.1016%2F1074-5521%2895%2990050-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Muegge, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, Y. C.</span><span> </span><span class="NLM_article-title">A general and fast scoring function for protein-ligand interactions: a simplified potential approach</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span><span class="refDoi"> DOI: 10.1021/jm980536j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980536j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADyaK1MXht1aksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=791-804&author=I.+Mueggeauthor=Y.+C.+Martin&title=A+general+and+fast+scoring+function+for+protein-ligand+interactions%3A+a+simplified+potential+approach&doi=10.1021%2Fjm980536j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A General and Fast Scoring Function for Protein-Ligand Interactions: A Simplified Potential Approach</span></div><div class="casAuthors">Muegge, Ingo; Martin, Yvonne C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A fast, simplified potential-based approach is presented that ests. the protein-ligand binding affinity based on the given 3D structure of a protein-ligand complex.  This general, knowledge-based approach exploits structural information of known protein-ligand complexes extd. from the Brookhaven Protein Data Bank and converts it into distance-dependent Helmholtz free interaction energies of protein-ligand atom pairs (potentials of mean force, PMF).  The definition of an appropriate ref. state and the introduction of a correction term accounting for the vol. taken by the ligand were found to be crucial for deriving the relevant interaction potentials that treat solvation and entropic contributions implicitly.  A significant correlation between exptl. binding affinities and computed score was found for sets of diverse protein-ligand complexes and for sets of different ligands bound to the same target.  For 77 protein-ligand complexes taken from the Brookhaven Protein Data Bank, the calcd. score showed a std. deviation from obsd. binding affinities of 1.8 log Ki units and an R2 value of 0.61.  The best results were obtained for the subset of 16 serine protease complexes with a std. deviation of 1.0 log Ki unit and an R2 value of 0.86.  A set of 33 inhibitors modeled into a crystal structure of HIV-1 protease yielded a std. deviation of 0.8 log Ki units from measured inhibition consts. and an R2 value of 0.74.  In contrast to empirical scoring functions that show similar or sometimes better correlation with obsd. binding affinities, our method does not involve deriving specific parameters that fit the obsd. binding affinities of protein-ligand complexes of a given training set.  We compared the performance of the PMF score, B.ovrddot.ohm's score (LUDI), and the SMOG score for eight different test sets of protein-ligand complexes.  It was found that for the majority of test sets the PMF score performs best.  The strength of the new approach presented here lies in its generality as no knowledge about measured binding affinities is needed to derive at. interaction potentials.  The use of the new scoring function in docking studies is outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1fvneEthHV7Vg90H21EOLACvtfcHk0ljdg0bw2yzQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXht1aksrk%253D&md5=92e0d327fa62b15e9d8033aaea5b9091</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm980536j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980536j%26sid%3Dliteratum%253Aachs%26aulast%3DMuegge%26aufirst%3DI.%26aulast%3DMartin%26aufirst%3DY.%2BC.%26atitle%3DA%2520general%2520and%2520fast%2520scoring%2520function%2520for%2520protein-ligand%2520interactions%253A%2520a%2520simplified%2520potential%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D791%26epage%3D804%26doi%3D10.1021%2Fjm980536j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Venkatachalam, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldfield, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, M.</span><span> </span><span class="NLM_article-title">LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/S1093-3263(02)00164-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1016%2FS1093-3263%2802%2900164-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=12479928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlWmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=289-307&author=C.+M.+Venkatachalamauthor=X.+Jiangauthor=T.+Oldfieldauthor=M.+Waldman&title=LigandFit%3A+a+novel+method+for+the+shape-directed+rapid+docking+of+ligands+to+protein+active+sites&doi=10.1016%2FS1093-3263%2802%2900164-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites</span></div><div class="casAuthors">Venkatachalam, C. M.; Jiang, X.; Oldfield, T.; Waldman, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">289-307</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">We present a new shape-based method, LigandFit, for accurately docking ligands into protein active sites.  The method employs a cavity detection algorithm for detecting invaginations in the protein as candidate active site regions.  A shape comparison filter is combined with a Monte Carlo conformational search for generating ligand poses consistent with the active site shape.  Candidate poses are minimized in the context of the active site using a grid-based method for evaluating protein-ligand interaction energies.  Errors arising from grid interpolation are dramatically reduced using a new non-linear interpolation scheme.  Results are presented for 19 diverse protein-ligand complexes.  The method appears quite promising, reproducing the x-ray structure ligand pose within an RMS of 2 Å in 14 out of the 19 complexes.  A high-throughput screening study applied to the thymidine kinase receptor is also presented in which LigandFit, when combined with LigScore, an internally developed scoring function, yields very good hit rates for a ligand pool seeded with known actives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqMpMvQ1uY5bVg90H21EOLACvtfcHk0ljdg0bw2yzQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlWmuro%253D&md5=0908c3b84f9eec3ffd05d30e938b9690</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS1093-3263%2802%2900164-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1093-3263%252802%252900164-X%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatachalam%26aufirst%3DC.%2BM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DOldfield%26aufirst%3DT.%26aulast%3DWaldman%26aufirst%3DM.%26atitle%3DLigandFit%253A%2520a%2520novel%2520method%2520for%2520the%2520shape-directed%2520rapid%2520docking%2520of%2520ligands%2520to%2520protein%2520active%2520sites%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2003%26volume%3D21%26spage%3D289%26epage%3D307%26doi%3D10.1016%2FS1093-3263%2802%2900164-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds(PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span><span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Lagorce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miteva, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villoutreix, B. O.</span><span> </span><span class="NLM_article-title">FAF-Drugs3: a web server for compound property calculation and chemical library design</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">W200</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1093/nar/gkv353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1093%2Fnar%2Fgkv353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=25883137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVymtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=W200-207&author=D.+Lagorceauthor=O.+Sperandioauthor=J.+B.+Baellauthor=M.+A.+Mitevaauthor=B.+O.+Villoutreix&title=FAF-Drugs3%3A+a+web+server+for+compound+property+calculation+and+chemical+library+design&doi=10.1093%2Fnar%2Fgkv353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">FAF-Drugs3: a web server for compound property calculation and chemical library design</span></div><div class="casAuthors">Lagorce, David; Sperandio, Olivier; Baell, Jonathan B.; Miteva, Maria A.; Villoutreix, Bruno O.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">W1</span>),
    <span class="NLM_cas:pages">W200-W207</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Drug attrition late in preclin. or clin. development is a serious economic problem in the field of drug discovery.  These problems can be linked, in part, to the quality of the compd. collections used during the hit generation stage and to the selection of compds. undergoing optimization.  Here, we present FAF-Drugs3, a web server that can be used for drug discovery and chem. biol. projects to help in prepg. compd. libraries and to assist decision-making during the hit selection/lead optimization phase.  Since it was first described in 2006, FAF-Drugs has been significantly modified.  The tool now applies an enhanced structure curation procedure, can filter or analyze mols. with user-defined or eight predefined physicochem. filters as well as with several simple ADMET (absorption, distribution, metab., excretion and toxicity) rules.  In addn., compds. can be filtered using an updated list of 154 hand-curated structural alerts while Pan Assay Interference compds. (PAINS) and other, generally unwanted groups are also investigated.  FAF-Drugs3 offers access to user-friendly html result pages and the possibility to download all computed data.  The server requires as input an SDF file of the compds.; it is open to all users and can be accessed without registration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYZ-hCUhlmrVg90H21EOLACvtfcHk0ljdg0bw2yzQDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVymtLfM&md5=5cf8888c489b90f392117ab065986214</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkv353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkv353%26sid%3Dliteratum%253Aachs%26aulast%3DLagorce%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DO.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DMiteva%26aufirst%3DM.%2BA.%26aulast%3DVilloutreix%26aufirst%3DB.%2BO.%26atitle%3DFAF-Drugs3%253A%2520a%2520web%2520server%2520for%2520compound%2520property%2520calculation%2520and%2520chemical%2520library%2520design%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2015%26volume%3D43%26spage%3DW200%26epage%3D207%26doi%3D10.1093%2Fnar%2Fgkv353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Tamzalit, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbieux, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plet, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedellec, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morisseau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortier, E.</span><span> </span><span class="NLM_article-title">IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">8565</span><span class="NLM_x">–</span> <span class="NLM_lpage">8570</span><span class="refDoi"> DOI: 10.1073/pnas.1405514111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;key=10.1073%2Fpnas.1405514111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=8565-8570&author=F.+Tamzalitauthor=I.+Barbieuxauthor=A.+Pletauthor=J.+Heimauthor=S.+Nedellecauthor=S.+Morisseauauthor=Y.+Jacquesauthor=E.+Mortier&title=IL-15.IL-15R%CE%B1+complex+shedding+following+trans-presentation+is+essential+for+the+survival+of+IL-15+responding+NK+and+T+cells&doi=10.1073%2Fpnas.1405514111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1405514111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1405514111%26sid%3Dliteratum%253Aachs%26aulast%3DTamzalit%26aufirst%3DF.%26aulast%3DBarbieux%26aufirst%3DI.%26aulast%3DPlet%26aufirst%3DA.%26aulast%3DHeim%26aufirst%3DJ.%26aulast%3DNedellec%26aufirst%3DS.%26aulast%3DMorisseau%26aufirst%3DS.%26aulast%3DJacques%26aufirst%3DY.%26aulast%3DMortier%26aufirst%3DE.%26atitle%3DIL-15.IL-15R%25CE%25B1%2520complex%2520shedding%2520following%2520trans-presentation%2520is%2520essential%2520for%2520the%2520survival%2520of%2520IL-15%2520responding%2520NK%2520and%2520T%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D8565%26epage%3D8570%26doi%3D10.1073%2Fpnas.1405514111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2B5I','PDB','2B5I'); return false;">PDB: 2B5I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z3Q','PDB','2Z3Q'); return false;">PDB: 2Z3Q</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00485">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80788"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00485">10.1021/acs.jmedchem.7b00485</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Docking scores of compounds selected from virtual screening, <i>in vitro</i> inhibitory effect of 5 compounds selected from virtual screening, dose–response curves of the effect of cytokines on 32Dβ cell proliferation, evaluation of the cytotoxicity of some compounds, SAR of <b>1</b> and its homologues <b>41</b>–<b>46</b>, SAR of <b>1</b> and its analogs <b>47</b>–<b>54</b> and <b>56</b>–<b>62</b>, dose–response curves of the effect of cytokines on p-Stat5 in NK-92 cells, synthesis and chemical characteristics of the halogenoalkylamides <b>6</b>–<b>39</b> and the azidoalkylamide <b>40</b>, and NMR spectra of the tested compounds <b>1</b> and <b>41</b>–<b>91</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_001.pdf">jm7b00485_si_001.pdf (15.44 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00485/suppl_file/jm7b00485_si_002.csv">jm7b00485_si_002.csv (6.14 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00485&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00485%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-14%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00485" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b43d8853d1ef","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
